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CHAPTER 1: INTRODUCTION
1.1 Autoimmune Regulator
1.1.1 APECED/APS-1
In the 1960s APECED was first described as a form of autoimmune Addison’s disease, a
pathology defined by adrenal insufficiency, by Blizzard and Kyle who found that these patients
present with circulating autoreactive antibodies against adrenal antigens (Blizzard and Kyle, 1963).
Over time, autoimmune Addison’s disease expanded and became associated with a number of
different symptoms such as chronic mucocutaneous candidiasis, diabetes, hypoparathyroidism,
and hypogonadism, and the category of polyglandular autoimmune syndrome was, eventually split
into three separate disorders: type 1, which we now know as autoimmune polyendocrinopathy
candidiasis ecotodermal dystrophy (APECED), type 2, or Schmidt’s syndrome, and type 3,
including patients with autoimmune thyroid disease, but do not present with Addison’s disease
(Neufeld et al., 1981).
APECED or autoimmune polyglandular syndrome type 1 (APS-1) is an autosomal
recessive autoimmune disorder occurring in approximately 1 out of 90,000-200,000 individuals in
most populations, but 10 times more frequently in Jewish, Sardinian, and Finnish populations
according to the NIH. Typically, APECED is diagnosed based on the presence of two out of three
major symptoms: chronic mucocutaneous candidiasis (chronic infections of the fungal pathogen,
Candida albicans), hypoparathyroidism, or adrenal insufficiency, of which chronic candidiasis is
the most prevalent (Husebye et al., 2009). Additionally, if a patient has a sibling who was
diagnosed with APECED, then only one of the symptoms is needed for diagnosis and, more
recently, due to the identification of the causal genetic lesions, testing for mutations in the gene,

2

autoimmune regulator (AIRE) (Finnish-German, 1997; Husebye et al., 2009; Nagamine et al.,
1997).
In most cases, the onset of APECED symptoms will occur at an early age with candidiasis
occurring just a few years after birth and, in most cases, primarily affects the mucosal tissues. This
is thought to be due to the production of high affinity, neutralizing, autoreactive antibodies against
cytokines such as IL-17 and IL-22, which are essential for controlling fungal pathogens (Kisand
et al., 2010; Meyer et al., 2016; Puel et al., 2010) and dysfunction in the Th17 compartment (Ng
et al., 2010). Other features of the disease result from direct immune activation against the
endocrine system leading to hormonal dysregulation and endocrine dysfunction. Overall, this
disease gives us valuable insight to the inner workings of immune tolerance and the mechanisms
involved in establishing immune tolerance and, as a result, a significant body of work describing
these mechanisms has been erected. Our goal in this dissertation is to add to that body and further
improve our understanding of immune regulation and tolerance.
1.1.2 T cell development and tolerance
T cells sit at the center of the adaptive immune system, orchestrating a myriad of
interactions and pathways involved in a proper, controlled immune response. These cells express
a collection of surface receptors, generated through DNA recombination, which allow them to
recognize, virtually, any protein antigen presented by the appropriate antigen presentation
machinery. Due to their importance, it is critical that these cells are, not only capable of being
activated by antigen presentation, but are able to discriminate between self and non-self. As a result,
the survival of the developing T cell is dependent upon the surface receptors it has created.
T cells arise from a self-renewing population of c-Kit and Sca-1 expressing, CD34 variable
hematopoietic stem cells (HSC) (Ikuta and Weissman, 1992; Osawa et al., 1996; Spangrude et al.,
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1988; Uchida and Weissman, 1992) that lose their ability to self-renew as they differentiate into
multipotent progenitors (MPP) (Ikuta and Weissman, 1992; Morrison and Weissman, 1994) and
begin to upregulate fms-like tyrosine kinase receptor-3 (Flt3) (Adolfsson et al., 2001) as they
develop into lymphoid-primed multipotent progenitors (LMPP). These cells retain the ability to
differentiate into most immune cell types, but are not able to significantly contribute erythroid and
megakaryocytic progeny compared to their Flt3 deficient counterparts (Adolfsson et al., 2005).
These cells will, eventually, further differentiate into common myeloid progenitors (CMP) or
common lymphoid progenitors (CLP), depending on the expression of IL-7 receptor (Akashi et al.,
2000; Kondo et al., 1997), the latter of which will lead to the development of T cells. In the late
2000s, CLPs, which were originally thought to have been a homogenous population, were subject
to novel (at the time) computational methods to determine developmentally regulated genes and it
was discovered that the CLP compartment was not homogeneous at all and that CLPs could be
divided into two groups based on Ly6d expression: one positive and one negative (Inlay et al.,
2009). Based on data generated from the reconstitution of sublethally irradiated mice, only the
Ly6d+ CLPs contributed significantly to the T cell pool whereas the Ly6d‒ fraction only
contributed to the development of B cells (Inlay et al., 2009). CLPs were then further analyzed
using single cell sequencing and divided into Rag-1low λ5‒, Rag-1high λ5‒, and Rag-1high λ5+
populations where Rag-1 experienced cells almost exclusively differentiated into B cells whereas
the Rag-1low λ5‒ population retained T cell and NK cell potential (Mansson et al., 2010). Of note,
the Rag-1 high cells showed higher surface expression of Ly6d, consistent with previous findings
(Mansson et al., 2010). To further differentiate into T cells, the CLPs need to migrate into the
thymus. To this end, the cells upregulate CCR9, a chemokine receptor for CCL25 (Uehara et al.,
2002; Zlotoff et al., 2010) expressed by thymic CD11c+ dendritic cells (DC) (Vicari et al., 1997)
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and thymic endothelial cells (Gossens et al., 2009), as well as CD43 (P-Selectin glycoprotein
ligand-1) which recognizes CD62P (P-selectin) (Rossi et al., 2005; Scimone et al., 2006), also
expressed by thymic epithelial cells (Gossens et al., 2009). Additionally, it has been observed that,
in the case of CCR9 deficiency, some cells still migrate to the thymus, leading to the discovery of
CCR7 as an additional signal to achieve migration (Misslitz et al., 2004; Zlotoff et al., 2010).
Once in the thymus, progenitor cells develop into double negative 1 cells (DN1) that
express neither CD4 nor CD8. These cells can be subdivided into two groups based on their
expression of c-Kit and further divided by their expression of CD24 (Porritt et al., 2004).
Additionally, as the cells transition into the thymus, there is a dependence Notch signaling to
maintain the T cell fate decision as deficiency can lead to differentiation into the B cell lineage
(Sambandam et al., 2005; Schmitt et al., 2004; Wilson et al., 2001). As the cells continue to
differentiate into DN2 and DN3, the myeloid potential is lost and, by the DN3 stage, the cell will
completely commit to T cell differentiation. During this time, the DN cells will begin to rearrange
the T cell receptor (TCR) through VDJ recombination starting with TCRβ for the conventional
αβT cells. The process of VDJ recombination depends on Rag-1 and Rag-2 that will begin by
joining a Dβ to a Jβ and subsequently joining the resulting construct to a Vβ and a pre-Tα with the
signaling CD3 components that may rescue the cells from cell death (von Boehmer and Fehling,
1997) or maturational arrest as a result of defective signaling from the pre-TCR complex
(Clements et al., 1998; Negishi et al., 1995; van Oers et al., 1996). Once developing T cells
recombine the TCRβ and begin to receive reduced amount of IL-7 signaling, they progress into
the double positive (DP) stage of development, expressing both CD4 and CD8, and upregulate
Bcl11b, which has been shown to be essential for commitment into the T cell lineage as well as
for positive selection (Albu et al., 2007; Ikawa et al., 2010). Upon differentiation into the DP stage,
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the T cells will undergo a second round of recombination to generate the α chain of the TCR
(Wilson et al., 1994) by joining a Vα and Jα segment. After rearrangement of the TCRα chain, the
T cell will have a fully constructed TCR that needs to be tested for functionality by means of
positive selection – selecting against T cells with non-functional TCRs where T cells must induce
survival mechanisms by reaching a TCR signaling threshold.
As it is known that self-peptides are required for positive selection, there seems to be a
paradox in which, while positive selection promotes survival of self-specific T cells, negative
selection would remove those same T cells. To untangle this paradox, several hypotheses regarding
the generation of antigens for positive selection. At first, it was proposed that the antigen pool
expressed by cortical thymic epithelial cells (cTECs) that are critical for antigen presentation
during positive selection, compared to other antigen presenting cells (APCs) in the thymic medulla
or anywhere else in the body (Marrack and Kappler, 1987). This model, dubbed the “altered
peptide” model, largely faded away as other APCs such as splenic DCs were shown to present the
same peptides as cTECs and that these peptides were capable of promoting positive selection in
developing T cells (Ebert et al., 2009; Hogquist et al., 1997; Marrack et al., 1993). In addition to
the altered peptide model, two additional models came to light: the avidity and affinity models.
The avidity model suggested that the quantity of peptide-MHC complexes presented by the cTECs
determined the selective capacity of the peptides themselves and this was supported by the finding
that peptides that efficiently activate mature T cells can support positive or negative selection
depending on the concentration (Ashton-Rickardt et al., 1994; Sebzda et al., 1994); however, it
was later observed that T cells selected this way had altered reactivity (Sebzda et al., 1996) and
the avidity model fell out of favor. Since then, there has been data supporting the affinity model,
the idea that the quality of the interaction between the peptide-MHC complex and TCR is
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responsible for the selection of the T cells (Alam et al., 1996; Lo et al., 2009; Moran et al., 2011),
though, in the mid-2000s, some data was presented to bring back the altered peptide model (Murata
et al., 2007). As of now, it seems that there is a combination of these models in that cTECS express
unique molecular machinery that allow for differential processing of peptides to generate a
completely unique pool of peptide-MHC molecules and that the affinity of the TCRs to these
unique molecules is what allows for positive selection (Klein et al., 2009).
After the developing T cell has established a working TCR, the cells must undergo negative
selection to remove the self-reactive TCRs from the mature repertoire. This has, classically, been
thought to occur exclusively in the thymic medulla, but there have been reports of negative
selection of DP thymocytes in the thymic cortex as well (Stritesky et al., 2013). In the medulla,
medullary thymic epithelial cells (mTECs) and thymic B cells (Yamano et al., 2015) generate
tissue specific antigens (TSAs), which are then presented either by the mTECs or thymic B cells
and DCs. Of note, mTECs do not efficiently present conventional MHC-II substrates and have
developed mechanisms for MHC-II loading to focus on self-antigens such as macroautophagy
(Aichinger et al., 2013; Atibalentja et al., 2009; Klein et al., 2001). Single positive (SP) thymocytes
that have migrated to the medulla and committed to either a CD4 or CD8 lineage that recognize
the self-peptide-MHC complexes presented during this stage are then negatively selected via cell
death or regulatory T cell conversion (Malchow et al., 2016). This process of negatively selecting
T cells that recognize self-peptides is essential for a healthy immune system as it establishes central
T cell tolerance, dysregulation of which leads to systemic autoimmune disorders such as APS1.Following negative selection in the medulla, the tolerized T cells can be released into the
periphery.
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1.1.3 Autoimmune regulator
AIRE, a gene located on chromosome 21q22.3, was first discovered as the gene responsible
for the autoimmune disorder, APECED (Finnish-German, 1997; Nagamine et al., 1997). The gene
encodes for a 58kDa protein that includes a caspase recruitment domain (CARD) on the Nterminus, a nuclear localization signal (NLS), a SAND (Sp100, Aire, NucP41/75, and deformed
epidermal autoregulatory factor-1 [DEAF-1]) domain, and two plant homeodomain (PHD) zinc
finger domains along with four LXXLL motifs. Based on the structure of the protein and the
domains contained within it, there seems to be a necessity for oligomerization and DNA interaction
for the function of the protein to remain intact as many of these domains are associated with DNA
binding and transcriptional regulation (Ferguson et al., 2008; Halonen et al., 2004; Heery et al.,
1997).
As it is clear that Aire is involved in the etiology of APECED, it is not unreasonable to
infer that Aire plays a critical role in the regulation and establishment of immune tolerance
(Finnish-German, 1997; Nagamine et al., 1997) and, based on its high level of expression in
mTECs, it is likely to function as a mechanism for T cell negative selection (Hubert et al., 2008;
Kishimoto and Sprent, 1997). Additionally, there had also been previous reports that a collection
of peripheral tissue antigens are ectopically expressed by mTECs (Kyewski and Klein, 2006). This
led to the hypothesis that Aire regulates the expression of PTAs by mTECs, thereby enforcing T
cell negative selection against self-antigens and, with the development of an Aire deficient mouse
model, this hypothesis could be tested (Ramsey et al., 2002). From my own experience, it seems
that the phenotype in Aire KO mice is somewhat mild as there does not seem to be any obvious
macroscopic defect; however, on a molecular level, multiorgan autoimmunity can be observed
(Anderson et al., 2002). In addition to multiorgan autoimmunity, it was also shown that Aire
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promotes the expression of PTAs in the thymus as Aire deficient mTECs showed a reduction in
the transcription of PTAs (Anderson et al., 2002). Similarly, Aire was found to be expressed in
thymic B cells that upregulate the expression of TSAs to assist in T cell negative selection
(Yamano et al., 2015). These B cells also seem to lose Aire expression and, as a result, TSA
expression with age (Cepeda et al., 2018), consistent with previous literature, which showed that
expression of Aire during the perinatal period is both necessary and sufficient to establish immune
tolerance and that the mechanisms controlled by Aire are largely dispensable in adults (Gueraude-Arellano et al., 2009).
Further interrogation of Aire function seems to indicate that the expression of PTAs was
not the only function for Aire in the thymus. Reports had been published showing that, even in
Aire sufficient systems, autoreactive T cells were still observed in the thymus as well as the
periphery (Taniguchi et al., 2012). In APECED patients, Treg suppressive capacity is also
diminished due to a reduction in the expression of forkhead box protein p3 (Foxp3) (Laakso et al.,
2010) and, in mice, Aire deficiency is associated with a slight reduction in thymic Tregs as well
as alterations in the development and repertoire of thymic Tregs (Anderson et al., 2005; Lei et al.,
2011; Malchow et al., 2013; Perry et al., 2014). In contrast, some groups have observed that, in an
Aire deficient model, Treg populations and functionality are retained (Anderson et al., 2005;
Kuroda et al., 2005; Liston et al., 2003). To determine the role of Aire in the development of Tregs,
one group performed follow up experiments and confirmed that Aire was essential for the
conversion of autoreactive T cells into Tregs, describing another path of T cell negative selection
and development of central T cell tolerance (Malchow et al., 2016).
In short, the classical model of Aire in mTECs states that the protein induces the expression
of TSAs to generate a self-antigen pool. Developing T cells use this antigen pool for negative
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selection and the cells that activate when presented a self-peptide-MHC molecule will undergo
either clonal deletion or Treg conversion (Figure 1.1). To add to this model, studies have reported
Aire acting to promoting immune tolerance in other manners such as inhibiting the generation of
IL-17 producing γδT cells through modulation of IL-7 (Fujikado et al., 2016) production and
regulation of thymocyte migration through its control of CCR4 and CCR7 (Laan et al., 2009).
Although there does seem to be quite a diversity in the downstream effects of Aire, it should be
noted that many of these findings were first observed in global knockout models or human patients,
therefore, more precise tools such as the recently generated Airefl/fl model (Dobes et al., 2018)
must be utilized as a confirmation method to determine the relative contribution of Aire expression
in individual cell types.
1.1.4 Role of Aire in the periphery
The majority of previous literature primarily focused on Aire expression in the thymus,
particularly in mTECs as it seemed to be the most consequential Aire expressing cell type in the
context of central T cell tolerance, however, several studies have shown the importance of Aire in
the peripheral stromal (Gardner et al., 2008; Lee et al., 2007) and hematopoietic (Gardner et al.,
2013; Heino et al., 2000; Kogawa et al., 2002; Poliani et al., 2010) populations.
The function of Aire in stromal cells was first explored to follow up on the observation that,
when CD8+ T cells specific for OVA (chicken ovalbumin) (OT-I) are transferred into iFABPtOVA mice, a mouse strain which expresses OVA as a self-antigen in intestinal epithelial cells
(IEC), the OT-I cells, expectedly, responded poorly in the spleen after mice were fed OVA, but,
surprisingly, responded strongly in the mesenteric lymph nodes (mLN), Peyer patches (PP), and
the extraintestinal lymph nodes (Lee et al., 2007). It was then found that, by blocking T cell exit
from the lymph nodes, there was no change in extraintestinal T cell proliferation in the lymph
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nodes, indicating that T cells were receiving OVA stimulation within the lymph nodes outside of
the intestines. This led to the discovery that, although CD8+ DCs present OVA in the mLN, lymph
node UEA-1+ stromal cells presented OVA, and other intestinal tissue associated antigens in the
extraintestinal lymph nodes, similar to mTECs (Lee et al., 2007). Follow up experiments showed
that lymph node stromal cells express Aire and that they promote deletion of OT-I T cells in
iFABP-tOVA mice, thus confirming that T cell negative selection occurs in the periphery and can
be mediated by non-hematopoietic cell types expressing Aire(Lee et al., 2007). These findings
were confirmed using an Aire driven Igrp-Gfp (AireAdig) mice in which a transgene with exon 2 of
Aire is replaced with GFP, including a 90kb upstream region and 85kb downstream region is
inserted into the genome (Gardner et al., 2008).
In the hematopoietic compartment, Aire was first discovered to be expressed by CD14+
monocytes as well as DCs (Kogawa et al., 2002). In monocytes, expression of Aire was associated
with upregulation of genes such as CCL22, CD25, ICAM-1, and RelB, which occur during DC
maturation; however, the major autoantigens associated with APECED were not found to be
significantly upregulated in these cell types as a result of Aire expression indicating that the role
of Aire in peripheral hematopoietic cells is different compared to thymic cells (Fergusson et al.,
2018; Sillanpaa et al., 2004). Following experiments showed some expression of TSAs in Aire
expressing DCs as well as expression of IL-10 suggesting that these DCs may play a role in
tolerance by inducing Tregs in the periphery (Poliani et al., 2010). An alternative method for the
induction of tolerance by extra thymic Aire expressing cells (eTAC) that show low expression of
DC specific markers such as CD11c and Zbtb46, is the expression of peptide-MHC complexes
that engage T cells and promote anergy through the absence of co-stimulation (Gardner et al.,
2013), though it is still uncertain the mechanism by which Aire regulates this pathway.

11

In the mid-2010s, it was discovered that, in the intestines, type 3 innate lymphoid cells
(ILC3) express MHC-II and present bacterial antigens to promote negative selection of CD4+ T
cells that are responsive to the microbiome (Hepworth et al., 2015; Hepworth et al., 2013). These
studies did not, however, determine whether the intestinal MHC-II+ ILC3 responsible for T cell
selection express Aire. A more recent found that ILC3-like cells in secondary lymphoid organs
that express high levels of MHC-II and co-stimulatory molecules also express Aire, although, in
the same study, it was observed that these ILC3-like cells are the only extrathymic cell that
expresses Aire protein (Yamano et al., 2019). Overall, these findings seem to challenge the body
of literature describing the expression and function of Aire in peripheral hematopoietic cells such
as DCs and additional experiments will need to be performed to confirm these results.
In non-lymphoid tissues such as the uterus (Soumya et al., 2016), ovaries (Jasti et al., 2012),
and testes (Radhakrishnan et al., 2016), Aire expression has been observed. It seems that in the
ovaries and testes, Aire expression has some control over fertility and T cell infiltration into the
reproductive organs and, in the uterus, it is responsible for maintaining homeostasis during
pregnancy; however, its function in these tissues is largely unknown as the majority of literature
is focused on its regulation of immune response in lymphoid organs. Additionally, its expression
was noted in the brain, but, similar to reproductive organs, its function has not been significantly
interrogated (Eldershaw et al., 2011).
1.1.5 Mechanisms of Aire function
In the nucleus, Aire localizes into punctate structures directly adjacent to nuclear speckles
(Su et al., 2008), subnuclear structures containing RNA splicing factors and other proteins
involved in pre-mRNA processing. These nuclear bodies do not contain chromatin or RNA
polymerase II (Pol-II) (Pitkanen et al., 2005) which means that they are not sites of active
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transcription, but it is possible that these nuclear bodies are acting to modify chromatin
organization or recruiting transcriptional complexes to specific regions of the genome(Tao et al.,
2006) and based on the chromosomal clustering of downstream genes (Johnnidis et al., 2005), the
protein likely has a more general function in the regulation of transcription.
In the context of transcriptional regulation, the first protein that was found to interact
directly with Aire was CREB-binding protein (CBP) (Pitkanen et al., 2000). Together, these
proteins regulate transcription of interferon-β (IFN-β) (Pitkanen et al., 2005) and may play a role
in the development of mTECs (Ferguson et al., 2008). After the discovery of CBP, more Aire
interacting partners were uncovered. Among these partners were protein inhibitor of activated
STAT1 (PIAS1) (Ilmarinen et al., 2008) and the DNA-dependent protein kinase (DNA-PK)
complex (Liiv et al., 2008) and interaction with these proteins suggests that Aire plays a role in
matrix-mediated transcriptional regulation (Peterson et al., 2008).
In an attempt to discover mechanisms by which Aire regulates such a large number of
genes, it was found that Aire is associated with a number of transcriptional programs. One of these
programs is the regulation of transcriptional elongation by Pol-II via positive transcriptional
elongation factor-b (P-TEFb).
Early studies associating human immunodeficiency virus (HIV) with c-myc and expression
of heat shock genes indicated that several mechanisms for regulating gene expression actually
regulated transcriptional elongation rather than initiation (Bentley and Groudine, 1986) and that
Pol-II pauses proximally to promoter regions as a method to rapidly modify transcriptional activity
(Rougvie and Lis, 1988, 1990). This transcriptional pausing is mediated by the pausing factors,
5,6‐dichloro‐1‐β‐D‐ribofuranosylbenzimidazole sensitivity inducing factor (DSIF), made up

13

of a heterodimeric complex of suppressor of Ty5 homolog (Spt5) and Spt4, and negative
elongation factor (NELF) that bind to Pol-II enriched for phosphorylation of serine 5 in the Cterminal domain heptapeptide repeats (Yamaguchi et al., 2013). Importantly, it was found that
Spt5 can function as an adaptor molecule to assist in targeting of transcriptional factors and
enzymes to the Pol-II complex (Lindstrom et al., 2003; Mayer et al., 2012; Pavri et al., 2010; Pei
and Shuman, 2002). To release Pol-II and promote transcriptional elongation, P-TEFb, a complex
of Cyclin T and Cyclin dependent kinase 9 (CDK9) (Peng et al., 1998), is released from 7SK small
nuclear RNA (snRNA) (Nguyen et al., 2001; Yang et al., 2001) and phosphorylates serine 2 in the
heptapeptide C-terminal repeats on Pol-II (Marshall et al., 1996) as well as NELF and DSIF which
then leads to dissociation of the inhibitory complex and converts DSIF into an elongation
promoting factor (Fujinaga et al., 2004; Liu et al., 2015; Wada et al., 1998; Yamada et al., 2006).
The association between Aire and this mechanism was first noticed when mTECs treated with IBET151, a small molecule bromodomain inhibitor that displaces bromodomain and extraterminal
domain (BET) proteins such as Brd4 from the chromatin, showed significant influence on their
transcriptional profiles (Yoshida et al., 2015). Based on these results, additional experiments were
performed to determine the connection between Aire and BET proteins. These experiments found
that Aire, through its CARD domain, interacts with Brd4 and that mutations disrupting this
interaction prevent the interaction between Aire and P-TEFb to promote the release of Pol-II at
Aire induced genes (Yoshida et al., 2015). These data tell us that Aire promotes transcription by
trafficking Brd4 to P-TEFb to release stalled Pol-II at promoter proximal regions on TSAs.
More recently, advanced genomic and biochemical techniques have been applied to
investigate the mechanism of Aire function. These experiments showed that there was strong
association between Aire and H3K27ac as well as H3K27me1, modifications which are indicative
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of super-enhancers, stretches of DNA binding a high density of transcription factors (Hnisz et al.,
2013; Whyte et al., 2013), and active transcription (Ferrari et al., 2014; Hnisz et al., 2013), but
very little association with H3K27me3, a modification associated with downregulation of nearby
genes (Bansal et al., 2017; Cui et al., 2009; Org et al., 2009). At these super-enhancers, Aire and
its critical interacting partners, topoisomerase 1 (TOP1) and topoisomerase 2 (TOP2), promote
chromatin availability and induce mTEC gene transcription. The importance of this mechanism is
highlighted by the fact that treatment of mice with the etoposide, topotecan, to interrupt the
interaction between Aire and TOP1/2 leads to dysfunctional negative selection of autoreactive T
cells; however did not disrupt Aire independent negative selection (Bansal et al., 2017). These data
seem to provide a second function of Aire independent of its regulation of transcriptional
elongation via P-TEFb and, instead, acts as an epigenetic regulator to increase chromatin
availability.
Previous studies have shown that, in hypothetical functional networks, Aire acts in
cooperation with the switch/sucrose non-fermentable (SWI/SNF) complex, which is known to
assist in chromatin remodeling (Giraud et al., 2014). Based on this information, experiments were
performed to test the relationship between Aire and Brg1, a known transcriptional activator and
catalytic subunit of SWI/SNF. This revealed that the accessibility of TSAs is promoted by Brg1
whereas Aire acts as a repressor to restrict chromatin availability, in contrast to the previous
findings that Aire acts as a promoter of chromatin availability (Hnisz et al., 2013; Koh et al., 2018).
It was also observed that Brg1 deficiency, similar to Aire deficiency, leads to multiorgan
autoimmunity due to the activation of autoreactive T cells, suggesting that Brg1 is essential for T
cell negative selection (Koh et al., 2018). It was observed that Aire restricts transcriptional
amplitude to, potentially, prevent the resulting proteins from perturbing physiological processes.
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Overall, it seems that Aire acts as a repressor and promoter of chromatin availability as well as an
activator of transcriptional elongation and that such an important regulatory protein must, itself,
be tightly regulated.
1.1.6 Regulation of Aire
The regulation of a gene/protein can occur transcriptionally by modifying the initiation or
continuation of transcription, translationally, and post-translationally by adding or removing
functional groups to the protein altering the protein function. To regulate transcriptional initiation
of Aire in the thymus, few mechanisms have been characterized; however, that the transcription
factor, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) is essential (Chin
et al., 2003; Haljasorg et al., 2015; Heino et al., 2000) and likely binds to conserved noncoding
sequence 1 (CNS1) upstream of Aire (Haljasorg et al., 2015), though this mechanism is not
sufficient to activate Aire expression on its own. In the thymus, this signaling can be initiated by
either receptor activator of NF-κB ligand (RANKL) signaling through RANK in mTECs (Rossi
et al., 2007) or through CD40 engagement of CD40L expressed by developing thymocytes in
thymic B cells (Yamano et al., 2015). In addition to NF-kB, several other transcription factors such
as the interferon regulatory factor (Irf) 4, Irf8, T-box transcription factor 21 (Tbx21), and
transcription factor 7 (Tcf7) have been implicated in the regulation of Aire expression (Herzig et
al., 2017). Interestingly, it has also been found that CCCTC-binding factor (CTCF), a protein
which regulates chromatin looping, is also responsible for regulating Aire and that removal of
CTCF from the Aire locus is required for transcription (Herzig et al., 2017). According to the
UCSC genome browser, there is also a consensus binding site for transcription factor PU.1 (Spi1)
and early B cell factor 1 (Ebf1) upstream of the Aire gene; however it is unclear whether these
proteins are involved in regulating the gene (Figure 1.2).
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There are very few studies describing the regulation of translation for Aire mRNA;
however, a recent study showed that ineffective splicing of intron 2 by Jumonji Domain Containing
6 (JMJD6), a member of the JmjC-domain containing proteins, which have been implicated in a
demethylation of histones by means of an oxidative mechanism involving iron and alphaketogluterate (Klose et al., 2006), improves Aire translation by promoting splicing of intron 2
resulting in a premature stop codon (Yanagihara et al., 2015). Although, currently, the substrate
for JMJD6 in the context of Aire intron retention is currently unknown, one candidate could be
U2AF65, a protein associated with intron splicing(Webby et al., 2009). This may not be the only
regulation of intron splicing for Aire since it is a protein activated by NF-kB, its translation may
be temporally regulated, though this regulation for Aire still needs to be tested (Hao and Baltimore,
2013; Werner et al., 2008).
The NLS of Aire has been suggested to actually be two separate NLSs, one from lysine
110 to lysine 130 and another between lysines 157 to 159 (Saltis et al., 2008). Lysine residues in
the NLS are particularly important as, in some proteins, acetylation of the residues improves
nuclear localization whereas, in others, nuclear localization is reduced, potentially as a result of
changing interaction with nuclear import proteins. For Aire, it seems as though acetylation of the
NLS by CBP leads to nuclear retention and regulatory function and that Aire can be regulated by
histone deacetylase (HDAC) 1 and HDAC2 (Incani et al., 2014). In addition to acetylation
phosphorylation by DNA-PK at threonine 69 and serine 156 (Liiv et al., 2008), the former being a
residue in the CARD domain, which is important for interaction with CBP (Yoshida et al., 2015).
These findings suggest that phosphorylation by DNA-PK in the CARD domain leads to interaction
with CBP and subsequent acetylation of lysine residues in the NLS, thus improving nuclear
retention and transcriptional regulation.
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Figure 1.1: UCSC genome browser tracks for transcription factor binding to AIRE
promoter. Both RelA and CTCF have consensus sequences in the Aire promoter. Additionally,
Spi1 (PU.1) has a consensus sequence and Ebf1 has a binding site; however, the functional
relevance is yet to be determined.
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1.2 B Cells and Antibodies
1.2.1 B cells
Early B cell research first began through the discovery of antibodies by Tiselius and Kabat
who ran electrophoretic analysis on serum (Tiselius and Kabat, 1938). Eventually, plasma cells,
the cells which produce the antibodies, were discovered (Fagraeus, 1948) and two competing
hypotheses of antibody formation developed. The first hypothesis was Niels Jerne’s natural
selection theory, which stipulated that antibodies were merely carriers of antigen to a cell that was
then able to replicate that antibody (Jerne, 1955). The second hypothesis was Sir Macfarlane
Burnet’s clonal selection theory, in which each antibody was made from a different cell specific
for a unique antigen (Burnet, 1976). The latter theory eventually gained prominence as data came
out to show that, when single cells are simultaneously stimulated with two different antigens, they
could only form antibody to one or the other, not both, meaning each individual cell only had the
capacity to generate antibody to a single antigen (Nossal, 1959). Eventually, B cells were defined
when studying the bursal lymphoid system in chickens (Cooper et al., 1965) and, as they were first
discovered in the bursa, were subsequently named “B cells”, though, at this time, it was still
uncertain what the function of these cells was.
Not long after the discovery of B cells, there became a link between them and antibody
production when it was discovered that surface immunoglobulin (Ig) could be used as a marker
for both normal and leukemic B cells (Coombs et al., 1969; Froland et al., 1971). Eventually,
monoclonal antibodies were developed, and we were able to characterize the cells with
significantly more detail and, to standardize the nomenclature, each monoclonal antibody was
given a designation as a cluster of differentiation (CD).
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Once the nomenclature was standardized and laboratories had the capability of
characterizing cells with greater precision, it was found that B cells were not a homogenous cell
type and that they came in many different forms with different functions. In the 1980s, B-1 cells,
a unique subset of B cells was first described as a CD5+ population (Hayakawa et al., 1983). These
B cells were then further subdivided into a CD5+(B-1a) and CD5‒(B-1b) populations and it was
discovered that these cells develop separately from B-2 B cells; however, their origin has been a
point of contention (Dorshkind and Montecino-Rodriguez, 2007), though we, currently, believe
that the majority of these cells arise from the fetal liver with very few coming from the adult bone
marrow (Montecino-Rodriguez et al., 2006). The B-1a and B-1b cell types were then functionally
defined and it was found that B-1a cells make natural antibodies, antibodies which are
predominantly IgM and do not require immunization for production, whereas B-1b cells mediate
adaptive antibody responses to polysaccharides and other T cell independent antigens (Haas et al.,
2005). Although B cells have been known to produce antibodies, these cells have functions that
help maintain tissue homeostasis through the production of cytokines such as progesterone induced
blocking factor during pregnancy in the case of B-1 B cells (Huang et al., 2017) and IL-10 in the
case of regulatory B cells (B10 or Breg) (Tedder, 2015).
In the spleen, a region surrounding the splenic follicles, separating the white pulp and red
pulp, known as the marginal zone (MZ) houses a group of MZ B cells, macrophages, and reticular
cells. In mice, MZ B cells are a lineage, separate from follicular B cells or B-1 B cells, which can
be characterized as IgMhiIgDloCD21hiCD23‒CD1dhi and express polyreactive, non-mutated B cell
receptors (BCR) (Cerutti et al., 2013). Additionally, mouse MZ B cells express high levels of toll
like receptors (TLR) (Rubtsov et al., 2008; Treml et al., 2007) that, when coupled with BCR
signaling, induces production of low affinity antibodies (Pone et al., 2012). In humans, MZ B cells
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are IgMhiIgDloCD1c+CD21hiCD23‒CD27+and occupy subcapsular regions of lymph nodes and
other lymphoid tissues (Dono et al., 2000; Puga et al., 2011; Tierens et al., 1999). In contrast to
mouse MZ B cells, they express both CD27 and mutated BCRs indicating that they have
experienced germinal center (GC) reactions prior to undergoing class switch recombination (CSR)
and that they may be equivalent to memory B cells (Dunn-Walters et al., 1995; Klein et al., 1998;
Seifert and Kuppers, 2009; Tierens et al., 1999), though they have a distinct repertoire and are not
as dependent on T cell help compared to canonical memory B cells (Berkowska et al., 2011; Weller
et al., 2001; Weller et al., 2008). Functionally, since MZ B cells are located in between the B cell
follicle rich white pulp and the blood-filled red pulp making them ideal for responding to blood
antigens. Additionally, due to their high levels of CD21, they are capable of efficiently capturing
complement (Guinamard et al., 2000) and, since they have elevated levels of Blimp-1 as well as a
pre-activated state, they are capable of rapidly dividing into plasmablasts (Martin et al., 2001;
Sintes et al., 2017).
The B cells that typically respond to T dependent antibody responses and generate much
of the high affinity antibodies in the body are follicular B cells. These cells have the most diverse
BCR repertoire and can undergo further diversification once activated. Once they mature, they can
either be found circulating in the blood and lymph or they can be found in established B cell
follicles in secondary lymphoid organs. Those that have encountered antigen in these follicles can
then be activated by nearby T cells. Alternatively, though not as common, follicular B cells can
home to the bone marrow to form perivascular sinusoids that assist in response to blood pathogens
(Cariappa et al., 2007; Cariappa et al., 2005).
Over the past several decades, since the discovery of antibodies, the study of B cells has
been one of the most productive avenues of research resulting in significant growth of our
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understanding of the immune system as well as improving therapies and clinical outcomes. We
have learned the origin of antibodies and how they help the body clear pathogens. Additionally,
we have discovered numerous different cell types and characterized their functions as well as
consequences of dysfunction. Continued research will help us understand, not just B cell biology,
but allow us to create better treatments for disease and create more effective methods for
vaccination.
1.2.2 B cell development and tolerance
In the bone marrow, the differentiation of B cells begins similarly to that of T cells.
Hematopoietic stem cells differentiate and, eventually, become c-Kit and IL-7R CLPs. As the
CLPs differentiate, they become restricted to the B cell lineage with the upregulation of B220 in
the early pre-pro-B cell stage without CD19, the molecule common to all later B cell stages, or
BCR rearrangement(Allman et al., 1999; Li et al., 1996; Ogawa et al., 2000). As these cells
continue to differentiate into pro-B cells, that begin to upregulate CD19 and CD40, IL-7, signaling
through Janus kinases, JAK1 and JAK3, and signal transducers and activators of transcription
(STAT), initiates numerous processes critical for B cell commitment such as proliferation
(Kittipatarin et al., 2006; Morrow et al., 1992), survival (Li et al., 2004; Lu et al., 1999), and IgH
recombination (Chowdhury and Sen, 2003; Corcoran et al., 1998); however, although IL-7
signaling is critical for the development of B cells in mice, generation of B cells in humans is not
dependent of IL-7 or IL-7R as humans with mutations in IL-7Rα and downstream signaling
develop a lack of T cells, but have normal numbers of NK and B cells (Macchi et al., 1995; Puel
et al., 1998; Russell et al., 1995).
Recombination of the BCR is one of the most important developmental checkpoints for B
cell maturation. The VDJ recombination mechanism can be divided into two separate stages:
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cleavage and repair – the genomic DNA sequences are broken and recombined through repair
mechanisms. To begin cleavage, the recombination activating (Rag) 1 and Rag2 recombinases
search for a recombination signal sequence (RSS) following the 12/23 rule, in which a heptamer
and nonamer are separated by either 12 or 23 nucleotides (Schatz and Swanson, 2011). The
recombination event begins with a nick formed on the 5’ end of the RSS to form a 3’ OH group
that then attacks a phosphate group on the opposing strand to form a double stranded break
containing a hairpin coding region and a blunt end signaling region (McBlane et al., 1995; van
Gent et al., 1996). The hairpin coding ends are then opened by Artemis and DNA-PK prior to
being processed via non-homologous end joining (NHEJ) before being joined (Lieber, 2010).
Once the heavy chain is recombined during the pro-B cell phase, a surrogate light chain,
λ5 and VpreB, combines with the heavy chain to form a pre-BCR that, necessarily, recognizes
self-antigen, and the cell differentiates into a large pre-B cell and is subjected to its first round of
positive selection, in which cells without a functioning pre-BCR either continue recombination on
the other chromosome or halt their development, as patients who cannot make functional surrogate
light chain develop agammaglobulinemia due to a complete block of differentiation in the B cell
compartment (Minegishi et al., 1998). In contrast, cells with a pre-BCR that is capable of
transmitting signal into the cell will rapidly proliferate (Winkler and Martensson, 2018),
specifically, the cells will undergo approximately five to six cell divisions (Decker et al., 1991). It
is possible that this proliferative phase assists in allelic exclusion – prevention of recombination
in the second chromosome – as it has been observed that Rag2 protein is destabilized during S
phase of proliferative cells (Grawunder et al., 1995; Lin and Desiderio, 1994). Ultimately,
signaling from the pre-BCR will lead to activation of SLP-65 that then downregulates PI3K
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activity, exit from the proliferative phase, and allows the cell to differentiate into a small-pre-B
cell (Jumaa et al., 1999; Koretzky et al., 2006; Pappu et al., 1999).
In addition to bringing the developing B cells out of the proliferative phase, SLP65
regulation of PI3K is a critical differentiation stage. PI3K is a powerful inhibitor of the FoxO
transcription factors, which are key activators of Rag1 and Rag2 (Amin and Schlissel, 2008;
Herzog et al., 2008). As Rag1 and Rag2 are reactivated and proliferation is halted, the light chain
is recombined to generate the complete, conventional BCR, which replaces the pre-BCR, signaling
is required for the maintenance of mature B cells since deletion of the BCR results in loss of mature
B cells (Lam et al., 1997). Once the B cell expresses a mature BCR on the cell surface, they become
classified as immature B cells.
Due to the variable nature of VDJ recombination, a mature B cell pool with the capacity to
recognize a staggering, almost unlimited number of antigens can be generated and, therefore, must
undergo a second round of selection to, not only be certain that the BCR is operational, but also
that self-reactive B cells are not released into the periphery as previous reports show that the
majority of early immature B cells express BCRs with self-reactivity (Wardemann et al., 2003).
One mechanism for ensuring self-tolerance is by halting development at the immature B cell stage.
It has been shown that when self-reactive B cells are treated with self-antigens, continued B cell
development is completely halted (Nemazee and Burki, 1989), though, should the recombination
take too much time, the cells may undergo cell death. A second mechanism for establishing B cell
tolerance is through receptor editing. B cells with receptors that strongly interact with multivalent
self-antigen will reactivate Rag1 and Rag2 to continue rearranging the VDJ region for the
opportunity to generate a new antigen binding region that is not self-reactive (Gay et al., 1993;
Koralov et al., 2006). Finally, strong activation of immature B cells to self-antigens may render
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the B cells inert, a state known as anergy (Goodnow et al., 1988). Generally, these B cells remain
inert; however, recently, it has been shown that stimulation with high-density foreign antigen can
lead to hypermutation and affinity maturation away from self-reactivity, a phenomenon termed
“antibody redemption” (Burnett et al., 2018). Though, as mentioned, there are several mechanisms
for the tolerization of B cells and removal of autoreactive cells from the repertoire, a significant
population of B cells in the thymus expressing self-reactive BCRs indicating that there are
mechanisms for B cells to escape tolerance(Rother et al., 2016). These autoreactive B cells are
thought to assist in the negative selection of T cells through the presentation of self-antigens to
thymocytes. Additionally, B cell precursors, whose development is influenced by microbial
colonization, have been discovered in the intestines, though it is unclear how the antigen pool on
which these cells are selected is generated (Wesemann et al., 2013). Once the cells are tolerized,
they leave the bone marrow as transitional B cells and home to their respective compartments.
Although most B cells develop in the way mentioned above, B-1 B cells, generally, follow
a separate path compared to conventional B cells. These cells are the predominant B cell formed
in the fetus and arise from the fetal liver rather than adult bone marrow(Hardy and Hayakawa,
1991). Importantly, during VDJ recombination in B-1 B cell precursors, there is an increase in
expression of terminal deoxynucleotidyl transferase (TdT), not seen in adult bone marrow
precursors, which allows for additional diversification in the BCR repertoire (Desiderio et al.,
1984). Although it is clear that these cells arise from the fetal liver, there is data to indicate that
they can potentially be replenished by the bone marrow in adults (Gu et al., 1990; Tornberg and
Holmberg, 1995); however, transgenic BCR mice have shown that B-1 and B-2 B cells have
distinct receptors where the receptor for one type cannot generate cells of the other type (Lam and
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Rajewsky, 1999). When fully functional, these cells will reside in the peritoneum and, when
activated, migrate to the spleen to differentiate into antibody secreting cells (Baumgarth, 2011).
1.2.3 B cell activation
Activation of B cells can occur in either a T dependent or T independent manner, though
in most cases, BCR signaling is critical. The BCR is a membrane bound antibody generated by the
B cell to recognize cognate antigen. Once these receptors recognize their respective antigens, the
receptors are crosslinked leading to activation of Src family kinases like Lyn as well as activation
of the kinase, Syk(Takata et al., 1994); however, there is an argument to be made that BCR does
not crosslink when activated, but is crosslinked when inactive and this interaction is dissociated
during activation (Klasener et al., 2014; Volkmann et al., 2016). Following phosphorylation of the
key kinases downstream of the BCR, additional signaling molecules such as phosphatidylinositol3’ kinase (PI3K), which phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2) to generate
phosphatidylinositol 3,4,5-triphosphate (PIP3), NF-kB, and mitogen activated protein kinase
(MAPK). These signals lead to B cell proliferation and effector function whereas inhibitory signals
such as FcγRIIB and SH2 domain-containing inositol 5′-phosphatase repress overstimulation
through the BCR, which can prove fatal for the cell.
In the case of T dependent activation, B cells that have captured antigen with their BCRs
internalize the antigen, processes them, and presents them as peptide-MHC-II. During this time,
Epstein-Barr virus-induced G-protein coupled receptor 2 (Ebi2) and CCR7, a chemokine receptor
for CCL19 and CCL21, home the activated B cells to the T zone in the lymphoid tissues (Gatto et
al., 2009; Gatto et al., 2011; Kelly et al., 2011; Pereira et al., 2009) where the peptide-MHC-II
expressed by the B cell will be presented to the T cell and engage the TCR. Should the B cell have
a relatively low affinity receptor, intercellular adhesion molecule (ICAM) 1 and ICAM2 can
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interact with Lymphocyte function-associated antigen 1 (LFA1) to improve the interaction
between the B and T cells (Zaretsky et al., 2017). The T cells provide B cell help by expressing
CD40L, a member of the TNF family ligands, which engages the CD40 expressed by B cells
leading to additional NF-kB signaling and continued activation of the B cells to allow additional
antibody diversification mechanisms to activate such as somatic hypermutation (SHM) and class
switch recombination (CSR) or undergo differentiation into plasma cells or memory cells.
For the most part, the mechanisms of T independent activation are employed by B-1 cells
and MZ B cells that respond to two distinct classes of signals: one being cytokine activation or
danger associated molecular pattern (DAMP) activation, which signal through cytokine receptors
or pattern recognition receptors respectively, and the second being stimulation through the BCR
or complement. B-1 B cells act as members of the innate immune system and help with cellular
signaling events as well as antibody production. When peritoneal B cells are activated, they
migrate into the mLN (Fagarasan et al., 2000; Okamoto et al., 1992) where they will undergo
proliferation and differentiation into plasma cells. The activation of these cells is critical for
generation of IgA against bacteria at mucosal surfaces (Macpherson et al., 2000) making them
crucial for the interactions between the host and microbiome. MZ B cells play a critical role in Tindependent responses to type two antigens (Guinamard et al., 2000). C3 deficiency or deficiency
in complement receptors on MZ B cells diminishes their ability to bind antigen and their preactivated state makes them more sensitive to stimulation (Sintes et al., 2017). Additionally, a
population of B helper neutrophils were discovered in the spleen and express B-cell activating
factor (BAFF), A proliferation-inducing ligand (APRIL), and IL-21, which assist MZ B cells in
differentiating into IgM, IgG, or IgA producing plasma cells independently of CD40 engagement
(Puga et al., 2011).
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Based on studies of T dependent B cell activation, it would seem that B cells are subservient
to T cells and that they depend on T cells for their function. This, however, is not the case as there
are numerous mechanisms by which B cells can be activated independently of T cells.
Evolutionarily, it is likely that these T independent mechanisms preceded the T dependent
mechanisms as they are methods to generate quick antibody and cytokine responses to
environmental stimuli. Further research in this area may give us a better understanding of the
evolution of B cells and the mechanisms regulating their function.
1.2.4 Antibody functions
As previously mentioned, antibodies were first discovered in the late 1930s through
electrophoresis of serum (Tiselius and Kabat, 1938); however, the functions of antibodies and their
physiological effects have been known. In the early 1700s, Lady Mary Wortley Montagu, Emanuel
Timoni and James Pylarini first attempted to inoculate small amounts of infectious smallpox
material into healthy subjects to prevent disease. Later, in 1798, Edward Jenner used cowpox as a
means of achieving a similar result, only, his treatment was significantly safer compared to that of
previous attempts at vaccination due to his use of cowpox (Weiss and Esparza, 2015). Following
the success of Jenner, in the late 1800s, the first reference to antibodies was made when Emil von
Behring when he showed that transfer of serum from animals immunized against diphtheria could
cure animals with the disease, a technique we now call, “passive immunization” (Kaufmann, 2017).
Since then, our understanding of antibody function has advanced considerably and, with it, our
ability to take advantage of these functions to produce more favorable clinical outcomes.
At the time of writing this dissertation, a novel coronavirus, SARS-CoV2, has ravaged the
world. To alleviate the situation, groups have been searching for potential therapies to prevent the
spread of disease, one of which is the discovery, purification, and transfer of neutralizing
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antibodies to patients at risk for contracting the virus (Ju et al., 2020; Liu et al., 2020; Rogers et
al., 2020). Neutralizing antibodies are typically thought to interfere with ligand/receptor
interactions, thus preventing pathogen attachment to the host; however, in reality, there are
multiple mechanisms by which antibodies can provide neutralizing function. These mechanisms
can be categorized as either pre-attachment neutralization in which the antibody interferes with the
functioning of the pathogen by agglutination/aggregation (Brioen et al., 1983; Phalipon et al.,
2002; Thomas et al., 1986), immobilization (separately of agglutination)(Bishop et al., 2010;
Campodonico et al., 2010), or by impacting cellular functions (LaRocca et al., 2009; McClelland
et al., 2010; Pachl et al., 2006; Watanabe and Blobel, 1989). The second classification for
neutralization mechanisms is post-attachment refers to the classical definition of neutralization,
interference of pathogen binding and invasion. Finally, neutralizing antibodies can act via postattachment mechanisms that inhibit pathogens after they have attached to their target cells,
including inhibition of intracellular processes as well as viral release. In light of the alternative
mechanisms for neutralization, a more accurate definition of neutralizing antibodies would be
those that are capable of modifying the ability of a pathogen to infect the host (Corthesy et al.,
2006; Hughey et al., 1995; Maciejewski et al., 1995; Mallery et al., 2010; Thouvenin et al., 2001;
Varghese et al., 2004).
In addition to neutralization, antibodies, particularly IgG and IgM, have the ability to
activate the complement cascade through the classical complement pathway. In this pathway,
antibody-antigen complexes bind to C1q via the antibody Fc region, thus activating C1r and C1s
serine proteases that cleave C2 and C4 (Dunkelberger and Song, 2010). The products of this
cleavage form a complex, C4bC2a, also known as the C3 convertase, which is capable of cleaving
C3 into C3a and C3b to assist in the construction of the membrane attack complex (Dunkelberger
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and Song, 2010). This mechanism is particularly important as it can assist in numerous innate
immune functions such as promoting inflammation, opsonization, cytotoxicity, and antigen
presentation. It is important to note that functions of antibodies are not mutually exclusive and that
antibodies, which are capable of fixing complement, are also capable of performing the other
functions mentioned here as well.
The third major function of antibodies is the activation of Fc receptors. These receptors
recognize the Fc regions of antibodies and are, typically, isotype specific and, although they tend
to have many different functions depending on environmental context, two major pathways stand
out as particularly important: antibody dependent cellular cytotoxicity (ADCC) and phagocytosis.
ADCC was first discovered in the context of HSV1 infection (Shore et al., 1974) and occurs when
an antibody bound to an infected cell interacts with Fc receptors on an effector cells, such as NK
cells and cytotoxic T cells, leading to the activation of cytotoxic effector pathways and death of
the target cell. In recent years, researchers have taken advantage of this mechanism to generate
monoclonal antibodies such as Herceptin and Rituximab, which target and kill cancer cells (Clynes
et al., 2000; Petricevic et al., 2013; Weiner, 2010). In contrast to ADCC, phagocytosis acts, not on
infected cell, but on, antibody coated material (Flannagan et al., 2012). Phagocytes such as
macrophage, DCs, and neutrophils bind the antibodies, distributed around the entire surface of the
molecule, via Fc receptors and engulf the material (Griffin et al., 1975; Griffin et al., 1976),
forming a phagosome. The phagosome then fuses with a lysosome to form a phagolysosome that
digests whatever material was phagocytosed. Molecules such as peptides resulting from the
enzymatic degradation within the phagolysosome can be used as activating signals for T cells when
presented on MHC-II or cross presented on MHC-I.
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Since the discovery of the physiological consequences of antibodies in the early 1700s, and
since the first discovery of the protein complexes, themselves, in the 1930s, significant progress
has been made in characterizing the function of antibodies. However, although we have a sense of
their functions in general, we have yet to fully characterize the specific functions of all the different
isotypes. Future research will continue to elucidate these functions and mechanisms as well as
further utilizing them to treat disease.
1.2.5 Antibodies and Autoimmunity
In the 1950s, autoreactive antibodies were first discovered when an observation was made
that a mysterious serum factor with the characteristics of IgG in patients with systemic lupus
erythematosus (SLE) reacted specifically with nuclei and was able to fix complement (Miescher
and Fauconnet, 1954; Robbins et al., 1957). Today, it is increasingly clear that autoreactive
antibodies play a critical role in the pathogenesis of numerous autoimmune diseases by mediating
both tissue injury and inflammation (Mackay, 2010), thus a significant body of literature pertaining
to the generation of autoreactive antibodies has been generated over the past several decades.
As previously mentioned, during B cell development, precautions are in place to prevent
autoreactivity such as receptor editing, anergy, cell death, and developmental arrest; however,
autoreactive B cells are not uncommon in healthy individuals indicating that these mechanisms
that establish central tolerance are not sufficient to completely tolerize the B cell repertoire.
Although it has been well-established that many autoreactive B cells belong to the B-1 and MZ
subclasses (Batten et al., 2000; Pao et al., 2007; Thien et al., 2004), it has been observed that
autoreactive antibodies in systemic autoimmune disease are class switched and harbor large
numbers of somatic mutations, indicating that they have likely undergone T dependent antibody
diversification (Diamond and Scharff, 1984; Mietzner et al., 2008; Schroder et al., 1996;
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Wellmann et al., 2005). Additionally, previous findings have shown defects in early B cell
tolerance mechanisms in patients with autoimmune disease (Samuels et al., 2005; Yurasov et al.,
2005); however, more recent data suggests that autoreactive memory antibodies arise from nonautoreactive, but polyreactive precursors (Mietzner et al., 2008). These data show that patients
with autoimmune disorders suffer from defects in tolerance mechanisms, but this deficiency does
not necessarily lead to the generation of pathogenic, autoreactive antibodies and that mechanisms
of regulating antibody diversification play a critical role. Accordingly, should autoreactive T cells
escape the thymus, B cell diversification would be directed toward autoreactivity in T dependent
responses.
Interestingly, many antigens targeted by autoreactive antibodies, such as DNA, RNA, and
oxidized phospholipids, are also ligands for pattern recognition receptors (PRRs) including TLRs
and Nod like receptors (NLRs) suggesting a role for these receptors in the generation of these
antibodies and the breakdown of tolerance (Horkko et al., 1997; Imai et al., 2008; Zhang et al.,
2009; Zhou et al., 2011). In support of this theory, studies have shown that deficiency in TLR7
and TLR9 as well as MyD88, the adaptor molecule for most TLR-associated signals is protective,
at least in part, against the development of anti-nuclear antibodies in SLE models (Christensen et
al., 2006; Ehlers et al., 2006; Groom et al., 2007; Hua et al., 2014). These receptors, when activated
by oxidized mitochondrial DNA in DCs can also induce pathogenic T dependent antibody
production due to the activation of CD4 T cells that help B cells through IL10 and succinate
(Caielli et al., 2019). Additionally, in T independent mechanisms, BCR signaling is synergistic
with TLR recognition of nuclear antigens, therefore, self-antigens capable of activating these
pathways can induce B cell activation (Chaturvedi et al., 2008; Lau et al., 2005; Viglianti et al.,
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2003) and, in developing B cells, dysregulate the establishment of central tolerance (Aranburu et
al., 2010; Azulay-Debby et al., 2007; Giltiay et al., 2013).
Taken together, these findings show that autoreactive antibodies, which carry with them
the potential to initiate immune responses in the same way as antibodies against foreign bodies,
can be generated through both T dependent and T independent mechanisms. Generally, it has been
thought that these antibodies are a result of dysfunctional central and peripheral B cell tolerance;
however, recent work has shown that autoreactivity can also arise from non-autoreactive B cells,
putting into perspective the importance of regulating peripheral antibody diversification
mechanisms. Further study into the creation of these antibodies can allow us to provide improved
treatments for patients with autoimmune disease such as SLE or rheumatoid arthritis.
1.3 Germinal Centers
1.3.1 Germinal centers
The immune system is capable of recognizing an infinite array of foreign substances
through the production of antibodies that bind with remarkably high affinity and specificity. For
many years, the mechanism by which a genome, limited by its size, is capable of producing such
a diverse pool of immunoglobulin specificities. Further research on the topic uncovered VDJ
recombination as the method to generate the original B cell repertoire (Hozumi and Tonegawa,
1976); however, studies observing antibodies of animals showed that antibody affinity increased
significantly over time, a process now known as affinity maturation (Eisen and Siskind, 1964;
Jerne, 1951). Following investigations found that the antibodies that emerge later in the immune
response were not a result of continued VDJ recombination, but, rather, highly mutated versions
of relatively lower affinity VDJ sequences (Berek and Milstein, 1987; McKean et al., 1984;
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Weigert et al., 1970) resulting from a combination of somatic hypermutation (SHM) followed by
selective pressure.
For the most part, the affinity maturation process occurs in microanatomical structures
known as germinal centers (GC), first described in 1884 by Walter Flemming. This was discovered
when single cells from GCs were dissected and shown to have high levels of somatic antibody
mutations (Berek et al., 1991; Jacob et al., 1991). GCs can be characterized by a mantle zone, a
ring of naïve B cells that are pushed aside as the GC expands, a light zone (LZ) proximal to the
capsule or marginal zone, containing FDCs and T cells, a gray zone (GZ), and a dark zone (DZ)
of actively proliferating cells (Figure 1.3).
FDCs are a radioresistant cell type that form a reticular network in both primary and GCs
where they are primarily localized to the LZ (Mandel et al., 1980). These cells are known to retain
antigens in a complement receptor 1 and 2 dependent manner (Barrington et al., 2002) and display
in intact forms on the cell surface in the form of immune complexes for long periods of time
(Mandel et al., 1981), therefore, it is believed that they act as a reservoir for antigens in the GC
from which B cells with BCRs specific for the antigens displayed are selected. Although FDCs
seem to play a critical role in the GC reaction, the necessity of FDCs for GC development has been
questioned as affinity maturation can still occur in mice with defective FDCs (Haberman and
Shlomchik, 2003). Currently, the data suggests that FDCs are essential for promoting affinity
maturation under suboptimal conditions in which antigen is scarce; however, are less important
when antigen is more abundant (Victora and Nussenzweig, 2012). In addition to antigen retention,
FDCs also express the Fc receptor, FcγRIIB, which impacts GC B cell development by acting as
an IgG sink to limit the number of Fc regions available to interact with the inhibitory receptors on
GC B cells (Ravetch and Lanier, 2000). Finally, FDCs assist in GC B cell migration into the light
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zone through the production of CXCL13 (Cyster et al., 2000), a ligand for CXCR5, which is
upregulated in GC B cells after DZ expansion, as well as other molecules such as IL-6 and BAFF,
which may play critical roles in B cell survival and development within the GCs (Allen and Cyster,
2008; Kopf et al., 1998; Wu et al., 2009).
T cells make up a small fraction of cells in the GC, but they are essential for GC formation,
maintenance, and affinity maturation as athymic mice cannot form GCs without adoptive transfer
of T cells prior to immunization (Jacobson et al., 1974). Specifically, these cells are critical due to
their expression of CD40L, which provides survival and activation signals to B cells. The
importance of this pathway is highlighted by experiments showing that injection of CD40-CD40L
blocking antibodies into mice dissolves ongoing GC reactions (Han et al., 1995) and, in humans,
loss of function mutations in either CD40 or CD40L lead to hyper IgM type 3 or type 1 respectively,
in which B cells are unable to undergo GC reactions and antibody diversification processes do not
occur. In recent years, a subset of GC T cells, T follicular helper cells (Tfh), the cells responsible
for providing T cell help within the GC , have been under intense investigation (Vinuesa et al.,
2005). Originally, these cells were found to express CXCR5 (Ansel et al., 1999), a receptor that is
required for GC entry, and CD28 family co-stimulatory molecules, inducible T-cell costimulatory
(ICOS) and programmed cell death protein 1 (PD-1) (Haynes et al., 2007; Hutloff et al., 1999),
which are essential for their GC localization and maintenance (Shi et al., 2018). Other T cell types
in the GCs that are less studied include T follicular cytotoxic cells, which express CD8, and are
thought to help control viral infections (Yu and Ye, 2018) and T follicular regulatory cells, which
help to limit Tfh function and GC reactions to prevent production of pathogenic antibodies
(Clement et al., 2019). As the importance of these other T cell types becomes more apparent, more
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research is focused on the mechanisms by which they assist in GC reactions and antibody
production.
Although GCs are made up of several different cell types, the vast majority of cells are
activated B cells. In contrast to their naïve counterparts, GC B cells divide rapidly with a division
time of between 6 and 12 hours (Allen et al., 2007; Hauser et al., 2007). They can be characterized
by their expression of Fas and n-glycolylneuraminic acid, which binds the antibody GL-7, as well
as binding of peanut agglutinin, loss of IgD expression, and changes in expression of CD38, which
is increased in human GC B cells, but reduced in mice (Cervenak et al., 2001; Naito et al., 2007;
Oliver et al., 1997; Rose et al., 1980; Yoshino et al., 1994). Additionally, Ebi2, an oxysterol
receptor is highly expressed by naïve B cells, but not GC B cells (Gatto et al., 2009; Pereira et al.,
2009) whereas S1P2, a sphingosine 1 phosphate receptor, that shows the opposite trend (Green et
al., 2011). Though there are many phenotypic differences between GC B cells and other B cell
types, one of the most critical transcriptional regulators expressed by GC B cells, but not naïve B
cells is Bcl-6 (Basso and Dalla-Favera, 2010). This protein is generally thought to be a
transcriptional repressor and mice lacking Bcl-6 are incapable of producing high affinity
antibodies (Dent et al., 1997; Ye et al., 1997) as this molecule regulates several major GC B cell
functions including cell survival (Ci et al., 2009; Saito et al., 2009), repression of p53 and DNA
damage molecules to allow the B cell to tolerate the mutational burdens of antibody diversification
(Phan and Dalla-Favera, 2004; Ranuncolo et al., 2007), silencing of B-lymphocyte-induced
maturation protein 1 (Blimp-1) to block differentiation to plasma cells (Shaffer et al., 2000), and
downregulation of BCR and CD40 signaling molecules (Basso et al., 2010).
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1.3.2 Germinal center dynamics
Germinal center reactions can be summarized into five major phases: entry, proliferation
and diversification, migration, selection, and, finally, differentiation. GC B cells that can
continuously cycle through the different phases to promote the generation of higher and higher
affinity antibodies through affinity maturation. Although GC B cells do not secrete much antibody,
they contribute to long lived responses through differentiation into long lived plasma cells. Due to
the importance of GC reactions to humoral immunity, many researchers have focused primarily
on describing the mechanisms by which GC B cells undergo affinity maturation and differentiation
as well as the mechanisms regulating these critical functions.
B cell entry and participation in the GC first requires that the cell recognizes cognate
antigen via the BCR, which can come directly from the environment or presented on the surface
of other cell types such as FDCs, DCs, and macrophage (Allen and Cyster, 2008; Carrasco and
Batista, 2007; Phan et al., 2007). Once the BCR has bound to cognate antigen, the B cell
internalizes the antigens, processes them, and presents peptide fragments on MHC-II.
Concomitantly, the B cells upregulate CCR7, a receptor for the chemokines CCL19 and CCL21
expressed in the T zone and begin migration (Okada et al., 2005). In the T zone, the B cells form
mobile conjugates with T cells (Okada et al., 2005) that express CD40L, ICOS, and PD-1.
Engagement of these receptors and ligands with B cells presenting peptide-MHC leads to
activation of mechanisms to undergo CSR prior to expansion and GC formation (Roco et al., 2019).
In T cells, engagement of ICOS by ICOSL expressed on B cells promotes the expression of
CXCR5 to localize the cells into the LZ of the GC.
After entry into the GC, B cells undergo cycles of interzonal migration. Using radiolabeled
nucleotides, cells were observed in vivo to first undergo expansion in the DZ and are then detected
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in the LZ several hours later (Hanna, 1964). These findings were later confirmed by Victora et al.
who used photoactivated GFP to also show less than 10% of LZ cells recirculate back into the DZ
whereas over 50% of the cells from the DZ migrate into the LZ within 4 hours, though the speed
of interzonal migration seems to be equal in both directions at approximately 7µm/min (Victora et
al., 2010). Furthermore, this study showed that cells having migrated to the DZ from the LZ
underwent clonal expansion, providing solid evidence for the cyclic re-entry theory, which
suggested that a fraction of positively selected B cells in the LZ return to the DZ for further rounds
of mutation and proliferation (Kepler and Perelson, 1993; Victora et al., 2010).
The evolutionary process of antibody affinity maturation and B cell selection in GCs is a
competition between B cells in which lower affinity cells are eliminated by means of cell death
and higher affinity cells survive resulting in an increased average affinity of BCRs in the GC
(Rajewsky, 1996). Once the B cells are in the GC, there is no minimum required affinity for
survival, the affinity must be higher relative to other B cells specific for the same antigen; however,
low affinity B cells are unable to form GCs when high affinity competitors are present (Dal Porto
et al., 2002; Schwickert et al., 2011) suggesting a competitiveness to GC formation as well as
affinity maturation. In the case of GCs, this competition can occur in the form of limitations on
antigen availability and presentation by FDCs that would cause higher affinity B cells to deplete
antigen pools or blocking lower affinity cells from accessing the antigens (Liu et al., 1989;
Tarlinton and Smith, 2000). This mechanism by which high affinity B cells act as a sink for antigen
and limit antigen availability is critical for the positive selection process since apoptosis is the
default fate for LZ GC B cells (Liu et al., 1989), therefore, low affinity B cells are not only
incapable of continuing through the GC reaction, but will undergo cell death leaving only the
higher affinity cells alive (Liu et al., 1989; Mayer et al., 2017). An alternative theory to this direct
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competition model suggests that Tfh are the limiting factor in GC B cell selection. In this model,
higher affinity B cells are capable of binding a greater amount of antigen, internalizing the antigen,
and presenting a greater concentration of peptide-MHC-II to Tfh compared to lower affinity B
cells (Batista et al., 2001). This suggests that all GC B cells can survive, even with limited BCR
signaling, but only those with sufficient levels of surface peptide-MHC-II would be able to engage
the limited number of Tfh for T cell help, thus the T cells would selectively give help to higher
affinity B cells (Meyer-Hermann et al., 2006). Previously, it was uncertain which model was more
favorable as determining the relative importance of T cell help compared to BCR signaling since
B cells that lose BCR expression as a result of hypermutation undergo rapid cell death (Mayer et
al., 2017). Consistently, both models require BCR signaling as a mechanism of cell survival;
however, experiments performed using α-DEC205-OVA, which created a situation in which all
GC B cells displayed the same amount of peptide-MHC-II, thus blinding T cells to BCR affinity,
showed a loss of selective pressure against low affinity BCRs thereby indicating that strong BCR
signaling, alone, is not sufficient for GC B cell selection (Victora et al., 2010).
After the cells receive T cell help, the cell will either choose to differentiate into a plasma
or memory cell, or continued GC cycling. In the case of continued GC cycling, the B cell will
upregulate mechanistic target of rapamycin complex 1 (mTORC1) and Myc to activate a cell
growth program necessary for continued clonal expansion with the number of proliferative cycles
being proportional to the amount of Myc expressed and the size of the cell after the growth cycle
(Ersching et al., 2017; Finkin et al., 2019). The cells then upregulate CXCR4, a receptor for
CXCL12, and migrates into the DZ to undergo both SHM and proliferation. The proliferation
continues through the DZ and into the GZ (Kennedy et al., 2020) until the new BCR is expressed
and signals through the serine/threonine kinase, Akt, to phosphorylate FoxO1 to expel it from the
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nucleus and allow migration back into the LZ (Luo et al., 2018) using CXCR5, where it will
undergo the same selection process as before. Over time, through continuing cycles of selection
and expansion, GCs will begin to lose diversity as a single clone dominates the reaction due to
having the highest affinity receptor for the immunizing antigen (Tas et al., 2016).
It has been nearly three decades since the emergence of a GC model that accounts for
affinity maturation. Based on what we currently understand, B cells undergo an activation stage in
which they encounter antigen and migrate into T cell zones to receive CD40-CD40L engagement.
This activation induces CSR prior and subsequent GC formation in which B cells undergo an
evolutionary process of SHM, proliferation, and selective pressure known as affinity maturation
(Figure 1.3). These mechanisms of antibody diversification allow our bodies to generate high
affinity antibodies to a virtually infinite number of antigens. Future research will continue to study
these mechanisms to describe, in more detail, the functions of lesser studied GC cell types such as
Tfr and the processes controlling the emergence of pathogenic autoreactive antibodies.
1.3.3 Activation induced cytidine deaminase
Activation induced cytidine deaminase (AID) was first discovered by the Honjo group in 1999 as
a novel member of the apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like
(APOBEC) family of mRNA editing enzymes, sharing homology with APOBEC-1 and inducing
cytosine to uracil mutations, expressed specifically in splenic B cells that had been activated
through immunization (Muramatsu et al., 1999). Following studies showed the importance of the
enzyme in inducing CSR and SHM as patients presenting with hyper IgM, later categorized as
hyper IgM type 2, were found to have loss of function mutations in this enzyme (Muramatsu et al.,
2000; Revy et al., 2000). At this time, due to its homology with APOBEC proteins, it was still
thought to regulate these diversification processes through deamination of RNA and it was not
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until the Neuberger group, in 2002, published their findings showing that expression of AID in
Escherichia coli leads to nucleotide transitions in the DNA rather than RNA that the true target of
AID was discovered. Due to the discovery of its mutagenic potential, much of the research
regarding AID has been aimed toward describing the regulatory networks that control the targeting
and expression of the enzyme as dysregulation can lead to severe pathologies such as
autoimmunity and cancers such as Burkitt’s lymphoma in which the Myc oncogene is recombined
into the IgH locus leading to constitutive expression (Adams et al., 1983; Klein et al., 2011; Ramiro
et al., 2004).
Transcriptionally, AID is under the control of transcriptional regulators such as NF-kB
(Park et al., 2013), HoxC4 (Park et al., 2013; Park et al., 2009), and Irf8 (Qi et al., 2009), of these,
NF-kB being one of the more important signals as it is downstream of nearly all activation signals
including CD40, BCRs, TLRs, Transmembrane activator and CAML interactor (TACI), APRIL,
and BAFF. Notably, all of these signaling cascades, excluding BCR signaling, are capable of
inducing AID expression (He et al., 2004; Kim et al., 2011; Park et al., 2013; Pone et al., 2012).
Additionally, signals such as CD40 induce both canonical p65 NF-kB activation as well as noncanonical p52 both of which play a critical role in AID expression as non-canonical NF-kB can be
recruited to the AID promoter while the canonical p65 can be recruited to enhancer regions
upstream of the gene (Park et al., 2009; Tran et al., 2010). Interestingly, AID expression peaks
approximately 2-3 days after stimulation, which mirrors the activation kinetics of the noncanonical NF-kB pathway (Pone et al., 2012), which may act to provide sustained expression levels
whereas the canonical pathway, which is more rapidly induced, may provide an immediate, short
term burst in expression (Zan and Casali, 2013). To prevent aberrant expression, two major
repressor proteins, Myb and E2F, are thought to be capable of silencing the gene as they both have

41

binding sites in cis-regulatory regions adjacent to the gene (Tran et al., 2010). As cells become
activated, Pax5 and E2A act as promoters for transcription; however, these factors can be
antagonized by Blimp-1 and Id2 (Xu et al., 2007).
After the protein is transcribed and translated, subcellular localization of the enzyme
heavily favors the cytoplasm rather than the nucleus, even though, at 24 kDa, the protein is small
enough to freely diffuse through the nuclear pores. The protein contains a nuclear export signal
that allows transport out of the nucleus in an chromosomal Maintenance 1 (CRM1) dependent
manner (McBride et al., 2004)and, in the cytosol, forms a complex with eEF1A and HSP90 (Hasler
et al., 2011; Ito et al., 2004; McBride et al., 2004; Orthwein et al., 2010). Additionally, in contrast
to cytosolic AID, the nuclear protein is rapidly targeted by proteasomes in both ubiquitin and nonubiquitin mediated degradation pathways

(Aoufouchi et al., 2008; Uchimura et al., 2011).

Although some factors have been found to assist in AID localization, few cytosolic mechanisms
maintaining compartmentalization of AID have been discovered and the details of its cytosolic
retention are still a mystery, though it is clear that his regulation is essential for avoiding off target
genome mutagenesis and genomic instability as nuclear restricted forms of the protein are
associated with increased mutagenesis both at the Ig locus and at non-Ig loci (Aoufouchi et al.,
2008).
One of the most common mechanisms for regulating protein function is through posttranslational modifications – the addition or subtraction of functional groups from a protein.
Previous studies on AID targeting have shown that DNA can be deaminated by phosphorylated
AID, but not by non-phosphorylated forms of the protein (Chaudhuri et al., 2004). This suggests
that phosphorylation of AID is important for its targeting to its DNA substrate. Additionally, due
to the reduction in phosphorylation of AID purified from non-B cells (Basu et al., 2005; McBride
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et al., 2006), there seems to be B cell specific mechanisms by which the protein is phosphorylated.
In B cells, AID can be phosphorylated on Ser38, a requirement for normal CSR and SHM (Basu
et al., 2005; Cheng et al., 2009; McBride et al., 2006), Thr27, also important for AID activity(Basu
et al., 2005), Thr 140, which is also important for both CSR and SHM, but preferentially favors
SHM(McBride et al., 2006), and Ser3, which seems to have a negative impact on the protein
function (Gazumyan et al., 2011). Consistent with previous findings, mutation of either Ser38 or
Thr140 do not impact catalytic activity, but likely interferes with targeting (McBride et al., 2006).
In addition to these residues, AID can also be phosphorylated on Tyr184 (Basu et al., 2005;
McBride et al., 2006); however the functional relevance of this phenomenon is still unclear as the
mutation of this residue to alanine does not seem to significantly affect CSR in activated B cells
(Basu et al., 2005).
Since AID is a deaminase that generates mutations in the genome, targeting of the enzyme
is crucial for preventing off target effects that can lead to severe pathologies such as cancer
resulting from deleterious genomic translocations. Early studies investigating AID targeting
looked for target sequences that may be unique to the Ig locus. These studies showed that switch
regions contained high frequencies of AGCT repeats, which are targeted by 14-3-3 adaptor
proteins that recruit AID to the DNA (Xu et al., 2010). Following these findings, the Nussenzweig
group showed that AID preferentially localizes to regions of stalled transcriptional elongation and
that it interacts with the DSIF component, Spt5 (Pavri et al., 2010) indicating that, not only does
AID recognize a specific target sequence, but it also requires that the target region initiates
transcription, but does not efficiently elongate the RNA product, which may provide an abundance
of ssDNA substrate as well as a greater amount of time for AID to interact with the DNA.
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More recently, it was discovered by the Chaudhuri group that AID targeting can be
mediated through interaction with non-coding RNAs generated following lariat branching (Zheng
et al., 2015). It was found that switch regions generate a transcript that contains G-quadruplexes,
secondary structures formed by sequences rich in guanines, and that these structures interact with
AID to assist in targeting (Zheng et al., 2015). Following this study, additional data showed that
AID can also bind G-quadruplexes in DNA and that AID oligomerizes at these genomic regions
to generate clustered mutations that may facilitate the formation of double stranded breaks (DSB)
(Qiao et al., 2017). Additionally, targeting of AID to these genomic structures was more robust
than targeting to the AGCT hotspot sequence or TTCT cold spot sequence as linear ssDNA with
or without the target sequences did not have any effect on the deamination of G-quadruplex
structured substrates (Qiao et al., 2017). Interestingly, it was observed that c-Myc, the transcription
factor that is commonly recombined to the IgH locus in B cell lymphoma, contains genomic Gquadruplexes in the first exon and intron that may be responsible for this off target AID effect
(Duquette et al., 2004; Duquette et al., 2005). In general, the targeting of AID seems to be similar
to that of clustered regularly interspaced short palindromic repeats (CRISPR) in which a guide
RNA is used to target a DNA modifying enzyme to a specific target sequence; however, AID
targeting includes the ability to bind DNA as well as RNA.
1.3.4 Somatic hypermutation
To make high affinity antibodies, B cells undergo a Darwinian-like process of selection
within germinal centers in which higher affinity B cells outcompete lower affinity B cells for
survival. Between rounds of selection in the GC LZ, B cells undergo SHM in the DZ, which allows
them to mutate the antigen binding region of the BCR and generate new BCRs. This process begins
with a deamination event caused by AID leading to a mismatched G:U in the DNA. The cell could
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simply replicate the mismatch, which would restrict the potential mutations to transitions – C to T
or G to A. Other types of mutations would depend on recognition of the lesion and activation of
DNA repair mechanisms such as base excision repair (BER) or mismatch repair and subsequent
recruitment of low fidelity DNA polymerases.
When the cell recognizes a G:U DNA lesion, the most common mechanism for its removal
is through BER. To initiate this pathway, the cell must first excise the uracil from the genome
using an enzyme such as uracil-DNA glycosylase (UNG), which leaves an abasic site that is
typically repaired through faithful BER mechanisms, thus generating no mutations (Krokan and
Bjoras, 2013). This is highlighted by the finding that deficiency in UNG leads to increased
mutational burdon at the Ig and non-Ig loci (Di Noia and Neuberger, 2002; Liu et al., 2008; Rada
et al., 2004). Alternatively, the abasic site can be cleaved by AP endonuclease (APE) 2 (Stavnezer
et al., 2014) and the following DNA synthesis is performed using a specialized DNA polymerase
such as Rev1, which can only introduce cytosines and is responsible for most C:G transversions
(Jansen et al., 2006), or Polη, which plays a major role in the generation of mutations at A:T pairs
(Delbos et al., 2007; Delbos et al., 2005).
During SHM, the majority of A:T mutations are dependent on MutSα and the exonuclease,
EXO1, components of the MMR pathway, and do not seem to be affected by UNG deficiency
(Rada et al., 2002). In this pathway, MSH2 and MSH6 recognize AID mediated U:G mismatches
and EXO1 recognizes a nick in the DNA breaks down a portion of the DNA in the 5’-3’ direction;
however, this step may not be necessary as mice with deficiency in EXO1 are still capable of
performing SHM (Schaetzlein et al., 2013). The DNA gaps formed after exonuclease activity are
then filled in by low fidelity polymerases such as Polη, Polζ, Polκ, and Polι (Faili et al., 2009;
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Maul et al., 2016; Zanotti and Gearhart, 2016). Of these polymerases, Polη makes the largest
contribution and deficiency in the rest does not significantly affect SHM (Figure 1.4).
The recruitment of low fidelity polymerases is key to the process of SHM, though the
mechanism by which they are recruited is not well understood. One major molecular event that
determines the recruitment of Polη and Rev1 is the monoubiquitination of proliferating cell nuclear
antigen (PCNA) at Lys164 (Guo et al., 2006; Kannouche et al., 2004; Moldovan et al., 2007).
Consistently, mutation of Lys164 on PCNA leads to deficiencies in SHM due to a reduction in the
recruitment of Polη, which results in decreased levels of mutations at A:T pairs, compensated by
an increase in mutations at C:G pairs (Langerak et al., 2007; Roa et al., 2008). Though it is clear
that PCNA plays a major role in SHM and that the ubiquitination at Lys164 is critical for the
recruitment of low fidelity polymerases, the mechanism by which generation or excision of uracil
lesions leads to the ubiquitination of PCNA is still a mystery.
1.3.5 Class switch recombination
Determined by the structure of the heavy chain constant region (CH), Antibodies have
several major isotypes, IgM, IgD, IgG, IgE, and IgA, each of which has its own unique effector
functions. Excluding IgM and IgD, which are expressed on mature naïve B cells by default, B cells
must undergo CSR to make the different antibody isotypes. This process involves the deletional
recombination of CH genes in the IgH locus, therefore, cells that have switched to a downstream
isotype cannot return to a previous isotype. Previously, it was believed that CSR occurred in the
LZ of the GC while SHM occurred in the DZ; however, recently, it was found that CSR occurs
prior to GC formation, around 2.5 days after antigen exposure, whereas the GC forms around day
3.5 and contains very few cells actively undergoing CSR (Roco et al., 2019).
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The initiation of CSR is similar to that of SHM – AID generates C to U mutations in the
switch regions upstream of each CH gene that become transcriptionally active depending on the
cytokine signaling experienced by the B cell. These mutations are then recognized by DNA
damage machinery including UNG and, in leu of APE2 as was seen in SHM, APE1. This step of
uracil removal by UNG, although it was optional in SHM, is critical for generating the necessary
DSBs to initiate recombination as CSR is almost entirely absent in UNG deficient mice and
patients (Imai et al., 2003; Petersen-Mahrt et al., 2002; Rada et al., 2002; Schrader et al., 2005).
Once the DSBs are generated, donor and acceptor S regions are joined by either NHEJ, which
includes the essential proteins Ku70 and Ku80 as well as the ligase complex containing XRCC4
and DNA ligase IV (Casellas et al., 1998; Manis et al., 1998; Pan-Hammarstrom et al., 2005;
Reina-San-Martin et al., 2003; Soulas-Sprauel et al., 2007) or alternative end joining (A-EJ),
though NHEJ is the main pathway (Bothmer et al., 2010; Ehrenstein et al., 2001; Yan et al., 2007).
In the case of NHEJ, the Ku70-Ku80 complex binds the DSB and helps recruit recombination
enzymes including XRCC4 and DNA ligase IV that join the two DNA ends (Figure 1.4).
After the discovery of these mechanisms, there was much speculation as to the mechanism
by which donor and acceptor regions would be properly aligned during the recombination process
and whether they were pre associated prior to DSB formation. Recently, the Alt group showed that
this process involved cis IgH organizational features (Dong et al., 2015), the same group later
characterized this as chromatin loop extrusion in which coshesin aligns the acceptor and donor
regions in preparation for AID mediated DSB formation (Zhang et al., 2019). This finding not only
answers the question of how acceptor and donor sites are aligned for proper recombination, but
also how the DSBs generated during CSR are recombined in a deletional manner rather than
inversional.
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1.3.6 Plasma cells
Antibodies are made by a subset of terminally differentiated B cells known as plasma cells
that can be characterized by their expression of CD138 and the transcription factor Blimp-1.
Plasma cells can be put into two major categories: short-lived plasma cells and long-lived plasma
cells. Short lived plasma cells are generally products of extrafollicular responses, therefore, they
undergo very little SHM and can be generated by B-1 cells, MZ B cells, and follicular B cells
(MacLennan et al., 2003). On the other hand, long-lived plasma cells are generated through GC
responses in a T dependent manner (Victora and Nussenzweig, 2012). Since these cells arise late
during the GC response (Weisel et al., 2016), they experience significant SHM and affinity
maturation and are, usually, very high affinity compared to short-lived plasma cells. After
differentiation in the secondary lymphoid organs, long-lived plasma cells migrate to the bone
marrow where they can survive for many years, providing long term immunity.
In the GCs, plasma cell precursors have been found in the LZ and were characterized as
cells that have low expression of Bcl-6 and high expression of CD69, Irf4, and Myc (Ise et al.,
2018). These cells make up approximately 1-3% of LZ B cells and were enriched for high affinity
BCRs compared to Bcl-6hiCD69hi cells that had relatively low BCR affinity (Ise et al., 2018).
Interestingly, Bcl-6loIrf4+CD69hi cells in the LZ do not express the classical plasma cell markers,
CD138 and Blimp-1, indicating that they may be early plasma cell precursors and not bona fide
plasma cells (Ise et al., 2018). Additionally, a population of Bcl-6loCD69hi cells with higher
expression of Irf4 and Blimp-1 were identified in the DZ (Ise et al., 2018; Krautler et al., 2017),
which may suggest that plasma cell precursors migrate from the LZ to the DZ to continue the
maturation process prior to exiting the GC from the DZ, consistent with prior models (Fooksman
et al., 2010; Meyer-Hermann et al., 2012).
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Since plasma cells generated from GC B cells tend to produce very high affinity antibodies,
the B cells that develop into plasma cells must have high affinity BCRs and should receive greater
or more consistent BCR signaling compared to lower affinity B cells. In addition to increased BCR
signaling, these cells would outcompete lower affinity cells for antigen and should present the
greatest amount of peptide-MHC-II on their cell surfaces, providing the greatest potential for T
cell help through CD40 engagement. Indeed, transcriptomic analysis of plasma cell precursors in
the LZ showed an enrichment of BCR and CD40 signaling signatures (Ise et al., 2018). In contrast,
a recent study using an MHC-II+/+ and MHC-II+/‒ chimeric mouse model, it was shown that a 50%
reduction in surface expression of peptide-MHC-II did not significantly affect GC B cell selection,
proliferation, or plasma cell differentiation (Yeh et al., 2018). This seems to contradict the previous
understanding; however, it is entirely possible that a two-fold difference in antigen presentation is
not significant to GC B cells and GC selection and differentiation is not sensitive to small
differences in peptide-MHC-II density.
Unlike T cell help, the role of BCR signaling in the selection and differentiation of plasma
cells is still unclear. Based on recent data, GC B cells seem to have attenuated BCR signaling
compared to naïve B cells; however, BCR signaling is still capable of selectively activating the
AKT pathway, which leads to phosphorylation and nuclear exclusion of FoxO1 (Luo et al., 2018),
therefore, it is possible that the duration and amplitude of BCR signaling may have finer control
over FoxO1 activity. Additionally, CD40 signaling induces nuclear localization of NF-kB, a driver
for Irf4 expression (Luo et al., 2018). Presumably, strong BCR signaling works synergistically to
direct GC B cells to commit to the plasma cell fate by inducing Myc and Irf4 while inhibiting
FoxO1. In support of this hypothesis, strong BCR and CD40 signaling led to degradation of Cbl
ubiquitin ligases that mediate ubiquitin dependent protein degradation of Irf4 (Li et al., 2018).
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1.3.7 Memory B cells
One of the defining features of the adaptive immune response is the ability to generate
memory to previous antigens. Humoral immune memory is maintained, in part, by long-lived
plasma cells in the bone marrow secreting antibody into circulation as well as by the formation of
memory B cells that can quickly respond to antigen. Previously, it was thought that these memory
B cells would recognize antigen and reenter GCs to boost affinity and differentiate into plasma
cells as they were assumed to be higher affinity compared to naïve B cells due to prior GC
experience; however, memory B cells generally arise from early GC reactions, or prior to GC
formation (Weisel et al., 2016), which allows for a high percentage of low affinity clones to persist
in the compartment compared to plasma cells that exit later during GC response and are, therefore,
higher affinity due to a greater amount of affinity maturation (Smith et al., 1997; Takahashi et al.,
2001). Additionally, recent findings show that, although the secondary antibody response is
dominated by few high affinity memory B cell clones, these cells rarely participate in recall GCs
(Mesin et al., 2020).
In humans, memory B cells have been characterized as cells expressing CD27 on the cell
surface as CD27+ cells show many characteristics of memory B cell identity such as isotype switch
and the presence of V region mutations (Klein et al., 1997; Tangye et al., 1998). Importantly,
though, it does not seem that memory B cells are exclusively CD27+ since minor populations have
been found that do not express the molecule (Ehrhardt et al., 2005; Fecteau et al., 2006). In mice,
memory B cells can be defined by their expression of CD80 and PD-L2, which is a product of the
strength of CD40 signaling provided during differentiation (Koike et al., 2019): double positive
cells are more prone to differentiate into plasma cells whereas double negative cells favor reentry
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into GCs while CD80‒PD-L2+ cells are more similar to double negative cells, but may be an
intermediate between the two (Zuccarino-Catania et al., 2014).
Memory B cells must provide protection against pathogens for a significant amount of time.
This led to questions regarding the mechanism by which these cells are maintained. A major
advance in understanding of the longevity of memory B cells was the finding that they do not
require BAFFR signals in neither humans nor mice (Benson et al., 2008; Scholz et al., 2008), but
Syk is necessary for their survival, potentially due to the need for tonic BCR signaling (Ackermann
et al., 2015; Kraus et al., 2004). In contrast to this, it does not seem as though antigen recognition
is important for memory B cell survival, as has been suggested (Gray and Skarvall, 1988), since
switching mouse BCRs to ones that do not recognized antigen complexes trapped on FDCs does
not affect the half-life of these cells (Maruyama et al., 2000). Additionally, T cells are not required
for their maintenance as T cell depletion does not affect recall responses (Vieira and Rajewsky,
1990). To date, it is still uncertain what external signals provide support for the maintenance of
memory B cells. Several factors have been suggested to be important for their survival such as
Puma (Clybouw et al., 2011) and Mcl-1 (Vikstrom et al., 2010); however, it is unclear whether
these molecules are important for the longevity of memory B cells or their formation (Weisel and
Shlomchik, 2017).
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Figure 1.2: Germinal centers. GC B cells undergo proliferation and SHM in the DZ, then
migrate into the light zone where they will pick up antigen from FDCs and look for T cell help.
After receiving T cell help, they can either undergo differentiation or continued SHM. If the cell
does not receive sufficient T cell help, then it will undergo cell death. This image was adapted
from (De Silva and Klein, 2015).
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Figure 1.3: Mechanism of SHM and CSR. A) Error free mismatch repair. B) Error inducing
DNA polymerases repair DNA lesion to introduce mutations in the VDJ region to promote SHM.
CSR occurs when upstream switch regions are recombined with downstream regions via NHEJ.
This image was taken from (Methot and Di Noia, 2017) with permission from Elsevier.
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1.4 Hypothesis and Specific Aims
To test our hypothesis that Aire expression in germinal center B cells acts as a checkpoint to
regulate the processes of antibody diversification, my thesis work was split into three aims in
chapters 2-4 respectively:
Specific Aim 1: To determine the function of Aire in germinal center B cells. Our
working hypothesis was that since germinal centers are the sites in which B cells undergo SHM
and CSR, Aire expression will likely have regulatory effects on the mechanisms of antibody
diversification.
Specific Aim 2: To determine the mechanism by which Aire regulates antibody
diversification. Our working hypothesis was that, if Aire is capable of regulating the processes of
antibody diversification, then it will have regulatory functions on AID, the enzyme that initiates
both processes.
Specific Aim 3: To determine the role of Aire in the regulation of autoreactive
antibodies. Our working hypothesis is that if Aire negatively regulates the process of SHM, then
the absence of Aire will likely lead to the generation of autoreactive B cell receptors. These B cell
receptors may then escape immune tolerance mechanisms and, eventually, lead to the generation
of autoreactive antibodies similar to what is seen in APS-1 patients.
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CHAPTER 2: AIRE EXPRESSION IN GC B CELLS
2.1 Introduction
Autoimmune Regulator (Aire) is a protein that has been shown to be expressed in a number
of different cell types both in the thymus as well as in the periphery. In the thymus, expression in
medullary thymic epithelial cells (mTECs) and B cells drives expression of peripheral tissue
antigens to generate an antigen pool on which developing thymocytes are negatively selected
(Anderson et al., 2002; Yamano et al., 2015). In the periphery, Aire has been observed in a subset
of extra thymic Aire expressing cells (eTACs) that play a role in regulating T cell activation
through the expression of peptide-MHC without co-stimulation (Gardner et al., 2013). As its name
suggests, in most contexts, Aire functions as a regulatory of immune response to prevent
autoreactivity.
Aire expression in the thymus is dependent on the transcription factor, NF-kB (Chin et al., 2003;
Haljasorg et al., 2015; Heino et al., 2000). In mTECs, this signaling can come from the receptor,
receptor activator of NF-kB ligand (RANKL) (Rossi et al., 2007) whereas, in thymic B cells, it
can be activated through engagement of CD40 by CD40L expressed on developing thymocytes
(Yamano et al., 2015). Due to the ability of CD40 signaling to activate Aire expression in thymic
B cells, it stands to reason that peripheral B cells activated by CD40-CD40L engagement would
also express Aire.
Germinal centers are structures composed primarily of activated B cells. These structures
can be divided into several major regions: a mantle zone composed of naïve B cells that get pushed
aside as activated GC B cells expand, a dark zone (DZ) in which GC B cells undergo proliferation
and somatic hypermutation (SHM), a gray zone (GZ) in which B cells continue proliferation, and
a light zone in which B cells receive survival signals and T cell help (Kennedy et al., 2020; Victora
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and Nussenzweig, 2012). GC B cells can be characterized by their expression of the transcription
factor, Bcl-6, and absence of surface IgD as the majority of these cells have already undergone
class switch recombination (CSR). Due to the dependence of B cells on T cell help in the form of
CD40-CD40L engagement with T follicular helper cells (Tfh) and due to the reduced BCR
signaling in GC B cells, we hypothesize that GC B cells would express Aire.
2.2 Materials and Methods
2.2.1 Patient Samples
Human tonsil samples were taken after pediatric tonsillectomy from the Children’s
Hospital of Michigan in collaboration with Dr. Janet Poulik. Peripheral blood was purchased from
the Red Cross in the form of blood filters.
2.2.2 Mice
AireAdig mice were previously described (Gardner et al., 2008) and provided by Dr. Mark
Anderson from University of California San Francisco. Mice were housed in the Division of
Laboratory Animal Resources (DLAR) facility at Wayne State University under the institutional
animal care and use committee (IACUC) protocol number, 18-07-0732. All mice were genotyped
by PCR to ensure inheritance of the transgene.
2.2.3 Cell lines
CH12 cells were cultured in RPMI-1640 medium further supplemented with 5% (v/v)
NCTC and 50 μM β-mercaptoethanol. To stimulate Aire expression and CSR, cells were activated
with 5µg/ml anti-CD40 + 100ng/ml IL-4 + 1ng/ml TGF-β1 (R&D 7666-MB/CF) for up to 3 days.
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2.2.4 Immunofluorescence
Tissue blocks were frozen in OCT prior to cutting 6µm sections. Sections were thawed in
cold PBS prior to fixation with 4% paraformaldehyde (PFA) for 15 minutes and permeabilization
with 0.2% Triton X-100 for 15 minutes. Slides were then blocked with either 5% BSA in PBS +
0.1% Tween or 10% serum of the secondary antibody source in the same buffer with 0.1mg/ml
human IgG for 1 hour at room temperature prior to antibody staining. Primary antibodies for IgD
(Southern 2032-02), Aire (Fisher 13-9534-82 or Miltenyi 130-105-401), Pax5 (BioLegend
649711), Bcl-6 (Ventana 227M), and CD23 (Beckman IM0529) were stained overnight at 4°C.
Secondary antibodies were stained the following day for 1 hour at room temperature. Slides were
sealed and imaged on a Leica TCS SP5 in the Wayne State MICR core facility.
2.2.5 Flow Cytometry
For human peripheral blood samples, cells were purified purified by gradient centrifugation using
Histopaque-1077 (Sigma 10771) prior to red blood cell (RBC) lysis. Tonsil samples were minced
and pushed through a 40µm cell strainer to generate single cell suspensions. Samples were blocked
using Fc blocking reagent (Miltenyi 130-059-901) prior to staining with fluorescently labeled
antibody and either GV510 (Tonbo 13-0870-T500) or 7AAD (Tonbo 13-6993-T500) for 1 hour at
room temperature. To show human tonsil expression of Aire, cells were stained with CD19
(BioLegend 302204), CD38 (BioLegend 303516), Aire (Miltenyi 130-105-401), IgD, CD27
(BioLegend 302812), and CD24 (eBioscience 47-0247). Events were captured on a Fortessa LSR
II and analyzed using Treestar FlowJo 7 or 10 software.
For mouse cells, spleens were harvested after intraperitoneal immunization with either
100µg NP32-KLH (Biosearch N-5060) mixed with Complete Freund's Adjuvant (CFA) for the first
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immunization and Incomplete Freund’s Adjuvant (IFA) (Fisher

77145) for 3 subsequent

immunizations or 4x108 SRBC mixed with or without Complete Freund's Adjuvant (CFA) (Fisher
77140). Spleens were then minced and pushed through a 40µm cell strainer prior to RBC lysis.
Staining was performed for 1 hour at room temperature with either GV510 or 7AAD after Fc block
(Tonbo 70-0161) for 10 minutes. To show Aire expression, cells were stained with a combination
of CD19 (BioLegend 115523), GL-7 (BD 561529), Fas (BD 554258), B220 (BioLegend 103224),
CXCR4 (eBioscience 13-9991), and CD83 (BioLegend 121515). Events were captured on a
Fortessa LSR II and analyzed using Treestar FlowJo 7 or 10 software. For sorting, cells were sorted
using a SONY Biotechnology SH800 cell sorter at the Wayne State MICR core facility.
2.2.6 RT-qPCR
RNA was purified using either a RNeasy purification kit (Qiagen 74004) or Trizol (Fisher
15596026) purification method. Reverse transcription was performed using an iScript reverse
transcription kit (BioRad 1708840) according to the manufacturer’s instructions. qPCR was
performed using either SYBR Green (BioRad 4367660) or with an iTaq universal SYBR Green
one-step kit (BioRad 172-5150) according to the manufacturer’s instructions. PCR was performed
using a StepOnePlus instrument (Applied Biosystems) and analyzed using the StepOne software.
2.2.7 Activation of cells in the presence of CAPE
Cells from peripheral blood were purified by gradient centrifugation using Histopaque1077 (Sigma 10771) prior to RBC lysis. B cells were purified by incubating peripheral blood
mononuclear cells with anti-IgD-Biotin (Southern 2032-08) for 10 minutes prior to conjugation
with anti-biotin magnetic beads (Miltenyi 130-090-485) and passage through a magnetic column.
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Cells were stimulated with 500ng/ml CD40L with or without 100ng/ml IL-4 and 25µM Caffeic
Acid (CAPE) (Cayman 70750).
Naïve B cells were purified from splenocytes using a B cell isolation kit (Miltenyi 130090-862) prior to stimulation with 500ng/ml CD40L (Peprotech 315-15) with or without 100ng/ml
IL-4 (Peprotech 214-14) or 25µM CAPE (Cayman 70750).
2.3 Results
2.3.1 Human GC Aire expression
To test Aire expression in GC B cells, human tonsil sections were stained with IgD to show
the mantle zone, Pax5, which indicates B cells, and Aire (Figure 2.1). To confirm these cells are,
in fact GC B cells, co-staining with Bcl-6 was performed (Figure 2.2). Staining in GC B cells
shows Aire staining in GC B cells with a speckled appearance, consistent with what is seen in
thymic epithelial cells due to the interaction of Aire with nuclear bodies (Ilmarinen et al., 2008;
Pitkanen et al., 2005); however no staining in mantle zone B cells was observed. These data were
confirmed with flow cytometry analysis (Figure 2.3) which shows that, in healthy human tonsils,
the majority of Aire positive cells in the CD19+ compartment are CD38 positive, indicating that
they are GC B cells (Oliver et al., 1997). Further analysis of the Aire positive cells show that they
are IgD negative indicating that they have already undergone CSR, consistent with what is
expected of GC B Cells (Roco et al., 2019). With the expression of Aire in GC B cells, we sought
to determine whether other B cell types also expressed Aire. To this end, peripheral blood naïve
(IgD+CD27– ), MZ (IgD+CD27+), switched memory (IgD–CD27+), switched non-memory (IgD‒
CD27‒) B cells as well as transitional (CD24hiCD38hi), mature (CD24intCD38int), memory
(CD24hiCD38–) B cells, and plasma cells (CD24–CD38hi) were analyzed for Aire expression by
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flow cytometry (Figure 2.4). None of these peripheral blood B cell types showed detectable
expression of Aire, therefore, we conclude that Aire expression is unique to GC B cells in the
periphery.
2.3.2 Mouse GC Aire expression
To test whether Aire expression in GC B cells shows the same characteristics in mice as it
does in humans, we utilized a transgenic reporter mouse, AireAdig, henceforth referred to as “Adig”,
in which a transgene containing an Aire driven Igrp GFP uses the Aire locus to drive expression
of GFP (Gardner et al., 2008). Mice were immunized with NP32-KLH with CFA and boosted with
NP32-KLH with IFA three times prior to tissue harvest. Splenocytes analyzed by flow cytometry
showed no expression of the GFP reporter in either non-GC B cells or plasma cells but showed
clear upregulation of GFP in GC B cells (Figure 2.5). These data were surprising as previous
studies have shown no GFP expression using this model (Yamano et al., 2015). To determine the
reason for this inconsistency, we attempted to perform the experiment using the published
immunization protocol that did not include adjuvant compared to immunization with adjuvant;
however, the data from repeating the published experiment were consistent with our previous data
showing upregulation of GFP in GC B cells, but no in blood, peritoneal, or non-GC B cells from
either the spleen or peripheral lymph nodes (Figure 2.6). To confirm the correlation between GFP
expression and Aire expression, GFP positive and negative cells were sorted from immunized Adig
mice and RNA was purified for qPCR. Aire transcript is upregulated in GFP positive GC B cells
compared to GFP negative non-GC B cells (Figure 2.7) confirming Aire expression in GC B cells
and that the GFP reporter accurately represents Aire expression in the Adig model. Therefore, the
reason for the inconsistency between our data and that which was previously published is still
unclear.
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2.3.3 LZ/DZ expression
As previously mentioned, GCs are split up into several regions: a LZ, DZ, GZ, and mantle
zone (Kennedy et al., 2020; Victora and Nussenzweig, 2012). To determine the distribution of
Aire expression in GC B cells, human tonsils were analyzed by immunofluorescence, staining for
CD23 to indicate follicular dendritic cells (FDCs), whichexist predominantly in the LZ and IgD
expressed by the naïve B cells in the mantle zone. Aire expression in both the LZ and DZ with
what appears to be an even distribution between both regions; however, Aire expression was not
observed in the mantle zone, confirming our previous results (Figure2.8).
To quantify this distribution, Adig mice were immunized with NP32-KLH with CFA and
boosted with NP32-KLH with IFA three times. Spleens were taken from the immunized mice and
flow cytometry analysis was performed to determine the distribution of GFP between the LZ and
DZ. Although the trend seemed to slightly favor CD83+ LZ localization, there was no significant
difference between the proportion of LZ to CXCR4+ DZ cells compared to total ratios (Figure 2.9)
indicating no difference in the percentage of Aire expressing cells between the LZ and DZ.
2.3.4 Regulation of Aire expression
In the thymus, B cells express Aire as a result of CD40-CD40L signaling through NF-kB
with thymic T cells (Yamano et al., 2015). Due to the dependence of GC reactions on this same
signaling pathway, it is reasonable that GC B cells may also utilize this pathway for inducing Aire
expression. To test this hypothesis, human IgD+ B cells were purified and stimulated with CD40L
+ IL-4 with and without an NF-kB specific inhibitor, Caffeic acid (CAPE). Upregulation of Aire
transcripts was observed after CD40L stimulation, which was ablated when CAPE was added
(Figure 2.10). Protein expression showing upregulation of Aire after CD40 stimulation and
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subsequent ablation was performed via western blot analysis (Figure 2.11). This effect was,
largely, the same in mouse B cells as purified Adig B cells showed upregulation of GFP signal
after CD40L treatment, which was absent when CAPE was added (Figure 2.12). Additionally,
CH12 mouse B cell lines treated with CD40L+IL-4+TGF-β showed increase in Aire RNA and
protein (Figures 2.13 and 2.14). These data are consistent with previous findings and indicate that
(Yamano et al., 2015), in B cells, CD40 signaling through NF-kB induces Aire expression.
2.4 Discussion
Our immunofluorescence, flow cytometry, qPCR, and western blot data suggest that the
transcriptional regulator, Aire, is expressed in both human and mouse GC B cells and that this
expression is not seen in peripheral blood B cell types. The expression of Aire seems to be evenly
distributed between the LZ and DZ and can be induced via CD40 signaling through NF-kB. This
finding is particularly surprising since previous reports using the same Adig mice showed no Aire
expression in GC B cells (Yamano et al., 2015). To determine the cause of this inconsistency, we
attempted to replicate previous experiments; however, these attempts showed that, using the
published protocols, Aire expression can still be observed in GC B cells. The conclusions drawn
from the previous paper suggest that Aire expression is repressed by high levels of BCR signaling
and that this repression is what leads to the lack of Aire in GC B cells (Yamano et al., 2015). This
is an interesting idea, but does not take into account the findings that GC B cell BCR signaling is
significantly reduced compared to naïve B cells (Khalil et al., 2012; Luo et al., 2018). Additionally,
although, treatment of B cells with a high concentration of anti-IgM does, in fact, reduce CD40
mediated Aire expression, it is not completely inhibitory with approximately 20% of cells still
showing positive GFP signal (Yamano et al., 2015). Therefore, we believe that it is entirely
possible for Aire to be expressed in GC B cells; despite BCR signaling.
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IgD AIRE Pax5 DAPI

Figure 2.1: Expression of Aire in human GC B cells. Immunofluorescence staining of a
germinal center in human tonsil.
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Figure 2.2: Aire expression in human tonsil Bcl-6 positive cells. Immunofluorescence
staining of a germinal center in human tonsil to confirm Bcl-6 expression in Aire positive GC
B cells
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Figure 2.3: Aire expression in human GC B cells by flow cytometry. Flow cytometry
analysis of Aire positive cells in human tonsils. Aire positive cells are positive for CD38 and
negative for IgD indicating they have undergone CSR.
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Figure 2.4: Aire is not expressed in human peripheral blood B cells. Flow cytometry analysis
of peripheral blood memory, plasma, and naïve B cells show no Aire expression in these
subpopulations.
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Figure 2.5: Aire expression in mouse B cells by flow cytometry. Immunized Adig mice show
GFP in GC B cells from spleen and ILN, but not in non-GC B cells or PCs.
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Figure 2.6: Comparison of immunization protocols. Adig mice immunized with or without
CFA to determine whether immunization protocol explains the discrepancy between our data
and those of other groups.

68

Figure 2.7: Aire expression in mouse B cells by qPCR. GFP+ GC B cells and non-GC B cells
were sorted from Adig mice to confirm the association between GFP expression and Aire
mRNA.
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Figure 2.8: Aire expression in both LZ and DZ in human GCs. Immunofluorescence
staining to show distribution of Aire in both DZ and LZ of human GC. Aire seems to be evenly
distributed between the LZ and DZ.
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Figure 2.9: Aire expression in LZ vs. DZ B cells in mouse GCs. Comparison of LZ and DZ
expression of Aire in immunized Adig mice. Aire expression seems evenly distributed between
the LZ and DZ.
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Figure 2.10: Human B cell Aire expression is induced by CD40 signaling through NF-kB.
Aire mRNA is upregulated in human B cells after stimulation with CD40L+IL-4. This
upregulation is inhibited with the addition of an NF-kB specific inhibitor.
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Figure 2.11: Human B cell Aire protein is upregulated by CD40 signaling through NF-kB.
Aire protein is upregulated in human B cells after stimulation with CD40L alone as well as with
CD40L+IL-4. This upregulation is inhibited with the addition of an NF-kB specific inhibitor.
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Figure 2.12: Reporter mouse upregulates GFP whith CD40 signaling through NF-kB. B
cells purified from Adig mice show upregulation of GFP after stimulation with CD40L alone
as well as with CD40L+IL-4. This upregulation is inhibited with the addition of an NF-kB
specific inhibitor.
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Figure 2.13: CH12 cells upregulate Aire RNA when activated through CD40. CH12 cells
show upregulation of Aire mRNA after stimulation with αCD40+IL-4+TGF-β for 48 and 72
hours.
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Figure 2.14: CH12 cells upregulate Aire protein when activated through CD40. CH12 cells
show upregulation of Aire protein after stimulation with αCD40+IL-4+TGF-β.
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CHAPTER 3: FUNCTION OF AIRE IN GC B CELLS
3.1 Introduction
Generally, Aire functions as a transcriptional regulator that helps prevent autoreactivity in
T cells and B cells. In the thymus, Aire expressed by mTECs induces the expression of tissue
restricted antigens on which developing thymocytes are negatively selected. This prevents the
release of autoreactive T cells into the periphery as well as generates a population of thymic
regulatory T cells that prevent self-activation in the periphery (Malchow et al., 2016).
Germinal centers are structures in which B cells undergo antibody diversification. GC B
cells, activated by T cell engagement, activate mechanisms for CSR and SHM that allow them to
generate high affinity antibodies of various antibody isotypes. This allows the B cells to
continuously alter antibody affinity and, with help from Tfh, significantly increase the affinity of
their BCRs over time (Victora and Nussenzweig, 2012). Based on the knowledge that, in nearly
all contexts, Aire acts as a promoter of immune tolerance and regulator of immune activation, we
hypothesize that Aire in GC B cells acts as a regulator of B cell function and antibody
diversification.
3.2 Materials and Methods
3.2.1 Patient samples
Autoimmune polyglandular syndrome 1 (APS-1) patients harboring loss of function
mutations in AIRE were enrolled with an approved protocol from the Ethics Committee of
Medicine from the Hospital District of Helsinki and Uusimaa, Finland. Samples were processed
and naïve B cells were sorted before being sent to Detroit from Finland. Healthy human blood was
purchased as previously mentioned.
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3.2.2 Mice
C57BL/6J, Aire−/−, CD45.2, and µMT mice were purchased from the Jackson Laboratory.
Mice were housed as mentioned above. Age and sex matched mice were randomly assigned to
control and experimental groups for experimentation.
3.2.3 Cell Lines
CH12 cells were cultured in RPMI-1640 medium supplemented with 5% (v/v) NCTC and
50 μM β-mercaptoethanol. To stimulate Aire expression and CSR, cells were activated with
5µg/ml anti-CD40 + 100ng/ml IL-4 + 1ng/ml TGF-β1 for up to 3 days. Aire knockout CH12 cells
were generated by Guang Wen Sun at School of Applied Science in Singapore.
3.2.4 Flow Cytometry
Mouse spleens were harvested after intraperitoneal immunization with 100µg NP32-KLH
mixed with Complete Freund's Adjuvant (CFA) for the first immunization and Incomplete
Freund’s Adjuvant (IFA) for 3 subsequent immunizations. Spleens were then minced and pushed
through a 40µm cell strainer prior to RBC lysis. Staining was performed for 1 hour at room
temperature with either GV510 or 7AAD after Fc block for 10 minutes. To show Aire expression,
cells were stained with a combination of CD19, GL-7, Fas, B220, CD3 (Tonbo 25-0032), CD4
(BioLegend 100406 or 100434), CXCR5 (BioLegend 145504), PD-1 (eBioscience 11-9985 or 259985), CD45.1 (Tonbo 60-0453), CD45.2 (Tonbo 65-0454), IgD (BioLegend 405727 or
eBioscience 25-5993), IgM (BioLegend 406509), NP8 (BioSearch N-5050F), and NP36
(BioSearch N-5070-1) for 1 hour at 4°C. For NP staining, cells were first stained with NP8 for 10
minutes on ice prior to staining with NP36. Events were captured on a Fortessa LSR II and
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analyzed using Treestar FlowJo 7 or 10 software. For sorting, cells were sorted using a Sony
Biotechnology SH800 cell sorter at the Wayne State MICR core facility.
3.2.5 RT-qPCR
APS-1 patient cells were pelleted and RNAlater was removed. Cells were washed with
PBS prior to RNA isolation using the Cells-to-CT 1-step SYBR Green kit (Fisher A25601) as per
manufacturer’s instructions. RNA was then amplified using iTaq Universal SYBR Green OneStep kit as previously mentioned.
For CH12 samples, RNA was purified using a Trizol purification method. Reverse
transcription was performed using an iScript reverse transcription kit according to the
manufacturer’s instructions. qPCR was performed using either SYBR Green. PCR was performed
using a StepOnePlus instrument and analyzed using the StepOne software.
3.2.6 Adoptive Transfers
For transfer of Aire−/− or Aire+/+ cells to µMT hosts, naïve resting B cells were purified
from spleens using a B cell isolation kit as previously mentioned. 2.5x107 B cells were then
injected into the tail vein of each recipient µMT host. Mice were then immunized intraperitoneally
with 100µg NP32-KLH mixed with Complete Freund's Adjuvant (CFA) for the first immunization
and Incomplete Freund’s Adjuvant (IFA) for 3 subsequent immunizations.
For bone marrow chimeras, bone marrow cells were isolated from femurs and tibias of
CD45.1 Aire+/+ and CD45.2 Aire−/− mice. After RBC lysis, B220+ bone marrow cells were
depleted by magnetic separation using a biotinylated anti-B220 antibody and anti-biotin magnetic
beads. WT and KO bone marrow cells were then mixed in a 1:1 ratio prior to transfer into µMT
mice that had received 10Gy total body irradiation the previous day. Each recipient received

79

1.5x107 cells bone marrow cells and were allowed to reconstitute for 28 days prior to tissue harvest
and purification of naïve resting B cells from splenocytes for secondary transfer. Mice were then
immunized using the above procedure.
3.2.7 Mutation Sequencing
Live naïve (IgM+IgD+) or switched (IgM−IgD−) NP specific B cells from spleens of µMT
mice, which have received either Aire WT or KO B cells and were immunized as mentioned above,
were sorted using a SONY Biotechnology SH800 cell sorter at the Wayne State MICR core facility.
High throughput IgHV profiling by RNA-seq was performed by iRepertoire, Inc. (Huntsville, AL,
USA). Sequences were analyzed using the IMonitor 1.1.0 pipeline as previously published (Zhang
et al., 2015). Mutation rate for each position was calculated for sequences with read depth ≥10
and frequency of nucleotide substitutions was computed for each isotype.
3.2.8 ELISA
After adoptive transfer and immunization, µMT blood was collected and serum was
extracted by centrifugation. Samples were titrated on NP29-BSA (BioSearch N-5050H-10)and
NP4-BSA (BioSearch N-5050L-10) coated microtiter plates to determine the ratio of NP29 to NP4
binding. Bound antibodies were probed using HRP conjugated anti mouse IgG1 (Jackson 115035-205), IgG2b (Jackson 115-035-207), IgG3 (Jackson 115-035-209), or IgM (Bethyl A90-101P)
prior to color development and quantitation on a microplate reader (BioTek Epoch) at 450nm.

80

3.3 Results
3.3.1 Effect of Aire on GC populations
To determine whether Aire expression in B cells had any effect on GC cell populations,
µMT mice were adoptively transferred with either Aire WT or KO B cells prior to immunization.
No differences in GC entry (Figure 3.1), Tfh (Figure 3.2), or Tfr (Figure 3.3) populations were
detected indicating that Aire does not affect GC biology by disrupting the overall number of cells.
3.3.2 Bone marrow chimera
As previously mentioned, GCs are regions in which B cells undergo antibody
diversification. One of the most important processes that occur in these structures is SHM and
affinity maturation. To determine whether GC B cell Aire affects this process, bone marrow
chimeras using CD45.1 Aire WT and CD45.2 Aire KO bone marrow, depleted of all B220 + cells
(Figure 3.5) were transferred to µMT hosts that had been irradiated the previous day (Figure 3.4).
Mice were allowed to reconstitute for 4 weeks prior to tissue harvest. Naïve resting B cells from
spleens were isolated and tested for purity (Figure 3.6) prior to secondary transfer into a new µMT
host in a 1:1 ratio of WT to KO cells (Figure 3.7). Additionally, these cells did not have any
differences in expression of stimulatory molecules (Figure 3.8), nor did they show any difference
in affinity to NP (Figure 3.9). Mice were then immunized via intraperitoneal injection of NP32KLH three times. After immunization, analysis of GC B cells showed a greater proportion of Aire
KO GC B cells (Figure 3.10), suggestive of improved GC survivability and selection. Analysis of
BCR affinity using fluorescently labeled NP8 and NP36 by flow cytometry (Figure 3.11) showed
increased BCR affinity of Aire KO B cells compared to Aire WT B cells (Figure 3.12 and 3.13)
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as shown by increased NP8 binding ratios. These data suggest that Aire negatively regulates the
process of Affinity maturation.
For CH12, cells were harvested and blocked using Fc blocking reagent for 10 minutes on
ice prior to staining with either GV510 or 7AAD and primary antibodies for CD19, B220, IgM
(BioLegend 406509), and IgA (BD 559354).
3.3.2 Effect of Aire on serum antibody affinity and mouse CSR
The second antibody diversification process associated with GC B cells is CSR. Although
CSR does not frequently occur within the GC, it is activated by the same signals that activate Aire
expression and can potentially fall under the same regulatory mechanism. To determine whether
Aire also regulates the process of CSR, adoptive transfer of either Aire WT or KO B cells into
µMT mice was performed. The mice were then immunized against NP prior to harvest of spleen
and blood (Figure 3.14). After immunization, mice that receive Aire KO B cells showed a greater
percentage of IgD‒IgM‒ cells in both the total B cell compartment as well as in the NP specific B
cell compartment indicating increased CSR (Figure 3.15). Consistent with previous experiments,
serum antibodies from these mice showed increased affinity for NP in the switched IgG isotypes,
but not in IgM (Figure 3.16).
3.3.2 Effect of Aire on SHM
As previous experiments showed the regulation of affinity maturation by Aire expression,
we attempted to determine whether this phenomenon was due to a change in SHM. To answer this
question, µMT mice received either Aire WT or Aire KO B cells prior to immunization against
NP (Figure 3.14). After immunization, naïve IgD+IgM+ and activated IgD‒IgM‒ NP specific B
cells were sorted and sent for repertoire sequencing (Figure 3.17). Sequencing results show that

82

Aire KO B cells acquired more mutations in switched isotypes such as IgG and IgE compared to
Aire WT B cells (Figure 3.18). These data suggest that Aire negatively affects affinity maturation
by regulating SHM.
3.3.2 APS-1 patient CSR
Our adoptive transfer experiments show that, in mice, Aire negatively regulates CSR. To
show that this is also the case in humans, APS-1 and health control patient B cells were stimulated
with either CD40L+IL-4 or CD40L+IFN-γ, inducing the cells to undergo CSR to either IgG1 or
IgG3 respectively. In these experiments, APS-1 patient B cells showed greater upregulation of IµCγ1 and Cγ3 transcripts (Figure 3.19 and 3.20) indicating increased CSR, consistent with our
mouse data.
3.3.2 Effect of Aire on CH12 cell CSR
Since these findings were consistent in both mice and humans, we attempted to show that
they could be replicated in cell culture as well. To this end, CH12 cells, a mouse B cell line, were
used to generate Aire KO clones 43, 53, and 69. Aire deficiency was confirmed by western blot
(Figure 3.21). WT CH12 as well as the KO clones were stimulated to undergo CSR to IgA. After
stimulation, the Aire KO clones showed an increased percentage of cells that have experienced
CSR compared to the WT clone (Figure 3.22). This was confirmed by qPCR to detect switch
circles, which shows increased expression after stimulation of Aire KO cells (Figure 3.23). to
show a causal relationship between this increase in CSR and Aire, a WT Aire-GFP construct was
transfected into an Aire KO clone, 69. After cells were stimulated to undergo CSR, cells that
received the Aire-GFP construct showed a reduction in CSR compared to cells that did not receive
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the construct, thus rescuing the phenotype. These data indicate that Aire causes a reduction in CSR
in CH12 cells.
3.4 Discussion
In this chapter, we show that Aire negatively regulates the processes of antibody
diversification associated with GC B Cells in mice, humans, and cell culture. B cell deficient mice
that receive Aire KO B cells show increased SHM and affinity maturation as well as an increased
rate of CSR, which is also observed in APS-1 patients and Aire KO CH12 cells. We did not,
however, test SHM in APS-1 patient B cells since there is no mechanism to show affinity
maturation in vitro and sorting GC B Cells from APS-1 patients would give wildly variable
mutation rates due to complicated infection history. Therefore, we do not believe that SHM data
using APS-1 patient GC B cells would provide meaningful results as it is known that these patients
suffer from an increased rate of infections compared to healthy patients. Additionally, we do not
observe increased SHM in mouse IgA after intraperitoneal immunization of NP (Figure 3.18), in
fact, the mutation rates may be slightly lower in Aire KO B cells compared to Aire WT B cells.
This inconsistency may be due to the nature of the immunogen and the route of immunization. IgA
is largely made at mucosal surfaces whereas we were testing B cells purified from the spleen.
Therefore, the mutation data for IgA may not accurately represent the total IgA repertoire and only
a very small percentage of the IgA positive cells that may skew the results (Bemark et al., 2016).
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Figure 3.1: Aire expression in GC B cells does not affect B cell entry into the GC. GL7+Fas+
B cells after immunization does not change between µMT mice that receive Aire WT and Aire
KO B cells

85

Figure 3.2: Aire expression in GC B cells does not affect Tfh proportions. PD-1+CXCR5+
T cells in secondary lymphoid organs does not change after immunization of µMT mice that
receive Aire WT and Aire KO B cells
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Figure 3.3: Aire expression in GC B cells does not affect Tfr proportions. PD-1+CXCR5+
regulatory T cells in secondary lymphoid organs does not change after immunization of µMT
mice that receive Aire WT and Aire KO B cells
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Figure 3.4: Chimera experimental setup. Bone marrow from CD45.1 Aire WT and CD45.2
Aire KO mice were depleted of B220 cells prior to transfer into a µMT irradiated host. Mice
were reconstituted for 4 weeks and naïve resting B cells were purified. B cells were then
transferred into a second µMT host that was immunized against NP.
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Figure 3.5: B cell depletion in bone marrow. Bone marrow B cells after depletion using αB220
MACS separation.
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Figure 3.6: Purity of transferred B cells. After MACS separation of B cells from host spleens,
purity was over 99%.
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Figure 3.7: CD45.1/.2 ratios prior to secondary transfer. After reconstitution, B cells were
transferred at a 1:1 ratio to secondary µMT hosts.
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Figure 3.8: Phenotype of transferred B cells prior to transfer. Aire WT and KO cells show
similar expression of surface markers.
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Figure 3.9: NP binding characteristics prior to transfer. Aire WT and KO cells show similar
NP binding characteristics prior to adoptive transfer.
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Figure 3.10: Percent GC B cells after immunization. Aire KO B cells represented a greater
proportion of cells within GCs after immunization.
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Figure 3.11: Method for analyzing NP ratios. GL7+Fas+ GC B cells were stained using
fluorescent NP8 and NP36 molecules to determine binding affinity of BCRs.
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Figure 3.12: NP8/NP36 binding ratios. Aire KO GC B cells had greater NP8/NP36 ratios
compared to Aire WT B cells in the same host.
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Figure 3.13: NP8/total binding ratios. Aire KO B cells had greater NP8 binding as a ratio of
total GC B cells.
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Figure 3.14: Experimental setup for second transfer experiment. Aire WT and KO cells are
separately transferred into µMT hosts prior to immunization to NP.
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Figure 3.15: Effect of B cell Aire on CSR. Mice that receive Aire KO B cells show increased
populations of IgM‒IgD‒ cells indicating increased CSR.
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Figure 3.16: Effect of B cell Aire on Affinity maturation. Class switched isotypes from mice
that receive Aire KO B cells are higher affinity for NP, indicated by a greater NP8/NP29 ratio,
compared to those from mice that receive Aire WT B cells
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Figure 3.17: Experimental setup for sequencing experiment. IgM+IgD+ and IgM‒IgD‒ cells
were sorted from µMT mice immunized against NP after adoptive transfer of Aire WT or Aire
KO B cells. RNA from cells was isolated and amplified by PCR prior to library construction and
sequencing of VDJ regions.
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Figure 3.18: Effect of B cell Aire on SHM. Sequencing analysis shows increased mutation
frequency in switched isotypes IgG and IgE, but not in unswitched isotypes IgD and IgM.
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Figure 3.19: CSR to IgG1 in APS-1 patients. APS-1 patient B cells were treated with
CD40L+IL-4 to stimulate switching to IgG1. APS-1 patient B cells show increased switch
transcripts after stimulation compared to healthy patient B cells.
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Figure 3.20: CSR to IgG3 in APS-1 patients. APS-1 patient B cells were treated with
CD40L+IFN-γ to stimulate switching to IgG3. APS-1 patient B cells show increased switch
transcripts after stimulation compared to healthy patient B cells.
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Figure 3.21: Confirming Aire KO in CH12 cells. CH12 Aire KO cells show no upregulation
of Aire protein after stimulation.
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Figure 3.22: Effect of Aire deficiency on CH12 CSR. Aire deficient CH12 cells show
increased CSR compared to WT.
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Figure 3.23: Expression of IgA switch circle in Aire deficient CH12 cells. Aire deficient
CH12 cells show increased expression of switch circles compared to WT.
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Figure 3.24: Rescue assay using WT Aire-GFP construct. Aire KO cells were transfected
with a WT Aire-GF construct prior to stimulation. GFP+ cells show reduced CSR compared to
GFP‒ cells.
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CHAPTER 4: MECHANISM OF AIRE IN GC B CELLS
4.1 Introduction
AID is known to initiate the processes of SHM and CSR by generating C to U mutations
in either the VDJ region or the switch regions (Petersen-Mahrt et al., 2002). These DNA lesions
are then excised and repaired in a manner that generates mutations in the case of SHM or
recombination in the case of CSR. There are several mechanisms by which AID is targeted to the
DNA to allow for the deamination event to take place. One of the most important mechanisms is
the initiation of transcription of AID target regions. The importance of the transcriptional
machinery at AID targets has three major functions: first, it opens the DNA to create single strands
so that AID can have access to the substrate, second, it creates a transcript that is utilized by AID
as a guide to target the enzyme to the proper location (Zheng et al., 2015), and third, it recruits
AID through interaction with stalled Pol II (Pavri et al., 2010). Due to the observation that Aire
negatively regulates both SHM and CSR, it is likely that it affects the function of AID either
through one of these mechanisms or through direct inhibition of catalytic activity.
4.2 Materials and Methods
4.2.1 Patient samples
Human tonsil samples were taken after pediatric tonsillectomy from the Children’s
Hospital of Michigan in collaboration with Dr. Janet Poulik.
4.2.2 Mice
C57BL/6J and Aire+/− mice were purchased from the Jackson Laboratory. Mice were
housed as mentioned above. Age and sex matched mice were randomly assigned to control and
experimental groups for experimentation.
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4.2.3 Cell lines
CH12 cells were cultured in RPMI-1640 medium supplemented with 5% (v/v) NCTC and
50 μM β-mercaptoethanol. To stimulate Aire expression and CSR, cells were activated with
5µg/ml anti-CD40 + 100ng/ml IL-4 + 1ng/ml TGF-β1 for up to 3 days. Aire knockout CH12 cells
were generated by Guang Wen Sun at School of Applied Science in Singapore.
HKB-11 cells, a human embryonic kidney cell/Burkitt’s lymphoma fusion, was cultured in
DMEM/F12 supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin,
0.25 μg/ml amphotericin B and 10% FBS.
4.2.4 Primary cell purification
Human tonsils were minced and pushed through a 40µm cell strainer. B cells were purified
by magnetic separation using anti-IgD-Biotin and anti-Biotin magnetic beads. To purify mouse
splenocytes, mouse spleens were minced and passed through a 40µm strainer prior to RBC lysis.
4.2.5 Flow cytometry
Tonsil samples were blocked using Fc blocking reagent for 10 minutes on ice prior to
staining with fluorescently labeled antibody and either GV510, 7AAD, or 4’,6-diamidine-2’phenylindole dihydrochloride (DAPI) for 1 hour at room temperature. To show human B cell
subcellular localization of Aire and AID, cells were stained with CD19, CD38, Aire, IgD, and AID
(BD 565785). For imaging flow, cells were imaged on an ImageStream X Mark II imaging flow
cytometer (Amnis) and analyzed using IDEAS 6.1 (Amnis).
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For CH12, cells were harvested and blocked using Fc blocking reagent for 10 minutes on
ice prior to staining with either GV510 or 7AAD and primary antibodies for CD19, B220, IgM,
and IgA.
4.2.6 Immunoprecipitation
Cells were harvested and washed prior to lysis with CelLytic M buffer (Sigma C2978)
containing protease inhibitor cocktail and phosphatase inhibitor for 1 hour on ice. Lysates were
centrifuged at 18,000 x g for 15 minutes at 4°C to pellet debris. Protein concentration was
measured using a BCA protein assay kit (Fisher 23225) as per the manufacturer’s instructions.
Lysates were precleared with protein G magnetic beads (Cell Signaling 8740 or Fisher 88847). IP
antibodies against AID, Aire (Santa Cruz sc-17986), or Myc (BioLegend 626802) were incubated
with magnetic beads prior to mixing with precleared lysates. Beads were incubated with lysates
overnight at 4°C while shaking. To precipitate flag, anti-flag magnetic beads were used instead
(Sigma F3165). Western blot analysis was performed using primary antibodies against Aire (Santa
Cruz sc-373703), AID (eBioscience 14-5959), Flag (Cell Signaling 2368), or His (BioLegend
652502).
4.2.7 RT-qPCR
For CH12 samples, RNA was purified using a Trizol purification method. Reverse
transcription was performed using an iScript reverse transcription kit according to the
manufacturer’s instructions. qPCR was performed using either SYBR Green. PCR was performed
using a StepOnePlus instrument and analyzed using the StepOne software.
4.2.8 Transfection
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HKB-11 cells were cultured to 70-90% confluence prior to transfection with 4µg plasmid.
Transfection was performed using Lipofectamine 30000 (Fisher L3000015) in Opti-MEM (Fisher
31985070) according to manufacturer’s instruction. CH12 cells were transfected using an Amaxa
cell line nucleofector kit V (Lonza VCA-1003) according to manufacturer’s instructions.
4.2.9 Uracil dot blot
Genomic uracil content was analyzed as described previously (Wei et al., 2017; Wei et al.,
2015).
4.2.10 ChIP-qPCR
CH12 cells were stimulated to undergo CSR. Chromatin immunoprecipitation (ChIP) was
performed with a ChIP assay kit (EMD Millipore 17-295) according to manufacturer’s instructions.
DNA was eluted from agarose after precipitation using 1% SDS, 0.1 M NaHCO3, pH 8.0 and
reverse-crosslinked from protein by incubation in 200mNaCl at 65°C for 4 hours. Samples were
cleaned with RNaseA (Sigma R6513) for 30 minutes at 37°C followed by treatment with 40µg/ml
proteinase K (Qiagen 9133) for 1 hour at 45°C. DNA was then purified using phenol/chloroform
extraction and ethanol precipitation prior to qPCR analysis as described above.
4.3 Results
4.3.1 Expression of germline transcripts
Germline transcription is critical for AID targeting and function. AID can be recruited into
transcriptional bubbles generated by Pol II and be assisted by the transcripts generated (Pavri et
al., 2010; Zheng et al., 2015). Additionally, it is well known that Aire is a transcriptional regulator
(Anderson et al., 2002; Bansal et al., 2017; Yoshida et al., 2015), therefore, to determine whether
Aire influences the transcription of AID or switch regions, qPCR CH12 cells were stimulated to
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undergo CSR to IgA. qPCR analysis showed no difference in transcription of either AID or switch
region genes, suggesting that Aire regulation of CSR is not a result of transcriptional repression at
AID or switch regions (Figure 4.1 – 4.3).
4.3.2 Aire interaction with AID
Due to the known functions of AID and Aire, both proteins must exist in the nucleus.
Indeed, this has been observed by many groups, though it is unclear whether both proteins are in
the nucleus together. To test whether both proteins co-localize in the nucleus, imaging flow was
performed on healthy human tonsils. Co-localization was observed in the nucleus of
CD19+IgD−CD38+ GC B cells (Figure 4.4). Since both proteins seem to exist in the nucleus, we
sought to determine whether these proteins interact with each other. To this end, human total
(CD19+), naïve (IgD+), and switched (CD19+IgD−) B cells were purified by magnetic separation
from tonsil samples. Cells were lysed and immunoprecipitation was performed on the purified
protein. AID was shown to co-immunoprecipitate with Aire in both the CD19+ and the CD19+IgD−
fractions, but little to no AID was pulled down from the IgD+ fraction, therefore, little to no Aire
was detected (Figure 4.5). To confirm these findings in mice, Aire KO and WT mice were
immunized to SRBC via four intraperitoneal injections with adjuvant and splenocytes were
harvested. Immunoprecipitation on purified protein was performed and western blot analysis
shows interaction of Aire with AID in the WT mice; however, due the deficiency of Aire in the
KO mice, no Aire was pulled down, showing the specificity of the antibody (Figure 4.6).
Since it is known that both of these proteins bind DNA, it is possible that they interact
through a DNA complex and not a protein-protein interaction. To determine whether these proteins
can interact directly, purified Aire-Flag and AID-His were incubated with an irrelevant protein,
IL-33. Immunoprecipitation of Flag and His were performed to show that the two purified proteins
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interact directly in vitro (Figure 4.7). Using HKB-11 cells transfected with various Aire and AID
constructs (Figures 4.8 and 4.10), it was determined that the interaction between Aire and AID
requires the CARD and NLS domains of Aire (Figure 4.9) as well as the catalytic and APOBEClike domains of AID (Figure 4.11). To determine whether this interaction was responsible for the
functional phenotypes described above, a WT Aire-GFP construct as well as an Aire-GFP with a
deletion in the CARD domain (ΔCARD) was transfected into the Aire deficient CH12 clone, 69,
prior to stimulation. The cells that received the Aire WT construct rescued the WT phenotype in
which CSR is reduced in the GFP+ cells; however, cells that received the ΔCARD construct did
not show any change relative to the GFP− cells (Figure 4.12). These data indicate that Aire
interaction with AID is important for its regulatory function.
4.3.3 Regulation of AID function by Aire
The function of AID as a DNA deaminase has been well established over the past couple
of decades (Petersen-Mahrt et al., 2002). Our data suggests that interaction between Aire and AID
negatively regulates CSR, therefore, it is likely that AID function is affected by this interaction.
We utilized a uracil dot blot assay (Figure 4.13) that measures genomic uracil content by
fluorescence signal (Figure 4.14). Using this assay, we show that there is an accumulation of
genomic uracil in Aire KO CH12 cells compared to the WT controls (Figure 4.15) Additionally,
this accumulation of genomic uracil is lost in AID deficient CH12 cells indicating that this assay
specifically recognizes AID directed mutagenesis. These data suggest that AID mediated C to U
mutations is reduced in the presence of Aire.
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4.3.4 Regulation of AID targeting by Aire
To determine whether the regulation of AID by Aire is due to inhibition of catalytic activity
or targeting of AID to the DNA substrate, immunoprecipitation of AID was performed in CH12
cells to show interaction with the transcriptional machinery. In Aire KO CH12 cells, increased
association of AID with Spt5 and pSer5 Pol II was detected indicating increased targeting of AID
to stalled Pol II in activated cells compared to the WT (Figure 4.16). Additionally, ChIP-qPCR
analysis shows enrichment of Sµ interaction with AID in stimulated Aire KO CH12 cells compared
to the WT, consistent with the finding that Aire reduces its targeting to stalled Pol II (Figure 4.17).
Taken together, these data suggest that Aire interaction with AID negatively regulates its targeting
to the DNA.
4.4 Discussion
Here, we describe a mechanism by which Aire negatively regulates AID activity. We did
not find any significant differences in transcription of AID or switch region transcripts between
Aire KO and Aire WT CH12 cells after stimulation to undergo CSR; however, we did observe a
direct protein-protein interaction between Aire and AID, in which the CARD and NLS of Aire
interacted with the catalytic and APOBEC-like domains of AID, that was necessary for protein
function. Genomic uracil quantification showed significantly increased uracil content in Aire KO
CH12 cells, confirming that Aire negatively regulates AID activity and immunoprecipitation
showed increased association of AID with the transcriptional machinery indicating that Aire
prevents AID targeting to the DNA. These findings were then confirmed with ChIP-qPCR to show
increased AID binding to DNA in Aire deficient CH12 cells.

115

At this time, it is still unclear exactly how this interaction between Aire and AID prevent
AID targeting. Several possibilities exist, though the most attractive is the sequestering of nuclear
AID, thus immobilizing the protein. Although the stoichiometry of this interaction is still unclear,
it should not require very high concentrations of Aire to inhibit AID due to the cytoplasmic
retention of the protein compared to the nuclear localization of Aire. Importantly, Aire expression
does not completely inhibit, but reduces AID function, thereby still allowing CSR and SHM to
take place. These data seem to suggest that Aire acts as an additional regulatory mechanism by
which AID is controlled to prevent excessive AID activity that could lead to autoimmunity and
cancer.
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Figure 4.1: Expression of AID in Aire deficient CH12 cells. AID expression is the same
between WT and KO CH12 cells.
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Figure 4.2: Expression of IgM germline transcripts in Aire deficient CH12 cells. IgM
germline transcript expression is the same between WT and KO CH12 cells.
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Figure 4.3: Expression of IgA germline transcripts in Aire deficient CH12 cells. IgA
germline transcript expression is the same between WT and KO CH12 cells.
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Figure 4.4: Aire and AID co-localization. Human GC B cells analyzed by imaging flow show
co-localization of Aire and AID in the nucleus.
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Figure 4.5: Aire and AID co-immunoprecipitation in human cells. CD19+ total B cells, IgD+
naïve B cells, and CD19+IgD‒ B cells were purified from patient tonsils. From the cell lysates,
AID was immunoprecipitated and western blot analysis was performed showing Aire interaction
with AID.
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Figure 4.6: Aire and AID co-immunoprecipitation in mouse cells. Aire WT and KO mice
were immunized with SRBC and splenic B cells were purified. Aire was immunoprecipitated
from the lysates and western blot analysis was performed to show interaction with AID.
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Figure 4.7: Aire interacts directly with AID. Flag tagged Aire and His tagged AID proteins
were incubated with an irrelevant protein, IL-33. Immunoprecipitation was performed for Flag
and His prior to western blot to show Aire interaction with AID.
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Figure 4.8: Aire domain constructs. Myc His tagged Aire constructs with deletions in specific
domains used for interaction assay with AID.
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Figure 4.9: Aire domains interacting with AID. Flag tagged AID was immunoprecipitated
with Myc His tagged Aire. M4-M7 show no interaction between AID and the Aire construct
indicating the necessity of the NLS and CARD domains of Aire.
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Figure 4.10: AID domain constructs. Flag tagged Aire constructs with deletions in specific
domains used for interaction assay with AID. M1 indicates a loss of function point mutation in
the catalytic domain. M2 indicates NLS is replaced with the NLS of nucleoplasmin. M6
indicates a loss of function mutation in the NLS whereby the protein does not localize to the
nucleus.
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Figure 4.11: AID domains interacting with Aire. Flag tagged AID was immunoprecipitated
with Myc His tagged Aire. M3 and M4 show no interaction between Aire and AID indicating a
necessity for both the catalytic domain and APOBEC like domain.
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Figure 4.12: Domain specific rescue assay. Aire KO cells were transfected with either a WT
Aire-GF or AireΔCARD-GFP construct prior to stimulation. GFP+ cells show reduced CSR in
the WT, but not AireΔCARD-GFP when compared to GFP‒ cells.
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Figure 4.13: Uracil assay chemistry. Uracil assay designed by the lab of Dr. Bhagwat to
quantify genomic uracil content.
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Figure 4.14: Correlation between fluorescence intensity and uracil content. Fluorescence
intensity of uracil dot blot strongly correlates with genomic uracil content.
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Figure 4.15: Effect of Aire on genomic AID mediate genomic uracil generation. Aire KO
CH12 cells harbor significantly more genomic uracils compared to WT CH12 cells.
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Figure 4.16: AID Co-immunoprecipitation with stalled RNA-Pol II. AID shows increased
association with stalled Pol-II in Aire KO CH12 cells compared to Aire WT.
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Figure 4.17: Effect of Aire on AID interaction with DNA. ChIP-qPCR analysis with WT and
Aire KO CH12 cells. Increased AID interaction with switch regions in Aire KO cells compared
to Aire WT after stimulation.
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CHAPTER 5: INSERT TITLE HERE
5.1 Introduction
One of the hallmarks of autoimmune polyglandular syndrome type 1 (APS-1) is the
appearance of chronic mucocutaneous candidiasis, chronic infection of the mucosal surfaces with
Candida albicans. Interestingly, it has been observed that this immunodeficiency phenotype is, in
fact, a result of an autoimmune reaction in which autoreactive B cells generate high affinity,
neutralizing antibodies against Th17 cytokines such as IL-17 and IL-22 which inhibit anti-fungal
immune response (Kisand et al., 2010; Meyer et al., 2016; Puel et al., 2010). Additionally, Th17
development may be hindered in APS-1 patients as, although APS-1 patient peripheral blood cells
have normal differentiation capacity to Th17, incubation of cells with APS-1 patient serum impairs
IL-17 production and Th17 proliferation (Ng et al., 2010). Generally, these phenotypes are thought
to be a result of T cell autoimmunity directing B cell diversification, but, with the novel finding
that B cells also have the capacity to express Aire, it will be important to test whether B cell specific
deficiency in Aire plays a role.
5.2 Materials and Methods
5.2.1 Mice
Aire+/−, and µMT mice were purchased from the Jackson Laboratory. To generate Aire+/+ and
Aire−/− mice, Aire+/− mice were bred and the offspring were genotyped. Age and sex matched mice
were randomly assigned to control and experimental groups for experimentation.
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5.2.2 Adoptive transfer
For transfer of Aire−/− or Aire+/+ cells to µMT hosts, naïve resting B cells were purified
from spleens using a B cell isolation kit as previously mentioned. 5x107 B cells were then injected
into the tail vein of each recipient µMT host.
5.2.3 Candida albicans culture
C. albicans was cultured in YPD broth at 30°C overnight with shaking at 220 rpm. Culture
was then diluted 1:10 with fresh YPD broth containing 10% fetal bovine serum and incubated at
37°C for 3 hours with shaking. Once approximately 95% of cells transitioned into the
pseudohyphal form, the culture was centrifuged at 4000 rpm for 10 minutes, washed, and
resuspended at a concentration of 5×106 CFU per 50 μl. These cells were either used for
intradermal infection or heat killed at 95°C for 2 hours prior to sonication on ice at 30% power for
5 seconds.
5.2.4 Fungal load analysis
µMT mice adoptively transferred with either Aire WT or KO B cells were immunized with
5 doses of 106 CFU heat-killed C. albicans pseudohyphae intraperitoneally every 4 days. Four
days after the final boost, mice were infected with 5×106 CFU live pseudohyphae in 50µl PBS per
spot adjacent to the spine. Four days after infection, fungal lesions were excised and either fixed
in formalin overnight for staining or minced and crushed using a pestle and mortar to free the fungi.
Live fungi were then used for serial dilution and plated on YPD agar to determine total CFU for
every milligram of tissue taken.
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5.2.5 ELISA
Blood was taken from µMT mice after immunization and serum was separated. Microtiter
plates were coated with 1µg/ml recombinant mouse IL-17A (Peprotech 210-17A), IL-17F
(Peprotech 210-17F) or IL-22 (Peprotech 210-22). Plates were blocked with 10% BSA, washed,
and incubated with the serum samples prior to probing with an anti-mouse IgG antibody (Vector
AP-2000) conjugated to alkaline phosphatase. Reaction was developed using BluePhos (KPL 5088-02) and quantitated as at 620nm.
For neutralization assays, mouse serum was incubated with overnight with recombinant
HRP conjugated (Abcam Ab102890) IL-17A, IL-17F, and IL-22. Microtiter plates were coated
with either IL-17RA (R&D 4481-MR-100) or IL-22Rα1 (R&D 4294-MR-050) prior to blocking
with 10% BSA. Serum-cytokine mixture was then added to the wells and incubated for 1 hour at
room temperature. Wells were washed prior to detection of HRP signal on a microplate reader at
450nm.
5.2.6 Flow cytometry
Excised fungal lesions were washed and digested using collagenase II (Worthington
LS004177) in HBSS at 37°C with shaking for 1 hour. Supernatant was collected and solid tissue
was pushed through a 100µm cell strainer. Cells were then restimulated with 500ng/ml PMA
(Sigma P1585-1MG), 500ng/ml ionomycin (Fisher I24222), and 1ug/ml Golgi plug (BD 55029)
at 37°C for 5 hours. Cells were collected, blocked with Fc blocking reagent, and stained with
GV510, CD45 (Tonbo 60-0459), CD3, and TCR-β (BioLegend 109227) for 1 hour on ice. Cells
were then fixed and permeabilized before staining for IL-17A (BioLegend 506929), and IL-22
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(BioLegend 516406) for 1 hour on ice. Events were captured on a Fortessa LSR II and data were
analyzed on FlowJo 10.
5.3 Results
5.3.1 Effect of B cell Aire on fungal clearance
APS-1 patients often suffer from chronic mucocutaneous candidiasis, chronic infections of
the fungal pathogen, C. albicans. To determine the role of B cell Aire in controlling C. albicans
infection, we developed a model in which µMT mice were adoptively transferred with either Aire
WT or Aire KO B cells. Mice were then immunized with heat killed C. albicans prior to
intradermal infection of live, pathogenic fungi. Four days after infection, injection sites and blood
were taken for analysis (Figure 5.1). After intradermal challenge, it was observed that mice that
received Aire KO B cells were unable to clear the fungal pathogen as effectively as mice that
received Aire WT B cells (Figures 5.2 and 5.3) indicating that Aire deficiency in B cells leads to
a similar immunodeficiency phenotype as seen in APS-1 patients.
5.3.2 Generation of autoreactive antibodies
As previously mentioned, it is thought that the chronic mucocutaneous candidiasis
phenotype observed in APS-1 patients is a result of the production of autoreactive, neutralizing
antibodies against Th17 cytokines, which are critical for clearing fungal pathogens (Meyer et al.,
2016). To determine whether susceptibility to C. albicans infection in our model is a result of
autoreactive antibodies, serum samples were tested for antibodies against IL-17A, IL-17F, and IL22. Indeed, we observed an increase in the titers of autoreactive antibodies against these cytokines
in mice that received Aire KO B cells compared to mice that received Aire WT B cells (Figures
5.4-5.6). Additionally, these antibodies seem to have some slight increase in neutralization
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capacity in the KO model (Figures 5.7-5.9). These data suggest that Aire deficiency, specifically
in the B cell compartment, can lead to an increased production of autoreactive, neutralizing
antibodies against Th17 cytokines.
5.3.3 Th17 dysfunction
Due to the importance of Th17 cells in the clearance of fungal pathogens, we sought to
determine whether Aire deficiency in B cells had any effect on the Th17 compartment. Lesions
resulting from fungal infection were excised from mice and digested to generate a single cell
suspension. After re-stimulation with PMA/Ionomycin, IL-17A and IL-22 producing T cells were
analyzed by flow cytometry. These data show a significant decrease in the CD45+TCR-β+ IL17A+IL22+, IL-17A+IL22‒, and IL-17A‒IL-22+ fractions in mice that received Aire KO B cells
compared to Aire WT B cells suggesting Th17 deficiency in these mice.
5.4 Discussion
To show that the chronic mucocutaneous candidiasis phenotype seen in APS-1 patients can,
in part, be attributed to B cell deficiency in Aire, we devised this adoptive transfer infection model
to show the production of neutralizing autoreactive antibodies as well as dysfunctional fungal
clearance. Our findings suggest that B cell Aire contributes to the overall protection against
production of anti-IL-17 and IL-22 antibodies responsible for the mucosal immunodeficiency
phenotype in APS-1; however, due to the seemingly small effect sizes, we believe that this
mechanism only contributes to the phenotype and is not the major pathway by which it arises and
that T cell autoimmunity must have even greater significance. Additionally, in accordance with
previous findings (Ng et al., 2010), we also see a reduction in Th17 cells, though this is likely not
a result of antibodies against IL-17A, IL-17F, or IL-22, but rather to a different cytokine, possibly
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type 1 interferon (Mourik et al., 2017) as an abundance of high affinity, neutralizing antibodies
against type 1 interferons have been described in APS-1 patients (Meyer et al., 2016). However,
due to the limited amount of sample we were able to extract from each mouse, we did not test for
anti-interferon antibodies.
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Figure 5.1: C. albicans infection model. µMT mice were adoptively transferred with either
Aire WT or Aire KO B cells prior to intraperitoneal immunization with heat-killed C. albicans.
After immunization, mice were challenged intradermally with live, pathogenic fungi.
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Figure 5.2: Silver staining of fungal lesion. Silver staining of fungal lesions shows increased
fungal load in mice that receive Aire deficient B cells compared to mice that receive Aire WT
B cells
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Figure 5.3: Effect of B cell Aire on fungal clearance. Skin lesions were excised and crushed
using a pestle and mortar. Serial dilutions were made to determine the number of CFU/mg tissue
in each lesion. Mice that receive Aire KO B cells showed an increased CFU/mg tissue compared
to mice that receive WT B cells.
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Figure 5.4: Effect of B cell Aire on autoreactive IL-17A antibodies. Mice that receive Aire
KO B cells show increased serum antibodies against IL-17A.

143

Figure 5.5: Effect of B cell Aire on autoreactive IL-17F antibodies. Mice that receive Aire
KO B cells show slightly increased, but not significant serum antibodies against IL-17F.
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Figure 5.6: Effect of B cell Aire on autoreactive IL-22 antibodies. Mice that receive Aire KO
B cells show increased serum antibodies against IL-22
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Figure 5.7: Neutralization capacity of anti-IL-17A antibodies. Serum from mice that
received Aire KO B cells show increased neutralization capacity to IL-17A compared to mice
that receive Aire WT B cells
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Figure 5.8: Neutralization capacity of anti-IL-17F antibodies. Serum from mice that received
Aire KO B cells show increased neutralization capacity to IL-17F compared to mice that receive
Aire WT B cells
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Figure 5.9: Neutralization capacity of anti-IL-22A antibodies. Serum from mice that
received Aire KO B cells show increased neutralization capacity to IL-22 compared to mice that
receive Aire WT B cells
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Figure 5.10: Gating strategy for Th17 cells. Single cells taken from the fungal lesion were
gated as CD45+CD3+TCRβ+ prior to analysis of IL-22 and IL-17A expression.
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Figure 5.11: Effect of B cell Aire on Th17 populations. Analysis of IL-22 and IL-17A
expression by T cells. Mice that received Aire WT B cells have significantly increased IL-17
and IL-22 producing T cells compared to mice that received Aire KO B cells
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CHAPTER 6: CONCLUSIONS AND FUTURE DIRECTIONS
6.1 Conclusions and significance
Here, we describe a novel mechanism for the regulation of antibody diversification in GC
B Cells. We find that Aire, a protein associated with establishing and maintaining immune
tolerance, is expressed in GC B cells in a CD40 dependent manner. Aire deficiency in B cells leads
to increased affinity maturation and SHM as well as increased CSR through a mechanism in which
a protein-protein interaction with AID, inhibits AID targeting to the substrate and subsequent
deamination events initiating the diversification process. Additionally, Aire deficiency in B cells
is associated with an increased serum titer of autoreactive, neutralizing antibodies against Th17
cytokines such as IL-17A, IL-17F, and IL-22 which are critical for clearing fungal pathogens,
highlighted by the reduction in Th17 cells and inability of mice with B cell Aire deficiency to clear
C. albicans as effectively as WT controls. Importantly, this mechanism does not seem to be
specific for self-antigens as immunization with the foreign antigen, NP, shows increased antibody
affinity, thus this mechanism can be utilized to generate high affinity antibodies for both
therapeutic and commercial purposes.
6.2 Future directions
To further characterize the importance and mechanism by which Aire regulates the
mechanisms of antibody diversification, it will be important for additional studies to focus on the
production of high affinity antibodies to a more diverse array of antigens. Currently, it is unclear
whether GC B cell Aire drives the expression of tissue restricted antigens and whether it has any
effect on the T helper cell compartment. Though our data seem to suggest that there is no effect
on the total number of T cells in the GC, it is possible that the repertoire is shifted. Additionally,
it will be interesting to see whether Aire deficient models can be utilized for the production of
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antibody vaccines for passive immunization, since the importance of efficient methods for this is
in extremely high demand due to the current pandemic. Finally, future research on this mechanism
may provide invaluable insight into the molecular characteristics of detrimental pathologies
associated with dysregulation of the GC B cell compartment such as cancer and autoimmunity.

152

REFERENCES
Ackermann, J.A., Nys, J., Schweighoffer, E., McCleary, S., Smithers, N., and Tybulewicz, V.L.
(2015). Syk tyrosine kinase is critical for B cell antibody responses and memory B cell survival. J
Immunol 194, 4650-4656.
Adams, J.M., Gerondakis, S., Webb, E., Corcoran, L.M., and Cory, S. (1983). Cellular myc
oncogene is altered by chromosome translocation to an immunoglobulin locus in murine
plasmacytomas and is rearranged similarly in human Burkitt lymphomas. Proceedings of the
National Academy of Sciences of the United States of America 80, 1982-1986.
Adolfsson, J., Borge, O.J., Bryder, D., Theilgaard-Monch, K., Astrand-Grundstrom, I., Sitnicka,
E., Sasaki, Y., and Jacobsen, S.E. (2001). Upregulation of Flt3 expression within the bone marrow
Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity.
Immunity 15, 659-669.
Adolfsson, J., Mansson, R., Buza-Vidas, N., Hultquist, A., Liuba, K., Jensen, C.T., Bryder, D.,
Yang, L., Borge, O.J., Thoren, L.A., et al. (2005). Identification of Flt3+ lympho-myeloid stem
cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage
commitment. Cell 121, 295-306.
Aichinger, M., Wu, C., Nedjic, J., and Klein, L. (2013). Macroautophagy substrates are loaded
onto MHC class II of medullary thymic epithelial cells for central tolerance. The Journal of
experimental medicine 210, 287-300.
Akashi, K., Traver, D., Miyamoto, T., and Weissman, I.L. (2000). A clonogenic common myeloid
progenitor that gives rise to all myeloid lineages. Nature 404, 193-197.
Alam, S.M., Travers, P.J., Wung, J.L., Nasholds, W., Redpath, S., Jameson, S.C., and Gascoigne,
N.R. (1996). T-cell-receptor affinity and thymocyte positive selection. Nature 381, 616-620.

153

Albu, D.I., Feng, D., Bhattacharya, D., Jenkins, N.A., Copeland, N.G., Liu, P., and Avram, D.
(2007). BCL11B is required for positive selection and survival of double-positive thymocytes. The
Journal of experimental medicine 204, 3003-3015.
Allen, C.D., and Cyster, J.G. (2008). Follicular dendritic cell networks of primary follicles and
germinal centers: phenotype and function. Semin Immunol 20, 14-25.
Allen, C.D., Okada, T., Tang, H.L., and Cyster, J.G. (2007). Imaging of germinal center selection
events during affinity maturation. Science 315, 528-531.
Allman, D., Li, J., and Hardy, R.R. (1999). Commitment to the B lymphoid lineage occurs before
DH-JH recombination. The Journal of experimental medicine 189, 735-740.
Amin, R.H., and Schlissel, M.S. (2008). Foxo1 directly regulates the transcription of
recombination-activating genes during B cell development. Nat Immunol 9, 613-622.
Anderson, M.S., Venanzi, E.S., Chen, Z., Berzins, S.P., Benoist, C., and Mathis, D. (2005). The
cellular mechanism of Aire control of T cell tolerance. Immunity 23, 227-239.
Anderson, M.S., Venanzi, E.S., Klein, L., Chen, Z., Berzins, S.P., Turley, S.J., von Boehmer, H.,
Bronson, R., Dierich, A., Benoist, C., et al. (2002). Projection of an immunological self shadow
within the thymus by the aire protein. Science 298, 1395-1401.
Ansel, K.M., McHeyzer-Williams, L.J., Ngo, V.N., McHeyzer-Williams, M.G., and Cyster, J.G.
(1999). In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their
response to lymphoid chemokines. The Journal of experimental medicine 190, 1123-1134.
Aoufouchi, S., Faili, A., Zober, C., D'Orlando, O., Weller, S., Weill, J.C., and Reynaud, C.A.
(2008). Proteasomal degradation restricts the nuclear lifespan of AID. The Journal of experimental
medicine 205, 1357-1368.

154

Aranburu, A., Ceccarelli, S., Giorda, E., Lasorella, R., Ballatore, G., and Carsetti, R. (2010). TLR
ligation triggers somatic hypermutation in transitional B cells inducing the generation of IgM
memory B cells. J Immunol 185, 7293-7301.
Ashton-Rickardt, P.G., Bandeira, A., Delaney, J.R., Van Kaer, L., Pircher, H.P., Zinkernagel, R.M.,
and Tonegawa, S. (1994). Evidence for a differential avidity model of T cell selection in the
thymus. Cell 76, 651-663.
Atibalentja, D.F., Byersdorfer, C.A., and Unanue, E.R. (2009). Thymus-blood protein interactions
are highly effective in negative selection and regulatory T cell induction. J Immunol 183, 79097918.
Azulay-Debby, H., Edry, E., and Melamed, D. (2007). CpG DNA stimulates autoreactive
immature B cells in the bone marrow. Eur J Immunol 37, 1463-1475.
Bansal, K., Yoshida, H., Benoist, C., and Mathis, D. (2017). The transcriptional regulator Aire
binds to and activates super-enhancers. Nat Immunol 18, 263-273.
Barrington, R.A., Pozdnyakova, O., Zafari, M.R., Benjamin, C.D., and Carroll, M.C. (2002). B
lymphocyte memory: role of stromal cell complement and FcgammaRIIB receptors. The Journal
of experimental medicine 196, 1189-1199.
Basso, K., and Dalla-Favera, R. (2010). BCL6: master regulator of the germinal center reaction
and key oncogene in B cell lymphomagenesis. Adv Immunol 105, 193-210.
Basso, K., Saito, M., Sumazin, P., Margolin, A.A., Wang, K., Lim, W.K., Kitagawa, Y., Schneider,
C., Alvarez, M.J., Califano, A., et al. (2010). Integrated biochemical and computational approach
identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B
cells. Blood 115, 975-984.

155

Basu, U., Chaudhuri, J., Alpert, C., Dutt, S., Ranganath, S., Li, G., Schrum, J.P., Manis, J.P., and
Alt, F.W. (2005). The AID antibody diversification enzyme is regulated by protein kinase A
phosphorylation. Nature 438, 508-511.
Batista, F.D., Iber, D., and Neuberger, M.S. (2001). B cells acquire antigen from target cells after
synapse formation. Nature 411, 489-494.
Batten, M., Groom, J., Cachero, T.G., Qian, F., Schneider, P., Tschopp, J., Browning, J.L., and
Mackay, F. (2000). BAFF mediates survival of peripheral immature B lymphocytes. The Journal
of experimental medicine 192, 1453-1466.
Baumgarth, N. (2011). The double life of a B-1 cell: self-reactivity selects for protective effector
functions. Nat Rev Immunol 11, 34-46.
Bemark, M., Hazanov, H., Stromberg, A., Komban, R., Holmqvist, J., Koster, S., Mattsson, J.,
Sikora, P., Mehr, R., and Lycke, N.Y. (2016). Limited clonal relatedness between gut IgA plasma
cells and memory B cells after oral immunization. Nat Commun 7, 12698.
Benson, M.J., Dillon, S.R., Castigli, E., Geha, R.S., Xu, S., Lam, K.P., and Noelle, R.J. (2008).
Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and
APRIL. J Immunol 180, 3655-3659.
Bentley, D.L., and Groudine, M. (1986). A block to elongation is largely responsible for decreased
transcription of c-myc in differentiated HL60 cells. Nature 321, 702-706.
Berek, C., Berger, A., and Apel, M. (1991). Maturation of the immune response in germinal centers.
Cell 67, 1121-1129.
Berek, C., and Milstein, C. (1987). Mutation drift and repertoire shift in the maturation of the
immune response. Immunol Rev 96, 23-41.

156

Berkowska, M.A., Driessen, G.J., Bikos, V., Grosserichter-Wagener, C., Stamatopoulos, K.,
Cerutti, A., He, B., Biermann, K., Lange, J.F., van der Burg, M., et al. (2011). Human memory B
cells originate from three distinct germinal center-dependent and -independent maturation
pathways. Blood 118, 2150-2158.
Bishop, A.L., Schild, S., Patimalla, B., Klein, B., and Camilli, A. (2010). Mucosal immunization
with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by
antilipopolysaccharide antibodies that inhibit bacterial motility. Infect Immun 78, 4402-4420.
Blizzard, R.M., and Kyle, M. (1963). Studies of the Adrenal Antigens and Antibodies in Addison's
Disease. J Clin Invest 42, 1653-1660.
Bothmer, A., Robbiani, D.F., Feldhahn, N., Gazumyan, A., Nussenzweig, A., and Nussenzweig,
M.C. (2010). 53BP1 regulates DNA resection and the choice between classical and alternative end
joining during class switch recombination. The Journal of experimental medicine 207, 855-865.
Brioen, P., Dekegel, D., and Boeye, A. (1983). Neutralization of poliovirus by antibody-mediated
polymerization. Virology 127, 463-468.
Burnet, F.M. (1976). A modification of Jerne's theory of antibody production using the concept of
clonal selection. CA Cancer J Clin 26, 119-121.
Burnett, D.L., Langley, D.B., Schofield, P., Hermes, J.R., Chan, T.D., Jackson, J., Bourne, K.,
Reed, J.H., Patterson, K., Porebski, B.T., et al. (2018). Germinal center antibody mutation
trajectories are determined by rapid self/foreign discrimination. Science 360, 223-226.
Caielli, S., Veiga, D.T., Balasubramanian, P., Athale, S., Domic, B., Murat, E., Banchereau, R.,
Xu, Z., Chandra, M., Chung, C.H., et al. (2019). A CD4(+) T cell population expanded in lupus
blood provides B cell help through interleukin-10 and succinate. Nat Med 25, 75-81.

157

Campodonico, V.L., Llosa, N.J., Grout, M., Doring, G., Maira-Litran, T., and Pier, G.B. (2010).
Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines. Infect Immun 78, 746755.
Cariappa, A., Chase, C., Liu, H., Russell, P., and Pillai, S. (2007). Naive recirculating B cells
mature simultaneously in the spleen and bone marrow. Blood 109, 2339-2345.
Cariappa, A., Mazo, I.B., Chase, C., Shi, H.N., Liu, H., Li, Q., Rose, H., Leung, H., Cherayil, B.J.,
Russell, P., et al. (2005). Perisinusoidal B cells in the bone marrow participate in T-independent
responses to blood-borne microbes. Immunity 23, 397-407.
Carrasco, Y.R., and Batista, F.D. (2007). B cells acquire particulate antigen in a macrophage-rich
area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity
27, 160-171.
Casellas, R., Nussenzweig, A., Wuerffel, R., Pelanda, R., Reichlin, A., Suh, H., Qin, X.F., Besmer,
E., Kenter, A., Rajewsky, K., et al. (1998). Ku80 is required for immunoglobulin isotype switching.
EMBO J 17, 2404-2411.
Cepeda, S., Cantu, C., Orozco, S., Xiao, Y., Brown, Z., Semwal, M.K., Venables, T., Anderson,
M.S., and Griffith, A.V. (2018). Age-Associated Decline in Thymic B Cell Expression of Aire and
Aire-Dependent Self-Antigens. Cell Rep 22, 1276-1287.
Cerutti, A., Cols, M., and Puga, I. (2013). Marginal zone B cells: virtues of innate-like antibodyproducing lymphocytes. Nat Rev Immunol 13, 118-132.
Cervenak, L., Magyar, A., Boja, R., and Laszlo, G. (2001). Differential expression of GL7
activation antigen on bone marrow B cell subpopulations and peripheral B cells. Immunol Lett 78,
89-96.

158

Chaturvedi, A., Dorward, D., and Pierce, S.K. (2008). The B cell receptor governs the subcellular
location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity
28, 799-809.
Chaudhuri, J., Khuong, C., and Alt, F.W. (2004). Replication protein A interacts with AID to
promote deamination of somatic hypermutation targets. Nature 430, 992-998.
Cheng, H.L., Vuong, B.Q., Basu, U., Franklin, A., Schwer, B., Astarita, J., Phan, R.T., Datta, A.,
Manis, J., Alt, F.W., et al. (2009). Integrity of the AID serine-38 phosphorylation site is critical
for class switch recombination and somatic hypermutation in mice. Proceedings of the National
Academy of Sciences of the United States of America 106, 2717-2722.
Chin, R.K., Lo, J.C., Kim, O., Blink, S.E., Christiansen, P.A., Peterson, P., Wang, Y., Ware, C.,
and Fu, Y.X. (2003). Lymphotoxin pathway directs thymic Aire expression. Nat Immunol 4, 11211127.
Chowdhury, D., and Sen, R. (2003). Transient IL-7/IL-7R signaling provides a mechanism for
feedback inhibition of immunoglobulin heavy chain gene rearrangements. Immunity 18, 229-241.
Christensen, S.R., Shupe, J., Nickerson, K., Kashgarian, M., Flavell, R.A., and Shlomchik, M.J.
(2006). Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing
inflammatory and regulatory roles in a murine model of lupus. Immunity 25, 417-428.
Ci, W., Polo, J.M., Cerchietti, L., Shaknovich, R., Wang, L., Yang, S.N., Ye, K., Farinha, P.,
Horsman, D.E., Gascoyne, R.D., et al. (2009). The BCL6 transcriptional program features
repression of multiple oncogenes in primary B cells and is deregulated in DLBCL. Blood 113,
5536-5548.

159

Clement, R.L., Daccache, J., Mohammed, M.T., Diallo, A., Blazar, B.R., Kuchroo, V.K., Lovitch,
S.B., Sharpe, A.H., and Sage, P.T. (2019). Follicular regulatory T cells control humoral and
allergic immunity by restraining early B cell responses. Nat Immunol 20, 1360-1371.
Clements, J.L., Yang, B., Ross-Barta, S.E., Eliason, S.L., Hrstka, R.F., Williamson, R.A., and
Koretzky, G.A. (1998). Requirement for the leukocyte-specific adapter protein SLP-76 for normal
T cell development. Science 281, 416-419.
Clybouw, C., Fischer, S., Auffredou, M.T., Hugues, P., Alexia, C., Bouillet, P., Raphael, M., Leca,
G., Strasser, A., Tarlinton, D.M., et al. (2011). Regulation of memory B-cell survival by the BH3only protein Puma. Blood 118, 4120-4128.
Clynes, R.A., Towers, T.L., Presta, L.G., and Ravetch, J.V. (2000). Inhibitory Fc receptors
modulate in vivo cytotoxicity against tumor targets. Nat Med 6, 443-446.
Coombs, R.R., Feinstein, A., and Wilson, A.B. (1969). Immunoglobulin determinants on the
surface of human lymphocytes. Lancet 2, 1157-1160.
Cooper, M.D., Peterson, R.D., and Good, R.A. (1965). Delineation of the Thymic and Bursal
Lymphoid Systems in the Chicken. Nature 205, 143-146.
Corcoran, A.E., Riddell, A., Krooshoop, D., and Venkitaraman, A.R. (1998). Impaired
immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature 391, 904-907.
Corthesy, B., Benureau, Y., Perrier, C., Fourgeux, C., Parez, N., Greenberg, H., and SchwartzCornil, I. (2006). Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via
intracellular neutralization but not via immune exclusion. J Virol 80, 10692-10699.
Cui, K., Zang, C., Roh, T.Y., Schones, D.E., Childs, R.W., Peng, W., and Zhao, K. (2009).
Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent
genes during differentiation. Cell Stem Cell 4, 80-93.

160

Cyster, J.G., Ansel, K.M., Reif, K., Ekland, E.H., Hyman, P.L., Tang, H.L., Luther, S.A., and Ngo,
V.N. (2000). Follicular stromal cells and lymphocyte homing to follicles. Immunol Rev 176, 181193.
Dal Porto, J.M., Haberman, A.M., Kelsoe, G., and Shlomchik, M.J. (2002). Very low affinity B
cells form germinal centers, become memory B cells, and participate in secondary immune
responses when higher affinity competition is reduced. The Journal of experimental medicine 195,
1215-1221.
De Silva, N.S., and Klein, U. (2015). Dynamics of B cells in germinal centres. Nat Rev Immunol
15, 137-148.
Decker, D.J., Boyle, N.E., Koziol, J.A., and Klinman, N.R. (1991). The expression of the Ig H
chain repertoire in developing bone marrow B lineage cells. J Immunol 146, 350-361.
Delbos, F., Aoufouchi, S., Faili, A., Weill, J.C., and Reynaud, C.A. (2007). DNA polymerase eta
is the sole contributor of A/T modifications during immunoglobulin gene hypermutation in the
mouse. The Journal of experimental medicine 204, 17-23.
Delbos, F., De Smet, A., Faili, A., Aoufouchi, S., Weill, J.C., and Reynaud, C.A. (2005).
Contribution of DNA polymerase eta to immunoglobulin gene hypermutation in the mouse. The
Journal of experimental medicine 201, 1191-1196.
Dent, A.L., Shaffer, A.L., Yu, X., Allman, D., and Staudt, L.M. (1997). Control of inflammation,
cytokine expression, and germinal center formation by BCL-6. Science 276, 589-592.
Desiderio, S.V., Yancopoulos, G.D., Paskind, M., Thomas, E., Boss, M.A., Landau, N., Alt, F.W.,
and Baltimore, D. (1984). Insertion of N regions into heavy-chain genes is correlated with
expression of terminal deoxytransferase in B cells. Nature 311, 752-755.

161

Di Noia, J., and Neuberger, M.S. (2002). Altering the pathway of immunoglobulin hypermutation
by inhibiting uracil-DNA glycosylase. Nature 419, 43-48.
Diamond, B., and Scharff, M.D. (1984). Somatic mutation of the T15 heavy chain gives rise to an
antibody with autoantibody specificity. Proceedings of the National Academy of Sciences of the
United States of America 81, 5841-5844.
Dobes, J., Edenhofer, F., Voboril, M., Brabec, T., Dobesova, M., Cepkova, A., Klein, L., Rajewsky,
K., and Filipp, D. (2018). A novel conditional Aire allele enables cell-specific ablation of the
immune tolerance regulator Aire. Eur J Immunol 48, 546-548.
Dong, J., Panchakshari, R.A., Zhang, T., Zhang, Y., Hu, J., Volpi, S.A., Meyers, R.M., Ho, Y.J.,
Du, Z., Robbiani, D.F., et al. (2015). Orientation-specific joining of AID-initiated DNA breaks
promotes antibody class switching. Nature 525, 134-139.
Dono, M., Zupo, S., Leanza, N., Melioli, G., Fogli, M., Melagrana, A., Chiorazzi, N., and Ferrarini,
M. (2000). Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone
equivalents. J Immunol 164, 5596-5604.
Dorshkind, K., and Montecino-Rodriguez, E. (2007). Fetal B-cell lymphopoiesis and the
emergence of B-1-cell potential. Nat Rev Immunol 7, 213-219.
Dunkelberger, J.R., and Song, W.C. (2010). Complement and its role in innate and adaptive
immune responses. Cell Res 20, 34-50.
Dunn-Walters, D.K., Isaacson, P.G., and Spencer, J. (1995). Analysis of mutations in
immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B
cells suggests that the MGZ of human spleen is a reservoir of memory B cells. The Journal of
experimental medicine 182, 559-566.

162

Duquette, M.L., Handa, P., Vincent, J.A., Taylor, A.F., and Maizels, N. (2004). Intracellular
transcription of G-rich DNAs induces formation of G-loops, novel structures containing G4 DNA.
Genes Dev 18, 1618-1629.
Duquette, M.L., Pham, P., Goodman, M.F., and Maizels, N. (2005). AID binds to transcriptioninduced structures in c-MYC that map to regions associated with translocation and hypermutation.
Oncogene 24, 5791-5798.
Ebert, P.J., Jiang, S., Xie, J., Li, Q.J., and Davis, M.M. (2009). An endogenous positively selecting
peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA
miR-181a. Nat Immunol 10, 1162-1169.
Ehlers, M., Fukuyama, H., McGaha, T.L., Aderem, A., and Ravetch, J.V. (2006). TLR9/MyD88
signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. The
Journal of experimental medicine 203, 553-561.
Ehrenstein, M.R., Rada, C., Jones, A.M., Milstein, C., and Neuberger, M.S. (2001). Switch
junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig
class switch recombination. Proceedings of the National Academy of Sciences of the United States
of America 98, 14553-14558.
Ehrhardt, G.R., Hsu, J.T., Gartland, L., Leu, C.M., Zhang, S., Davis, R.S., and Cooper, M.D.
(2005). Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based
population of memory B cells. The Journal of experimental medicine 202, 783-791.
Eisen, H.N., and Siskind, G.W. (1964). Variations in Affinities of Antibodies during the Immune
Response. Biochemistry 3, 996-1008.
Eldershaw, S.A., Sansom, D.M., and Narendran, P. (2011). Expression and function of the
autoimmune regulator (Aire) gene in non-thymic tissue. Clin Exp Immunol 163, 296-308.

163

Ersching, J., Efeyan, A., Mesin, L., Jacobsen, J.T., Pasqual, G., Grabiner, B.C., Dominguez-Sola,
D., Sabatini, D.M., and Victora, G.D. (2017). Germinal Center Selection and Affinity Maturation
Require Dynamic Regulation of mTORC1 Kinase. Immunity 46, 1045-1058 e1046.
Fagarasan, S., Shinkura, R., Kamata, T., Nogaki, F., Ikuta, K., Tashiro, K., and Honjo, T. (2000).
Alymphoplasia (aly)-type nuclear factor kappaB-inducing kinase (NIK) causes defects in
secondary lymphoid tissue chemokine receptor signaling and homing of peritoneal cells to the gutassociated lymphatic tissue system. The Journal of experimental medicine 191, 1477-1486.
Fagraeus, A. (1948). The plasma cellular reaction and its relation to the formation of antibodies in
vitro. J Immunol 58, 1-13.
Faili, A., Stary, A., Delbos, F., Weller, S., Aoufouchi, S., Sarasin, A., Weill, J.C., and Reynaud,
C.A. (2009). A backup role of DNA polymerase kappa in Ig gene hypermutation only takes place
in the complete absence of DNA polymerase eta. J Immunol 182, 6353-6359.
Fecteau, J.F., Cote, G., and Neron, S. (2006). A new memory CD27-IgG+ B cell population in
peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol 177,
3728-3736.
Ferguson, B.J., Alexander, C., Rossi, S.W., Liiv, I., Rebane, A., Worth, C.L., Wong, J., Laan, M.,
Peterson, P., Jenkinson, E.J., et al. (2008). AIRE's CARD revealed, a new structure for central
tolerance provokes transcriptional plasticity. J Biol Chem 283, 1723-1731.
Fergusson, J.R., Morgan, M.D., Bruchard, M., Huitema, L., Heesters, B.A., van Unen, V., van
Hamburg, J.P., van der Wel, N.N., Picavet, D., Koning, F., et al. (2018). Maturing Human CD127+
CCR7+ PDL1+ Dendritic Cells Express AIRE in the Absence of Tissue Restricted Antigens. Front
Immunol 9, 2902.

164

Ferrari, K.J., Scelfo, A., Jammula, S., Cuomo, A., Barozzi, I., Stutzer, A., Fischle, W., Bonaldi, T.,
and Pasini, D. (2014). Polycomb-dependent H3K27me1 and H3K27me2 regulate active
transcription and enhancer fidelity. Mol Cell 53, 49-62.
Finkin, S., Hartweger, H., Oliveira, T.Y., Kara, E.E., and Nussenzweig, M.C. (2019). Protein
Amounts of the MYC Transcription Factor Determine Germinal Center B Cell Division Capacity.
Immunity 51, 324-336 e325.
Finnish-German, A.C. (1997). An autoimmune disease, APECED, caused by mutations in a novel
gene featuring two PHD-type zinc-finger domains. Nat Genet 17, 399-403.
Flannagan, R.S., Jaumouille, V., and Grinstein, S. (2012). The cell biology of phagocytosis. Annu
Rev Pathol 7, 61-98.
Fooksman, D.R., Schwickert, T.A., Victora, G.D., Dustin, M.L., Nussenzweig, M.C., and Skokos,
D. (2010). Development and migration of plasma cells in the mouse lymph node. Immunity 33,
118-127.
Froland, S., Natvig, J.B., and Berdal, P. (1971). Surface-bound immunoglobulin as a marker of B
lymphocytes in man. Nat New Biol 234, 251-252.
Fujikado, N., Mann, A.O., Bansal, K., Romito, K.R., Ferre, E.M.N., Rosenzweig, S.D., Lionakis,
M.S., Benoist, C., and Mathis, D. (2016). Aire Inhibits the Generation of a Perinatal Population of
Interleukin-17A-Producing gammadelta T Cells to Promote Immunologic Tolerance. Immunity
45, 999-1012.
Fujinaga, K., Irwin, D., Huang, Y., Taube, R., Kurosu, T., and Peterlin, B.M. (2004). Dynamics
of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates
negative effectors from the transactivation response element. Mol Cell Biol 24, 787-795.

165

Gardner, J.M., Devoss, J.J., Friedman, R.S., Wong, D.J., Tan, Y.X., Zhou, X., Johannes, K.P., Su,
M.A., Chang, H.Y., Krummel, M.F., et al. (2008). Deletional tolerance mediated by extrathymic
Aire-expressing cells. Science 321, 843-847.
Gardner, J.M., Metzger, T.C., McMahon, E.J., Au-Yeung, B.B., Krawisz, A.K., Lu, W., Price,
J.D., Johannes, K.P., Satpathy, A.T., Murphy, K.M., et al. (2013). Extrathymic Aire-expressing
cells are a distinct bone marrow-derived population that induce functional inactivation of CD4(+)
T cells. Immunity 39, 560-572.
Gatto, D., Paus, D., Basten, A., Mackay, C.R., and Brink, R. (2009). Guidance of B cells by the
orphan G protein-coupled receptor EBI2 shapes humoral immune responses. Immunity 31, 259269.
Gatto, D., Wood, K., and Brink, R. (2011). EBI2 operates independently of but in cooperation with
CXCR5 and CCR7 to direct B cell migration and organization in follicles and the germinal center.
J Immunol 187, 4621-4628.
Gay, D., Saunders, T., Camper, S., and Weigert, M. (1993). Receptor editing: an approach by
autoreactive B cells to escape tolerance. The Journal of experimental medicine 177, 999-1008.
Gazumyan, A., Timachova, K., Yuen, G., Siden, E., Di Virgilio, M., Woo, E.M., Chait, B.T., Reina
San-Martin, B., Nussenzweig, M.C., and McBride, K.M. (2011). Amino-terminal phosphorylation
of activation-induced cytidine deaminase suppresses c-myc/IgH translocation. Mol Cell Biol 31,
442-449.
Giltiay, N.V., Chappell, C.P., Sun, X., Kolhatkar, N., Teal, T.H., Wiedeman, A.E., Kim, J., Tanaka,
L., Buechler, M.B., Hamerman, J.A., et al. (2013). Overexpression of TLR7 promotes cellintrinsic expansion and autoantibody production by transitional T1 B cells. The Journal of
experimental medicine 210, 2773-2789.

166

Giraud, M., Jmari, N., Du, L., Carallis, F., Nieland, T.J., Perez-Campo, F.M., Bensaude, O., Root,
D.E., Hacohen, N., Mathis, D., et al. (2014). An RNAi screen for Aire cofactors reveals a role for
Hnrnpl in polymerase release and Aire-activated ectopic transcription. Proceedings of the National
Academy of Sciences of the United States of America 111, 1491-1496.
Goodnow, C.C., Crosbie, J., Adelstein, S., Lavoie, T.B., Smith-Gill, S.J., Brink, R.A., PritchardBriscoe, H., Wotherspoon, J.S., Loblay, R.H., Raphael, K., et al. (1988). Altered immunoglobulin
expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334,
676-682.
Gossens, K., Naus, S., Corbel, S.Y., Lin, S., Rossi, F.M., Kast, J., and Ziltener, H.J. (2009). Thymic
progenitor homing and lymphocyte homeostasis are linked via S1P-controlled expression of
thymic P-selectin/CCL25. The Journal of experimental medicine 206, 761-778.
Grawunder, U., Leu, T.M., Schatz, D.G., Werner, A., Rolink, A.G., Melchers, F., and Winkler,
T.H. (1995). Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional
immunoglobulin heavy chain rearrangement. Immunity 3, 601-608.
Gray, D., and Skarvall, H. (1988). B-cell memory is short-lived in the absence of antigen. Nature
336, 70-73.
Green, J.A., Suzuki, K., Cho, B., Willison, L.D., Palmer, D., Allen, C.D., Schmidt, T.H., Xu, Y.,
Proia, R.L., Coughlin, S.R., et al. (2011). The sphingosine 1-phosphate receptor S1P(2) maintains
the homeostasis of germinal center B cells and promotes niche confinement. Nat Immunol 12, 672680.
Griffin, F.M., Jr., Griffin, J.A., Leider, J.E., and Silverstein, S.C. (1975). Studies on the mechanism
of phagocytosis. I. Requirements for circumferential attachment of particle-bound ligands to

167

specific receptors on the macrophage plasma membrane. The Journal of experimental medicine
142, 1263-1282.
Griffin, F.M., Jr., Griffin, J.A., and Silverstein, S.C. (1976). Studies on the mechanism of
phagocytosis. II. The interaction of macrophages with anti-immunoglobulin IgG-coated bone
marrow-derived lymphocytes. The Journal of experimental medicine 144, 788-809.
Groom, J.R., Fletcher, C.A., Walters, S.N., Grey, S.T., Watt, S.V., Sweet, M.J., Smyth, M.J.,
Mackay, C.R., and Mackay, F. (2007). BAFF and MyD88 signals promote a lupuslike disease
independent of T cells. The Journal of experimental medicine 204, 1959-1971.
Gu, H., Forster, I., and Rajewsky, K. (1990). Sequence homologies, N sequence insertion and JH
gene utilization in VHDJH joining: implications for the joining mechanism and the ontogenetic
timing of Ly1 B cell and B-CLL progenitor generation. EMBO J 9, 2133-2140.
Guerau-de-Arellano, M., Martinic, M., Benoist, C., and Mathis, D. (2009). Neonatal tolerance
revisited: a perinatal window for Aire control of autoimmunity. The Journal of experimental
medicine 206, 1245-1252.
Guinamard, R., Okigaki, M., Schlessinger, J., and Ravetch, J.V. (2000). Absence of marginal zone
B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat Immunol 1, 31-36.
Guo, C., Sonoda, E., Tang, T.S., Parker, J.L., Bielen, A.B., Takeda, S., Ulrich, H.D., and Friedberg,
E.C. (2006). REV1 protein interacts with PCNA: significance of the REV1 BRCT domain in vitro
and in vivo. Mol Cell 23, 265-271.
Haas, K.M., Poe, J.C., Steeber, D.A., and Tedder, T.F. (2005). B-1a and B-1b cells exhibit distinct
developmental requirements and have unique functional roles in innate and adaptive immunity to
S. pneumoniae. Immunity 23, 7-18.

168

Haberman, A.M., and Shlomchik, M.J. (2003). Reassessing the function of immune-complex
retention by follicular dendritic cells. Nat Rev Immunol 3, 757-764.
Haljasorg, U., Bichele, R., Saare, M., Guha, M., Maslovskaja, J., Kond, K., Remm, A., Pihlap, M.,
Tomson, L., Kisand, K., et al. (2015). A highly conserved NF-kappaB-responsive enhancer is
critical for thymic expression of Aire in mice. Eur J Immunol 45, 3246-3256.
Halonen, M., Kangas, H., Ruppell, T., Ilmarinen, T., Ollila, J., Kolmer, M., Vihinen, M., Palvimo,
J., Saarela, J., Ulmanen, I., et al. (2004). APECED-causing mutations in AIRE reveal the
functional domains of the protein. Hum Mutat 23, 245-257.
Han, S., Hathcock, K., Zheng, B., Kepler, T.B., Hodes, R., and Kelsoe, G. (1995). Cellular
interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J
Immunol 155, 556-567.
Hanna, M.G., Jr. (1964). An Autoradiographic Study of the Germinal Center in Spleen White Pulp
during Early Intervals of the Immune Response. Lab Invest 13, 95-104.
Hao, S., and Baltimore, D. (2013). RNA splicing regulates the temporal order of TNF-induced
gene expression. Proceedings of the National Academy of Sciences of the United States of
America 110, 11934-11939.
Hardy, R.R., and Hayakawa, K. (1991). A developmental switch in B lymphopoiesis. Proceedings
of the National Academy of Sciences of the United States of America 88, 11550-11554.
Hasler, J., Rada, C., and Neuberger, M.S. (2011). Cytoplasmic activation-induced cytidine
deaminase (AID) exists in stoichiometric complex with translation elongation factor 1alpha
(eEF1A). Proceedings of the National Academy of Sciences of the United States of America 108,
18366-18371.

169

Hauser, A.E., Junt, T., Mempel, T.R., Sneddon, M.W., Kleinstein, S.H., Henrickson, S.E., von
Andrian, U.H., Shlomchik, M.J., and Haberman, A.M. (2007). Definition of germinal-center B
cell migration in vivo reveals predominant intrazonal circulation patterns. Immunity 26, 655-667.
Hayakawa, K., Hardy, R.R., Parks, D.R., and Herzenberg, L.A. (1983). The "Ly-1 B" cell
subpopulation in normal immunodefective, and autoimmune mice. The Journal of experimental
medicine 157, 202-218.
Haynes, N.M., Allen, C.D., Lesley, R., Ansel, K.M., Killeen, N., and Cyster, J.G. (2007). Role of
CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death
gene-1high germinal center-associated subpopulation. J Immunol 179, 5099-5108.
He, B., Qiao, X., and Cerutti, A. (2004). CpG DNA induces IgG class switch DNA recombination
by activating human B cells through an innate pathway that requires TLR9 and cooperates with
IL-10. J Immunol 173, 4479-4491.
Heery, D.M., Kalkhoven, E., Hoare, S., and Parker, M.G. (1997). A signature motif in
transcriptional co-activators mediates binding to nuclear receptors. Nature 387, 733-736.
Heino, M., Peterson, P., Sillanpaa, N., Guerin, S., Wu, L., Anderson, G., Scott, H.S., Antonarakis,
S.E., Kudoh, J., Shimizu, N., et al. (2000). RNA and protein expression of the murine autoimmune
regulator gene (Aire) in normal, RelB-deficient and in NOD mouse. Eur J Immunol 30, 1884-1893.
Hepworth, M.R., Fung, T.C., Masur, S.H., Kelsen, J.R., McConnell, F.M., Dubrot, J., Withers,
D.R., Hugues, S., Farrar, M.A., Reith, W., et al. (2015). Immune tolerance. Group 3 innate
lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4(+) T cells.
Science 348, 1031-1035.

170

Hepworth, M.R., Monticelli, L.A., Fung, T.C., Ziegler, C.G., Grunberg, S., Sinha, R., Mantegazza,
A.R., Ma, H.L., Crawford, A., Angelosanto, J.M., et al. (2013). Innate lymphoid cells regulate
CD4+ T-cell responses to intestinal commensal bacteria. Nature 498, 113-117.
Herzig, Y., Nevo, S., Bornstein, C., Brezis, M.R., Ben-Hur, S., Shkedy, A., Eisenberg-Bord, M.,
Levi, B., Delacher, M., Goldfarb, Y., et al. (2017). Transcriptional programs that control
expression of the autoimmune regulator gene Aire. Nat Immunol 18, 161-172.
Herzog, S., Hug, E., Meixlsperger, S., Paik, J.H., DePinho, R.A., Reth, M., and Jumaa, H. (2008).
SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo
pathway. Nat Immunol 9, 623-631.
Hnisz, D., Abraham, B.J., Lee, T.I., Lau, A., Saint-Andre, V., Sigova, A.A., Hoke, H.A., and
Young, R.A. (2013). Super-enhancers in the control of cell identity and disease. Cell 155, 934947.
Hogquist, K.A., Tomlinson, A.J., Kieper, W.C., McGargill, M.A., Hart, M.C., Naylor, S., and
Jameson, S.C. (1997). Identification of a naturally occurring ligand for thymic positive selection.
Immunity 6, 389-399.
Horkko, S., Miller, E., Branch, D.W., Palinski, W., and Witztum, J.L. (1997). The epitopes for
some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1
(and other proteins). Proceedings of the National Academy of Sciences of the United States of
America 94, 10356-10361.
Hozumi, N., and Tonegawa, S. (1976). Evidence for somatic rearrangement of immunoglobulin
genes coding for variable and constant regions. Proceedings of the National Academy of Sciences
of the United States of America 73, 3628-3632.

171

Hua, Z., Gross, A.J., Lamagna, C., Ramos-Hernandez, N., Scapini, P., Ji, M., Shao, H., Lowell,
C.A., Hou, B., and DeFranco, A.L. (2014). Requirement for MyD88 signaling in B cells and
dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice. J
Immunol 192, 875-885.
Huang, B., Faucette, A.N., Pawlitz, M.D., Pei, B., Goyert, J.W., Zhou, J.Z., El-Hage, N.G., Deng,
J., Lin, J., Yao, F., et al. (2017). Interleukin-33-induced expression of PIBF1 by decidual B cells
protects against preterm labor. Nat Med 23, 128-135.
Hubert, F.X., Kinkel, S.A., Webster, K.E., Cannon, P., Crewther, P.E., Proeitto, A.I., Wu, L.,
Heath, W.R., and Scott, H.S. (2008). A specific anti-Aire antibody reveals aire expression is
restricted to medullary thymic epithelial cells and not expressed in periphery. J Immunol 180,
3824-3832.
Hughey, P.G., Roberts, P.C., Holsinger, L.J., Zebedee, S.L., Lamb, R.A., and Compans, R.W.
(1995). Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus
assembly. Virology 212, 411-421.
Husebye, E.S., Perheentupa, J., Rautemaa, R., and Kampe, O. (2009). Clinical manifestations and
management of patients with autoimmune polyendocrine syndrome type I. J Intern Med 265, 514529.
Hutloff, A., Dittrich, A.M., Beier, K.C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., and
Kroczek, R.A. (1999). ICOS is an inducible T-cell co-stimulator structurally and functionally
related to CD28. Nature 397, 263-266.
Ikawa, T., Hirose, S., Masuda, K., Kakugawa, K., Satoh, R., Shibano-Satoh, A., Kominami, R.,
Katsura, Y., and Kawamoto, H. (2010). An essential developmental checkpoint for production of
the T cell lineage. Science 329, 93-96.

172

Ikuta, K., and Weissman, I.L. (1992). Evidence that hematopoietic stem cells express mouse c-kit
but do not depend on steel factor for their generation. Proceedings of the National Academy of
Sciences of the United States of America 89, 1502-1506.
Ilmarinen, T., Kangas, H., Kytomaa, T., Eskelin, P., Saharinen, J., Seeler, J.S., Tanhuanpaa, K.,
Chan, F.Y., Slattery, R.M., Alakurtti, K., et al. (2008). Functional interaction of AIRE with PIAS1
in transcriptional regulation. Mol Immunol 45, 1847-1862.
Imai, K., Slupphaug, G., Lee, W.I., Revy, P., Nonoyama, S., Catalan, N., Yel, L., Forveille, M.,
Kavli, B., Krokan, H.E., et al. (2003). Human uracil-DNA glycosylase deficiency associated with
profoundly impaired immunoglobulin class-switch recombination. Nat Immunol 4, 1023-1028.
Imai, Y., Kuba, K., Neely, G.G., Yaghubian-Malhami, R., Perkmann, T., van Loo, G., Ermolaeva,
M., Veldhuizen, R., Leung, Y.H., Wang, H., et al. (2008). Identification of oxidative stress and
Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133, 235-249.
Incani, F., Serra, M., Meloni, A., Cossu, C., Saba, L., Cabras, T., Messana, I., and Rosatelli, M.C.
(2014). AIRE acetylation and deacetylation: effect on protein stability and transactivation activity.
J Biomed Sci 21, 85.
Inlay, M.A., Bhattacharya, D., Sahoo, D., Serwold, T., Seita, J., Karsunky, H., Plevritis, S.K., Dill,
D.L., and Weissman, I.L. (2009). Ly6d marks the earliest stage of B-cell specification and
identifies the branchpoint between B-cell and T-cell development. Genes Dev 23, 2376-2381.
Ise, W., Fujii, K., Shiroguchi, K., Ito, A., Kometani, K., Takeda, K., Kawakami, E., Yamashita,
K., Suzuki, K., Okada, T., et al. (2018). T Follicular Helper Cell-Germinal Center B Cell
Interaction Strength Regulates Entry into Plasma Cell or Recycling Germinal Center Cell Fate.
Immunity 48, 702-715 e704.

173

Ito, S., Nagaoka, H., Shinkura, R., Begum, N., Muramatsu, M., Nakata, M., and Honjo, T. (2004).
Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like
apolipoprotein B mRNA editing catalytic polypeptide 1. Proceedings of the National Academy of
Sciences of the United States of America 101, 1975-1980.
Jacob, J., Kelsoe, G., Rajewsky, K., and Weiss, U. (1991). Intraclonal generation of antibody
mutants in germinal centres. Nature 354, 389-392.
Jacobson, E.B., Caporale, L.H., and Thorbecke, G.J. (1974). Effect of thymus cell injections on
germinal center formation in lymphoid tissues of nude (thymusless) mice. Cell Immunol 13, 416430.
Jansen, J.G., Langerak, P., Tsaalbi-Shtylik, A., van den Berk, P., Jacobs, H., and de Wind, N.
(2006). Strand-biased defect in C/G transversions in hypermutating immunoglobulin genes in
Rev1-deficient mice. The Journal of experimental medicine 203, 319-323.
Jasti, S., Warren, B.D., McGinnis, L.K., Kinsey, W.H., Petroff, B.K., and Petroff, M.G. (2012).
The autoimmune regulator prevents premature reproductive senescence in female mice. Biol
Reprod 86, 110.
Jerne, N.K. (1951). A study of avidity based on rabbit skin responses to diphtheria toxin-antitoxin
mixtures. Acta Pathol Microbiol Scand Suppl 87, 1-183.
Jerne, N.K. (1955). The Natural-Selection Theory of Antibody Formation. Proceedings of the
National Academy of Sciences of the United States of America 41, 849-857.
Johnnidis, J.B., Venanzi, E.S., Taxman, D.J., Ting, J.P., Benoist, C.O., and Mathis, D.J. (2005).
Chromosomal clustering of genes controlled by the aire transcription factor. Proceedings of the
National Academy of Sciences of the United States of America 102, 7233-7238.

174

Ju, B., Zhang, Q., Ge, J., Wang, R., Sun, J., Ge, X., Yu, J., Shan, S., Zhou, B., Song, S., et al.
(2020). Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature 584, 115-119.
Jumaa, H., Wollscheid, B., Mitterer, M., Wienands, J., Reth, M., and Nielsen, P.J. (1999).
Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor
protein SLP-65. Immunity 11, 547-554.
Kannouche, P.L., Wing, J., and Lehmann, A.R. (2004). Interaction of human DNA polymerase eta
with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to
DNA damage. Mol Cell 14, 491-500.
Kaufmann, S.H. (2017). Remembering Emil von Behring: from Tetanus Treatment to Antibody
Cooperation with Phagocytes. mBio 8.
Kelly, L.M., Pereira, J.P., Yi, T., Xu, Y., and Cyster, J.G. (2011). EBI2 guides serial movements
of activated B cells and ligand activity is detectable in lymphoid and nonlymphoid tissues. J
Immunol 187, 3026-3032.
Kennedy, D.E., Okoreeh, M.K., Maienschein-Cline, M., Ai, J., Veselits, M., McLean, K.C.,
Dhungana, Y., Wang, H., Peng, J., Chi, H., et al. (2020). Novel specialized cell state and spatial
compartments within the germinal center. Nat Immunol 21, 660-670.
Kepler, T.B., and Perelson, A.S. (1993). Cyclic re-entry of germinal center B cells and the
efficiency of affinity maturation. Immunol Today 14, 412-415.
Khalil, A.M., Cambier, J.C., and Shlomchik, M.J. (2012). B cell receptor signal transduction in
the GC is short-circuited by high phosphatase activity. Science 336, 1178-1181.
Kim, H.A., Seo, G.Y., and Kim, P.H. (2011). Macrophage-derived BAFF induces AID expression
through the p38MAPK/CREB and JNK/AP-1 pathways. J Leukoc Biol 89, 393-398.

175

Kisand, K., Boe Wolff, A.S., Podkrajsek, K.T., Tserel, L., Link, M., Kisand, K.V., Ersvaer, E.,
Perheentupa, J., Erichsen, M.M., Bratanic, N., et al. (2010). Chronic mucocutaneous candidiasis
in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. The
Journal of experimental medicine 207, 299-308.
Kishimoto, H., and Sprent, J. (1997). Negative selection in the thymus includes semimature T cells.
The Journal of experimental medicine 185, 263-271.
Kittipatarin, C., Li, W.Q., Bulavin, D.V., Durum, S.K., and Khaled, A.R. (2006). Cell cycling
through Cdc25A: transducer of cytokine proliferative signals. Cell Cycle 5, 907-912.
Klasener, K., Maity, P.C., Hobeika, E., Yang, J., and Reth, M. (2014). B cell activation involves
nanoscale receptor reorganizations and inside-out signaling by Syk. Elife 3, e02069.
Klein, I.A., Resch, W., Jankovic, M., Oliveira, T., Yamane, A., Nakahashi, H., Di Virgilio, M.,
Bothmer, A., Nussenzweig, A., Robbiani, D.F., et al. (2011). Translocation-capture sequencing
reveals the extent and nature of chromosomal rearrangements in B lymphocytes. Cell 147, 95-106.
Klein, L., Hinterberger, M., Wirnsberger, G., and Kyewski, B. (2009). Antigen presentation in the
thymus for positive selection and central tolerance induction. Nat Rev Immunol 9, 833-844.
Klein, L., Roettinger, B., and Kyewski, B. (2001). Sampling of complementing self-antigen pools
by thymic stromal cells maximizes the scope of central T cell tolerance. Eur J Immunol 31, 24762486.
Klein, U., Kuppers, R., and Rajewsky, K. (1997). Evidence for a large compartment of IgMexpressing memory B cells in humans. Blood 89, 1288-1298.
Klein, U., Rajewsky, K., and Kuppers, R. (1998). Human immunoglobulin (Ig)M+IgD+ peripheral
blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region

176

genes: CD27 as a general marker for somatically mutated (memory) B cells. The Journal of
experimental medicine 188, 1679-1689.
Klose, R.J., Kallin, E.M., and Zhang, Y. (2006). JmjC-domain-containing proteins and histone
demethylation. Nat Rev Genet 7, 715-727.
Kogawa, K., Nagafuchi, S., Katsuta, H., Kudoh, J., Tamiya, S., Sakai, Y., Shimizu, N., and Harada,
M. (2002). Expression of AIRE gene in peripheral monocyte/dendritic cell lineage. Immunol Lett
80, 195-198.
Koh, A.S., Miller, E.L., Buenrostro, J.D., Moskowitz, D.M., Wang, J., Greenleaf, W.J., Chang,
H.Y., and Crabtree, G.R. (2018). Rapid chromatin repression by Aire provides precise control of
immune tolerance. Nat Immunol 19, 162-172.
Koike, T., Harada, K., Horiuchi, S., and Kitamura, D. (2019). The quantity of CD40 signaling
determines the differentiation of B cells into functionally distinct memory cell subsets. Elife 8.
Kondo, M., Weissman, I.L., and Akashi, K. (1997). Identification of clonogenic common
lymphoid progenitors in mouse bone marrow. Cell 91, 661-672.
Kopf, M., Herren, S., Wiles, M.V., Pepys, M.B., and Kosco-Vilbois, M.H. (1998). Interleukin 6
influences germinal center development and antibody production via a contribution of C3
complement component. The Journal of experimental medicine 188, 1895-1906.
Koralov, S.B., Novobrantseva, T.I., Konigsmann, J., Ehlich, A., and Rajewsky, K. (2006).
Antibody repertoires generated by VH replacement and direct VH to JH joining. Immunity 25, 4353.
Koretzky, G.A., Abtahian, F., and Silverman, M.A. (2006). SLP76 and SLP65: complex regulation
of signalling in lymphocytes and beyond. Nat Rev Immunol 6, 67-78.

177

Kraus, M., Alimzhanov, M.B., Rajewsky, N., and Rajewsky, K. (2004). Survival of resting mature
B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell 117, 787-800.
Krautler, N.J., Suan, D., Butt, D., Bourne, K., Hermes, J.R., Chan, T.D., Sundling, C., Kaplan, W.,
Schofield, P., Jackson, J., et al. (2017). Differentiation of germinal center B cells into plasma cells
is initiated by high-affinity antigen and completed by Tfh cells. The Journal of experimental
medicine 214, 1259-1267.
Krokan, H.E., and Bjoras, M. (2013). Base excision repair. Cold Spring Harb Perspect Biol 5,
a012583.
Kuroda, N., Mitani, T., Takeda, N., Ishimaru, N., Arakaki, R., Hayashi, Y., Bando, Y., Izumi, K.,
Takahashi, T., Nomura, T., et al. (2005). Development of autoimmunity against transcriptionally
unrepressed target antigen in the thymus of Aire-deficient mice. J Immunol 174, 1862-1870.
Kyewski, B., and Klein, L. (2006). A central role for central tolerance. Annu Rev Immunol 24,
571-606.
Laakso, S.M., Laurinolli, T.T., Rossi, L.H., Lehtoviita, A., Sairanen, H., Perheentupa, J.,
Kekalainen, E., and Arstila, T.P. (2010). Regulatory T cell defect in APECED patients is
associated with loss of naive FOXP3(+) precursors and impaired activated population. J
Autoimmun 35, 351-357.
Laan, M., Kisand, K., Kont, V., Moll, K., Tserel, L., Scott, H.S., and Peterson, P. (2009).
Autoimmune regulator deficiency results in decreased expression of CCR4 and CCR7 ligands and
in delayed migration of CD4+ thymocytes. J Immunol 183, 7682-7691.
Lam, K.P., Kuhn, R., and Rajewsky, K. (1997). In vivo ablation of surface immunoglobulin on
mature B cells by inducible gene targeting results in rapid cell death. Cell 90, 1073-1083.

178

Lam, K.P., and Rajewsky, K. (1999). B cell antigen receptor specificity and surface density
together determine B-1 versus B-2 cell development. The Journal of experimental medicine 190,
471-477.
Langerak, P., Nygren, A.O., Krijger, P.H., van den Berk, P.C., and Jacobs, H. (2007). A/T
mutagenesis in hypermutated immunoglobulin genes strongly depends on PCNAK164
modification. The Journal of experimental medicine 204, 1989-1998.
LaRocca, T.J., Holthausen, D.J., Hsieh, C., Renken, C., Mannella, C.A., and Benach, J.L. (2009).
The bactericidal effect of a complement-independent antibody is osmolytic and specific to Borrelia.
Proceedings of the National Academy of Sciences of the United States of America 106, 1075210757.
Lau, C.M., Broughton, C., Tabor, A.S., Akira, S., Flavell, R.A., Mamula, M.J., Christensen, S.R.,
Shlomchik, M.J., Viglianti, G.A., Rifkin, I.R., et al. (2005). RNA-associated autoantigens activate
B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. The Journal of
experimental medicine 202, 1171-1177.
Lee, J.W., Epardaud, M., Sun, J., Becker, J.E., Cheng, A.C., Yonekura, A.R., Heath, J.K., and
Turley, S.J. (2007). Peripheral antigen display by lymph node stroma promotes T cell tolerance to
intestinal self. Nat Immunol 8, 181-190.
Lei, Y., Ripen, A.M., Ishimaru, N., Ohigashi, I., Nagasawa, T., Jeker, L.T., Bosl, M.R., Hollander,
G.A., Hayashi, Y., Malefyt Rde, W., et al. (2011). Aire-dependent production of XCL1 mediates
medullary accumulation of thymic dendritic cells and contributes to regulatory T cell development.
The Journal of experimental medicine 208, 383-394.
Li, W.Q., Jiang, Q., Khaled, A.R., Keller, J.R., and Durum, S.K. (2004). Interleukin-7 inactivates
the pro-apoptotic protein Bad promoting T cell survival. J Biol Chem 279, 29160-29166.

179

Li, X., Gadzinsky, A., Gong, L., Tong, H., Calderon, V., Li, Y., Kitamura, D., Klein, U., Langdon,
W.Y., Hou, F., et al. (2018). Cbl Ubiquitin Ligases Control B Cell Exit from the Germinal-Center
Reaction. Immunity 48, 530-541 e536.
Li, Y.S., Wasserman, R., Hayakawa, K., and Hardy, R.R. (1996). Identification of the earliest B
lineage stage in mouse bone marrow. Immunity 5, 527-535.
Lieber, M.R. (2010). The mechanism of double-strand DNA break repair by the nonhomologous
DNA end-joining pathway. Annu Rev Biochem 79, 181-211.
Liiv, I., Rebane, A., Org, T., Saare, M., Maslovskaja, J., Kisand, K., Juronen, E., Valmu, L.,
Bottomley, M.J., Kalkkinen, N., et al. (2008). DNA-PK contributes to the phosphorylation of
AIRE: importance in transcriptional activity. Biochim Biophys Acta 1783, 74-83.
Lin, W.C., and Desiderio, S. (1994). Cell cycle regulation of V(D)J recombination-activating
protein RAG-2. Proceedings of the National Academy of Sciences of the United States of America
91, 2733-2737.
Lindstrom, D.L., Squazzo, S.L., Muster, N., Burckin, T.A., Wachter, K.C., Emigh, C.A., McCleery,
J.A., Yates, J.R., 3rd, and Hartzog, G.A. (2003). Dual roles for Spt5 in pre-mRNA processing and
transcription elongation revealed by identification of Spt5-associated proteins. Mol Cell Biol 23,
1368-1378.
Liston, A., Lesage, S., Wilson, J., Peltonen, L., and Goodnow, C.C. (2003). Aire regulates negative
selection of organ-specific T cells. Nat Immunol 4, 350-354.
Liu, L., Wang, P., Nair, M.S., Yu, J., Rapp, M., Wang, Q., Luo, Y., Chan, J.F., Sahi, V., Figueroa,
A., et al. (2020). Potent Neutralizing Monoclonal Antibodies Directed to Multiple Epitopes on the
SARS-CoV-2 Spike. bioRxiv.

180

Liu, M., Duke, J.L., Richter, D.J., Vinuesa, C.G., Goodnow, C.C., Kleinstein, S.H., and Schatz,
D.G. (2008). Two levels of protection for the B cell genome during somatic hypermutation. Nature
451, 841-845.
Liu, X., Kraus, W.L., and Bai, X. (2015). Ready, pause, go: regulation of RNA polymerase II
pausing and release by cellular signaling pathways. Trends Biochem Sci 40, 516-525.
Liu, Y.J., Joshua, D.E., Williams, G.T., Smith, C.A., Gordon, J., and MacLennan, I.C. (1989).
Mechanism of antigen-driven selection in germinal centres. Nature 342, 929-931.
Lo, W.L., Felix, N.J., Walters, J.J., Rohrs, H., Gross, M.L., and Allen, P.M. (2009). An
endogenous peptide positively selects and augments the activation and survival of peripheral
CD4+ T cells. Nat Immunol 10, 1155-1161.
Lu, L., Chaudhury, P., and Osmond, D.G. (1999). Regulation of cell survival during B
lymphopoiesis: apoptosis and Bcl-2/Bax content of precursor B cells in bone marrow of mice with
altered expression of IL-7 and recombinase-activating gene-2. J Immunol 162, 1931-1940.
Luo, W., Weisel, F., and Shlomchik, M.J. (2018). B Cell Receptor and CD40 Signaling Are
Rewired for Synergistic Induction of the c-Myc Transcription Factor in Germinal Center B Cells.
Immunity 48, 313-326 e315.
Macchi, P., Villa, A., Giliani, S., Sacco, M.G., Frattini, A., Porta, F., Ugazio, A.G., Johnston, J.A.,
Candotti, F., O'Shea, J.J., et al. (1995). Mutations of Jak-3 gene in patients with autosomal severe
combined immune deficiency (SCID). Nature 377, 65-68.
Maciejewski, J.P., Weichold, F.F., Young, N.S., Cara, A., Zella, D., Reitz, M.S., Jr., and Gallo,
R.C. (1995). Intracellular expression of antibody fragments directed against HIV reverse
transcriptase prevents HIV infection in vitro. Nat Med 1, 667-673.

181

Mackay, I.R. (2010). Travels and travails of autoimmunity: a historical journey from discovery to
rediscovery. Autoimmun Rev 9, A251-258.
MacLennan, I.C., Toellner, K.M., Cunningham, A.F., Serre, K., Sze, D.M., Zuniga, E., Cook, M.C.,
and Vinuesa, C.G. (2003). Extrafollicular antibody responses. Immunol Rev 194, 8-18.
Macpherson, A.J., Gatto, D., Sainsbury, E., Harriman, G.R., Hengartner, H., and Zinkernagel, R.M.
(2000). A primitive T cell-independent mechanism of intestinal mucosal IgA responses to
commensal bacteria. Science 288, 2222-2226.
Malchow, S., Leventhal, D.S., Lee, V., Nishi, S., Socci, N.D., and Savage, P.A. (2016). Aire
Enforces Immune Tolerance by Directing Autoreactive T Cells into the Regulatory T Cell Lineage.
Immunity 44, 1102-1113.
Malchow, S., Leventhal, D.S., Nishi, S., Fischer, B.I., Shen, L., Paner, G.P., Amit, A.S., Kang, C.,
Geddes, J.E., Allison, J.P., et al. (2013). Aire-dependent thymic development of tumor-associated
regulatory T cells. Science 339, 1219-1224.
Mallery, D.L., McEwan, W.A., Bidgood, S.R., Towers, G.J., Johnson, C.M., and James, L.C.
(2010). Antibodies mediate intracellular immunity through tripartite motif-containing 21
(TRIM21). Proceedings of the National Academy of Sciences of the United States of America 107,
19985-19990.
Mandel, T.E., Phipps, R.P., Abbot, A., and Tew, J.G. (1980). The follicular dendritic cell: long
term antigen retention during immunity. Immunol Rev 53, 29-59.
Mandel, T.E., Phipps, R.P., Abbot, A.P., and Tew, J.G. (1981). Long-term antigen retention by
dendritic cells in the popliteal lymph node of immunized mice. Immunology 43, 353-362.

182

Manis, J.P., Gu, Y., Lansford, R., Sonoda, E., Ferrini, R., Davidson, L., Rajewsky, K., and Alt,
F.W. (1998). Ku70 is required for late B cell development and immunoglobulin heavy chain class
switching. The Journal of experimental medicine 187, 2081-2089.
Mansson, R., Zandi, S., Welinder, E., Tsapogas, P., Sakaguchi, N., Bryder, D., and Sigvardsson,
M. (2010). Single-cell analysis of the common lymphoid progenitor compartment reveals
functional and molecular heterogeneity. Blood 115, 2601-2609.
Marrack, P., Ignatowicz, L., Kappler, J.W., Boymel, J., and Freed, J.H. (1993). Comparison of
peptides bound to spleen and thymus class II. The Journal of experimental medicine 178, 21732183.
Marrack, P., and Kappler, J. (1987). The T cell receptor. Science 238, 1073-1079.
Marshall, N.F., Peng, J., Xie, Z., and Price, D.H. (1996). Control of RNA polymerase II elongation
potential by a novel carboxyl-terminal domain kinase. J Biol Chem 271, 27176-27183.
Martin, F., Oliver, A.M., and Kearney, J.F. (2001). Marginal zone and B1 B cells unite in the early
response against T-independent blood-borne particulate antigens. Immunity 14, 617-629.
Maruyama, M., Lam, K.P., and Rajewsky, K. (2000). Memory B-cell persistence is independent
of persisting immunizing antigen. Nature 407, 636-642.
Maul, R.W., MacCarthy, T., Frank, E.G., Donigan, K.A., McLenigan, M.P., Yang, W., Saribasak,
H., Huston, D.E., Lange, S.S., Woodgate, R., et al. (2016). DNA polymerase iota functions in the
generation of tandem mutations during somatic hypermutation of antibody genes. The Journal of
experimental medicine 213, 1675-1683.
Mayer, A., Schreieck, A., Lidschreiber, M., Leike, K., Martin, D.E., and Cramer, P. (2012). The
spt5 C-terminal region recruits yeast 3' RNA cleavage factor I. Mol Cell Biol 32, 1321-1331.

183

Mayer, C.T., Gazumyan, A., Kara, E.E., Gitlin, A.D., Golijanin, J., Viant, C., Pai, J., Oliveira,
T.Y., Wang, Q., Escolano, A., et al. (2017). The microanatomic segregation of selection by
apoptosis in the germinal center. Science 358.
McBlane, J.F., van Gent, D.C., Ramsden, D.A., Romeo, C., Cuomo, C.A., Gellert, M., and
Oettinger, M.A. (1995). Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2
proteins and occurs in two steps. Cell 83, 387-395.
McBride, K.M., Barreto, V., Ramiro, A.R., Stavropoulos, P., and Nussenzweig, M.C. (2004).
Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced
deaminase. The Journal of experimental medicine 199, 1235-1244.
McBride, K.M., Gazumyan, A., Woo, E.M., Barreto, V.M., Robbiani, D.F., Chait, B.T., and
Nussenzweig, M.C. (2006). Regulation of hypermutation by activation-induced cytidine
deaminase phosphorylation. Proceedings of the National Academy of Sciences of the United States
of America 103, 8798-8803.
McClelland, E.E., Nicola, A.M., Prados-Rosales, R., and Casadevall, A. (2010). Ab binding alters
gene expression in Cryptococcus neoformans and directly modulates fungal metabolism. J Clin
Invest 120, 1355-1361.
McKean, D., Huppi, K., Bell, M., Staudt, L., Gerhard, W., and Weigert, M. (1984). Generation of
antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin.
Proceedings of the National Academy of Sciences of the United States of America 81, 3180-3184.
Mesin, L., Schiepers, A., Ersching, J., Barbulescu, A., Cavazzoni, C.B., Angelini, A., Okada, T.,
Kurosaki, T., and Victora, G.D. (2020). Restricted Clonality and Limited Germinal Center Reentry
Characterize Memory B Cell Reactivation by Boosting. Cell 180, 92-106 e111.

184

Methot, S.P., and Di Noia, J.M. (2017). Molecular Mechanisms of Somatic Hypermutation and
Class Switch Recombination. Adv Immunol 133, 37-87.
Meyer-Hermann, M., Mohr, E., Pelletier, N., Zhang, Y., Victora, G.D., and Toellner, K.M. (2012).
A theory of germinal center B cell selection, division, and exit. Cell Rep 2, 162-174.
Meyer-Hermann, M.E., Maini, P.K., and Iber, D. (2006). An analysis of B cell selection
mechanisms in germinal centers. Math Med Biol 23, 255-277.
Meyer, S., Woodward, M., Hertel, C., Vlaicu, P., Haque, Y., Karner, J., Macagno, A., Onuoha,
S.C., Fishman, D., Peterson, H., et al. (2016). AIRE-Deficient Patients Harbor Unique HighAffinity Disease-Ameliorating Autoantibodies. Cell 166, 582-595.
Miescher, P., and Fauconnet, M. (1954). [Absorption of L. E. factor by isolated cell nuclei].
Experientia 10, 252-253.
Mietzner, B., Tsuiji, M., Scheid, J., Velinzon, K., Tiller, T., Abraham, K., Gonzalez, J.B., Pascual,
V., Stichweh, D., Wardemann, H., et al. (2008). Autoreactive IgG memory antibodies in patients
with systemic lupus erythematosus arise from nonreactive and polyreactive precursors.
Proceedings of the National Academy of Sciences of the United States of America 105, 9727-9732.
Minegishi, Y., Coustan-Smith, E., Wang, Y.H., Cooper, M.D., Campana, D., and Conley, M.E.
(1998). Mutations in the human lambda5/14.1 gene result in B cell deficiency and
agammaglobulinemia. The Journal of experimental medicine 187, 71-77.
Misslitz, A., Pabst, O., Hintzen, G., Ohl, L., Kremmer, E., Petrie, H.T., and Forster, R. (2004).
Thymic T cell development and progenitor localization depend on CCR7. The Journal of
experimental medicine 200, 481-491.
Moldovan, G.L., Pfander, B., and Jentsch, S. (2007). PCNA, the maestro of the replication fork.
Cell 129, 665-679.

185

Montecino-Rodriguez, E., Leathers, H., and Dorshkind, K. (2006). Identification of a B-1 B cellspecified progenitor. Nat Immunol 7, 293-301.
Moran, A.E., Holzapfel, K.L., Xing, Y., Cunningham, N.R., Maltzman, J.S., Punt, J., and Hogquist,
K.A. (2011). T cell receptor signal strength in Treg and iNKT cell development demonstrated by
a novel fluorescent reporter mouse. The Journal of experimental medicine 208, 1279-1289.
Morrison, S.J., and Weissman, I.L. (1994). The long-term repopulating subset of hematopoietic
stem cells is deterministic and isolatable by phenotype. Immunity 1, 661-673.
Morrow, M.A., Lee, G., Gillis, S., Yancopoulos, G.D., and Alt, F.W. (1992). Interleukin-7 induces
N-myc and c-myc expression in normal precursor B lymphocytes. Genes Dev 6, 61-70.
Mourik, B.C., Lubberts, E., de Steenwinkel, J.E.M., Ottenhoff, T.H.M., and Leenen, P.J.M. (2017).
Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned
from Autoimmune Diseases. Front Immunol 8, 294.
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., and Honjo, T. (2000). Class
switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a
potential RNA editing enzyme. Cell 102, 553-563.
Muramatsu, M., Sankaranand, V.S., Anant, S., Sugai, M., Kinoshita, K., Davidson, N.O., and
Honjo, T. (1999). Specific expression of activation-induced cytidine deaminase (AID), a novel
member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 274, 1847018476.
Murata, S., Sasaki, K., Kishimoto, T., Niwa, S., Hayashi, H., Takahama, Y., and Tanaka, K. (2007).
Regulation of CD8+ T cell development by thymus-specific proteasomes. Science 316, 1349-1353.

186

Nagamine, K., Peterson, P., Scott, H.S., Kudoh, J., Minoshima, S., Heino, M., Krohn, K.J., Lalioti,
M.D., Mullis, P.E., Antonarakis, S.E., et al. (1997). Positional cloning of the APECED gene. Nat
Genet 17, 393-398.
Naito, Y., Takematsu, H., Koyama, S., Miyake, S., Yamamoto, H., Fujinawa, R., Sugai, M., Okuno,
Y., Tsujimoto, G., Yamaji, T., et al. (2007). Germinal center marker GL7 probes activationdependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative
modulation of B-cell activation. Mol Cell Biol 27, 3008-3022.
Negishi, I., Motoyama, N., Nakayama, K., Nakayama, K., Senju, S., Hatakeyama, S., Zhang, Q.,
Chan, A.C., and Loh, D.Y. (1995). Essential role for ZAP-70 in both positive and negative
selection of thymocytes. Nature 376, 435-438.
Nemazee, D.A., and Burki, K. (1989). Clonal deletion of B lymphocytes in a transgenic mouse
bearing anti-MHC class I antibody genes. Nature 337, 562-566.
Neufeld, M., Maclaren, N.K., and Blizzard, R.M. (1981). Two types of autoimmune Addison's
disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine
(Baltimore) 60, 355-362.
Ng, W.F., von Delwig, A., Carmichael, A.J., Arkwright, P.D., Abinun, M., Cant, A.J., Jolles, S.,
and Lilic, D. (2010). Impaired T(H)17 responses in patients with chronic mucocutaneous
candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
J Allergy Clin Immunol 126, 1006-1015, 1015 e1001-1004.
Nguyen, V.T., Kiss, T., Michels, A.A., and Bensaude, O. (2001). 7SK small nuclear RNA binds
to and inhibits the activity of CDK9/cyclin T complexes. Nature 414, 322-325.
Nossal, G.J. (1959). Antibody production by single cells. III. The histology of antibody production.
Br J Exp Pathol 40, 301-311.

187

Ogawa, M., ten Boekel, E., and Melchers, F. (2000). Identification of CD19(-)B220(+)cKit(+)Flt3/Flk-2(+)cells as early B lymphoid precursors before pre-B-I cells in juvenile mouse
bone marrow. Int Immunol 12, 313-324.
Okada, T., Miller, M.J., Parker, I., Krummel, M.F., Neighbors, M., Hartley, S.B., O'Garra, A.,
Cahalan, M.D., and Cyster, J.G. (2005). Antigen-engaged B cells undergo chemotaxis toward the
T zone and form motile conjugates with helper T cells. PLoS Biol 3, e150.
Okamoto, M., Murakami, M., Shimizu, A., Ozaki, S., Tsubata, T., Kumagai, S., and Honjo, T.
(1992). A transgenic model of autoimmune hemolytic anemia. The Journal of experimental
medicine 175, 71-79.
Oliver, A.M., Martin, F., and Kearney, J.F. (1997). Mouse CD38 is down-regulated on germinal
center B cells and mature plasma cells. J Immunol 158, 1108-1115.
Org, T., Rebane, A., Kisand, K., Laan, M., Haljasorg, U., Andreson, R., and Peterson, P. (2009).
AIRE activated tissue specific genes have histone modifications associated with inactive
chromatin. Hum Mol Genet 18, 4699-4710.
Orthwein, A., Patenaude, A.M., Affar el, B., Lamarre, A., Young, J.C., and Di Noia, J.M. (2010).
Regulation of activation-induced deaminase stability and antibody gene diversification by Hsp90.
The Journal of experimental medicine 207, 2751-2765.
Osawa, M., Hanada, K., Hamada, H., and Nakauchi, H. (1996). Long-term lymphohematopoietic
reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273, 242-245.
Pachl, J., Svoboda, P., Jacobs, F., Vandewoude, K., van der Hoven, B., Spronk, P., Masterson, G.,
Malbrain, M., Aoun, M., Garbino, J., et al. (2006). A randomized, blinded, multicenter trial of
lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of
heat shock protein 90 in patients with invasive candidiasis. Clin Infect Dis 42, 1404-1413.

188

Pan-Hammarstrom, Q., Jones, A.M., Lahdesmaki, A., Zhou, W., Gatti, R.A., Hammarstrom, L.,
Gennery, A.R., and Ehrenstein, M.R. (2005). Impact of DNA ligase IV on nonhomologous end
joining pathways during class switch recombination in human cells. The Journal of experimental
medicine 201, 189-194.
Pao, L.I., Lam, K.P., Henderson, J.M., Kutok, J.L., Alimzhanov, M., Nitschke, L., Thomas, M.L.,
Neel, B.G., and Rajewsky, K. (2007). B cell-specific deletion of protein-tyrosine phosphatase Shp1
promotes B-1a cell development and causes systemic autoimmunity. Immunity 27, 35-48.
Pappu, R., Cheng, A.M., Li, B., Gong, Q., Chiu, C., Griffin, N., White, M., Sleckman, B.P., and
Chan, A.C. (1999). Requirement for B cell linker protein (BLNK) in B cell development. Science
286, 1949-1954.
Park, S.R., Kim, P.H., Lee, K.S., Lee, S.H., Seo, G.Y., Yoo, Y.C., Lee, J., and Casali, P. (2013).
APRIL stimulates NF-kappaB-mediated HoxC4 induction for AID expression in mouse B cells.
Cytokine 61, 608-613.
Park, S.R., Zan, H., Pal, Z., Zhang, J., Al-Qahtani, A., Pone, E.J., Xu, Z., Mai, T., and Casali, P.
(2009). HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID
expression, class-switch DNA recombination and somatic hypermutation. Nat Immunol 10, 540550.
Pavri, R., Gazumyan, A., Jankovic, M., Di Virgilio, M., Klein, I., Ansarah-Sobrinho, C., Resch,
W., Yamane, A., Reina San-Martin, B., Barreto, V., et al. (2010). Activation-induced cytidine
deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell 143,
122-133.
Pei, Y., and Shuman, S. (2002). Interactions between fission yeast mRNA capping enzymes and
elongation factor Spt5. J Biol Chem 277, 19639-19648.

189

Peng, J., Zhu, Y., Milton, J.T., and Price, D.H. (1998). Identification of multiple cyclin subunits
of human P-TEFb. Genes Dev 12, 755-762.
Pereira, J.P., Kelly, L.M., Xu, Y., and Cyster, J.G. (2009). EBI2 mediates B cell segregation
between the outer and centre follicle. Nature 460, 1122-1126.
Perry, J.S.A., Lio, C.J., Kau, A.L., Nutsch, K., Yang, Z., Gordon, J.I., Murphy, K.M., and Hsieh,
C.S. (2014). Distinct contributions of Aire and antigen-presenting-cell subsets to the generation of
self-tolerance in the thymus. Immunity 41, 414-426.
Petersen-Mahrt, S.K., Harris, R.S., and Neuberger, M.S. (2002). AID mutates E. coli suggesting a
DNA deamination mechanism for antibody diversification. Nature 418, 99-103.
Peterson, P., Org, T., and Rebane, A. (2008). Transcriptional regulation by AIRE: molecular
mechanisms of central tolerance. Nat Rev Immunol 8, 948-957.
Petricevic, B., Laengle, J., Singer, J., Sachet, M., Fazekas, J., Steger, G., Bartsch, R., JensenJarolim, E., and Bergmann, M. (2013). Trastuzumab mediates antibody-dependent cell-mediated
cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast
cancer patients. J Transl Med 11, 307.
Phalipon, A., Cardona, A., Kraehenbuhl, J.P., Edelman, L., Sansonetti, P.J., and Corthesy, B.
(2002). Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo.
Immunity 17, 107-115.
Phan, R.T., and Dalla-Favera, R. (2004). The BCL6 proto-oncogene suppresses p53 expression in
germinal-centre B cells. Nature 432, 635-639.
Phan, T.G., Grigorova, I., Okada, T., and Cyster, J.G. (2007). Subcapsular encounter and
complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol 8,
992-1000.

190

Pitkanen, J., Doucas, V., Sternsdorf, T., Nakajima, T., Aratani, S., Jensen, K., Will, H., Vahamurto,
P., Ollila, J., Vihinen, M., et al. (2000). The autoimmune regulator protein has transcriptional
transactivating properties and interacts with the common coactivator CREB-binding protein. J Biol
Chem 275, 16802-16809.
Pitkanen, J., Rebane, A., Rowell, J., Murumagi, A., Strobel, P., Moll, K., Saare, M., Heikkila, J.,
Doucas, V., Marx, A., et al. (2005). Cooperative activation of transcription by autoimmune
regulator AIRE and CBP. Biochem Biophys Res Commun 333, 944-953.
Poliani, P.L., Kisand, K., Marrella, V., Ravanini, M., Notarangelo, L.D., Villa, A., Peterson, P.,
and Facchetti, F. (2010). Human peripheral lymphoid tissues contain autoimmune regulatorexpressing dendritic cells. Am J Pathol 176, 1104-1112.
Pone, E.J., Zhang, J., Mai, T., White, C.A., Li, G., Sakakura, J.K., Patel, P.J., Al-Qahtani, A., Zan,
H., Xu, Z., et al. (2012). BCR-signalling synergizes with TLR-signalling for induction of AID and
immunoglobulin class-switching through the non-canonical NF-kappaB pathway. Nat Commun 3,
767.
Porritt, H.E., Rumfelt, L.L., Tabrizifard, S., Schmitt, T.M., Zuniga-Pflucker, J.C., and Petrie, H.T.
(2004). Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different
capacities to generate T cell and non-T cell lineages. Immunity 20, 735-745.
Puel, A., Doffinger, R., Natividad, A., Chrabieh, M., Barcenas-Morales, G., Picard, C., Cobat, A.,
Ouachee-Chardin, M., Toulon, A., Bustamante, J., et al. (2010). Autoantibodies against IL-17A,
IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune
polyendocrine syndrome type I. The Journal of experimental medicine 207, 291-297.
Puel, A., Ziegler, S.F., Buckley, R.H., and Leonard, W.J. (1998). Defective IL7R expression in
T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 20, 394-397.

191

Puga, I., Cols, M., Barra, C.M., He, B., Cassis, L., Gentile, M., Comerma, L., Chorny, A., Shan,
M., Xu, W., et al. (2011). B cell-helper neutrophils stimulate the diversification and production of
immunoglobulin in the marginal zone of the spleen. Nat Immunol 13, 170-180.
Qi, C.F., Li, Z., Raffeld, M., Wang, H., Kovalchuk, A.L., and Morse, H.C., 3rd (2009). Differential
expression of IRF8 in subsets of macrophages and dendritic cells and effects of IRF8 deficiency
on splenic B cell and macrophage compartments. Immunol Res 45, 62-74.
Qiao, Q., Wang, L., Meng, F.L., Hwang, J.K., Alt, F.W., and Wu, H. (2017). AID Recognizes
Structured DNA for Class Switch Recombination. Mol Cell 67, 361-373 e364.
Rada, C., Di Noia, J.M., and Neuberger, M.S. (2004). Mismatch recognition and uracil excision
provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation.
Mol Cell 16, 163-171.
Rada, C., Williams, G.T., Nilsen, H., Barnes, D.E., Lindahl, T., and Neuberger, M.S. (2002).
Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNGdeficient mice. Curr Biol 12, 1748-1755.
Radhakrishnan, K., Bhagya, K.P., Kumar, A.T., Devi, A.N., Sengottaiyan, J., and Kumar, P.G.
(2016). Autoimmune Regulator (AIRE) Is Expressed in Spermatogenic Cells, and It Altered the
Expression of Several Nucleic-Acid-Binding and Cytoskeletal Proteins in Germ Cell 1
Spermatogonial (GC1-spg) Cells. Mol Cell Proteomics 15, 2686-2698.
Rajewsky, K. (1996). Clonal selection and learning in the antibody system. Nature 381, 751-758.
Ramiro, A.R., Jankovic, M., Eisenreich, T., Difilippantonio, S., Chen-Kiang, S., Muramatsu, M.,
Honjo, T., Nussenzweig, A., and Nussenzweig, M.C. (2004). AID is required for c-myc/IgH
chromosome translocations in vivo. Cell 118, 431-438.

192

Ramsey, C., Winqvist, O., Puhakka, L., Halonen, M., Moro, A., Kampe, O., Eskelin, P., PeltoHuikko, M., and Peltonen, L. (2002). Aire deficient mice develop multiple features of APECED
phenotype and show altered immune response. Hum Mol Genet 11, 397-409.
Ranuncolo, S.M., Polo, J.M., Dierov, J., Singer, M., Kuo, T., Greally, J., Green, R., Carroll, M.,
and Melnick, A. (2007). Bcl-6 mediates the germinal center B cell phenotype and
lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR. Nat
Immunol 8, 705-714.
Ravetch, J.V., and Lanier, L.L. (2000). Immune inhibitory receptors. Science 290, 84-89.
Reina-San-Martin, B., Difilippantonio, S., Hanitsch, L., Masilamani, R.F., Nussenzweig, A., and
Nussenzweig, M.C. (2003). H2AX is required for recombination between immunoglobulin switch
regions but not for intra-switch region recombination or somatic hypermutation. The Journal of
experimental medicine 197, 1767-1778.
Revy, P., Muto, T., Levy, Y., Geissmann, F., Plebani, A., Sanal, O., Catalan, N., Forveille, M.,
Dufourcq-Labelouse, R., Gennery, A., et al. (2000). Activation-induced cytidine deaminase (AID)
deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102,
565-575.
Roa, S., Avdievich, E., Peled, J.U., Maccarthy, T., Werling, U., Kuang, F.L., Kan, R., Zhao, C.,
Bergman, A., Cohen, P.E., et al. (2008). Ubiquitylated PCNA plays a role in somatic
hypermutation and class-switch recombination and is required for meiotic progression.
Proceedings of the National Academy of Sciences of the United States of America 105, 1624816253.
Robbins, W.C., Holman, H.R., Deicher, H., and Kunkel, H.G. (1957). Complement fixation with
cell nuclei and DNA in lupus erythematosus. Proc Soc Exp Biol Med 96, 575-579.

193

Roco, J.A., Mesin, L., Binder, S.C., Nefzger, C., Gonzalez-Figueroa, P., Canete, P.F., Ellyard, J.,
Shen, Q., Robert, P.A., Cappello, J., et al. (2019). Class-Switch Recombination Occurs
Infrequently in Germinal Centers. Immunity 51, 337-350 e337.
Rogers, T.F., Zhao, F., Huang, D., Beutler, N., Burns, A., He, W.T., Limbo, O., Smith, C., Song,
G., Woehl, J., et al. (2020). Isolation of potent SARS-CoV-2 neutralizing antibodies and protection
from disease in a small animal model. Science 369, 956-963.
Rose, M.L., Birbeck, M.S., Wallis, V.J., Forrester, J.A., and Davies, A.J. (1980). Peanut lectin
binding properties of germinal centres of mouse lymphoid tissue. Nature 284, 364-366.
Rossi, F.M., Corbel, S.Y., Merzaban, J.S., Carlow, D.A., Gossens, K., Duenas, J., So, L., Yi, L.,
and Ziltener, H.J. (2005). Recruitment of adult thymic progenitors is regulated by P-selectin and
its ligand PSGL-1. Nat Immunol 6, 626-634.
Rossi, S.W., Kim, M.Y., Leibbrandt, A., Parnell, S.M., Jenkinson, W.E., Glanville, S.H.,
McConnell, F.M., Scott, H.S., Penninger, J.M., Jenkinson, E.J., et al. (2007). RANK signals from
CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic
medulla. The Journal of experimental medicine 204, 1267-1272.
Rother, M.B., Schreurs, M.W., Kroek, R., Bartol, S.J., van Dongen, J.J., and van Zelm, M.C.
(2016). The Human Thymus Is Enriched for Autoreactive B Cells. J Immunol 197, 441-448.
Rougvie, A.E., and Lis, J.T. (1988). The RNA polymerase II molecule at the 5' end of the
uninduced hsp70 gene of D. melanogaster is transcriptionally engaged. Cell 54, 795-804.
Rougvie, A.E., and Lis, J.T. (1990). Postinitiation transcriptional control in Drosophila
melanogaster. Mol Cell Biol 10, 6041-6045.

194

Rubtsov, A.V., Swanson, C.L., Troy, S., Strauch, P., Pelanda, R., and Torres, R.M. (2008). TLR
agonists promote marginal zone B cell activation and facilitate T-dependent IgM responses. J
Immunol 180, 3882-3888.
Russell, S.M., Tayebi, N., Nakajima, H., Riedy, M.C., Roberts, J.L., Aman, M.J., Migone, T.S.,
Noguchi, M., Markert, M.L., Buckley, R.H., et al. (1995). Mutation of Jak3 in a patient with SCID:
essential role of Jak3 in lymphoid development. Science 270, 797-800.
Saito, M., Novak, U., Piovan, E., Basso, K., Sumazin, P., Schneider, C., Crespo, M., Shen, Q.,
Bhagat, G., Califano, A., et al. (2009). BCL6 suppression of BCL2 via Miz1 and its disruption in
diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences of the United
States of America 106, 11294-11299.
Saltis, M., Criscitiello, M.F., Ohta, Y., Keefe, M., Trede, N.S., Goitsuka, R., and Flajnik, M.F.
(2008). Evolutionarily conserved and divergent regions of the autoimmune regulator (Aire) gene:
a comparative analysis. Immunogenetics 60, 105-114.
Sambandam, A., Maillard, I., Zediak, V.P., Xu, L., Gerstein, R.M., Aster, J.C., Pear, W.S., and
Bhandoola, A. (2005). Notch signaling controls the generation and differentiation of early T
lineage progenitors. Nat Immunol 6, 663-670.
Samuels, J., Ng, Y.S., Coupillaud, C., Paget, D., and Meffre, E. (2005). Impaired early B cell
tolerance in patients with rheumatoid arthritis. The Journal of experimental medicine 201, 16591667.
Schaetzlein, S., Chahwan, R., Avdievich, E., Roa, S., Wei, K., Eoff, R.L., Sellers, R.S., Clark,
A.B., Kunkel, T.A., Scharff, M.D., et al. (2013). Mammalian Exo1 encodes both structural and
catalytic functions that play distinct roles in essential biological processes. Proceedings of the
National Academy of Sciences of the United States of America 110, E2470-2479.

195

Schatz, D.G., and Swanson, P.C. (2011). V(D)J recombination: mechanisms of initiation. Annu
Rev Genet 45, 167-202.
Schmitt, T.M., Ciofani, M., Petrie, H.T., and Zuniga-Pflucker, J.C. (2004). Maintenance of T cell
specification and differentiation requires recurrent notch receptor-ligand interactions. The Journal
of experimental medicine 200, 469-479.
Scholz, J.L., Crowley, J.E., Tomayko, M.M., Steinel, N., O'Neill, P.J., Quinn, W.J., 3rd, Goenka,
R., Miller, J.P., Cho, Y.H., Long, V., et al. (2008). BLyS inhibition eliminates primary B cells but
leaves natural and acquired humoral immunity intact. Proceedings of the National Academy of
Sciences of the United States of America 105, 15517-15522.
Schrader, C.E., Linehan, E.K., Mochegova, S.N., Woodland, R.T., and Stavnezer, J. (2005).
Inducible DNA breaks in Ig S regions are dependent on AID and UNG. The Journal of
experimental medicine 202, 561-568.
Schroder, A.E., Greiner, A., Seyfert, C., and Berek, C. (1996). Differentiation of B cells in the
nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proceedings
of the National Academy of Sciences of the United States of America 93, 221-225.
Schwickert, T.A., Victora, G.D., Fooksman, D.R., Kamphorst, A.O., Mugnier, M.R., Gitlin, A.D.,
Dustin, M.L., and Nussenzweig, M.C. (2011). A dynamic T cell-limited checkpoint regulates
affinity-dependent B cell entry into the germinal center. The Journal of experimental medicine 208,
1243-1252.
Scimone, M.L., Aifantis, I., Apostolou, I., von Boehmer, H., and von Andrian, U.H. (2006). A
multistep adhesion cascade for lymphoid progenitor cell homing to the thymus. Proceedings of the
National Academy of Sciences of the United States of America 103, 7006-7011.

196

Sebzda, E., Kundig, T.M., Thomson, C.T., Aoki, K., Mak, S.Y., Mayer, J.P., Zamborelli, T.,
Nathenson, S.G., and Ohashi, P.S. (1996). Mature T cell reactivity altered by peptide agonist that
induces positive selection. The Journal of experimental medicine 183, 1093-1104.
Sebzda, E., Wallace, V.A., Mayer, J., Yeung, R.S., Mak, T.W., and Ohashi, P.S. (1994). Positive
and negative thymocyte selection induced by different concentrations of a single peptide. Science
263, 1615-1618.
Seifert, M., and Kuppers, R. (2009). Molecular footprints of a germinal center derivation of human
IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation. The Journal of
experimental medicine 206, 2659-2669.
Shaffer, A.L., Yu, X., He, Y., Boldrick, J., Chan, E.P., and Staudt, L.M. (2000). BCL-6 represses
genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity
13, 199-212.
Shi, J., Hou, S., Fang, Q., Liu, X., Liu, X., and Qi, H. (2018). PD-1 Controls Follicular T Helper
Cell Positioning and Function. Immunity 49, 264-274 e264.
Shore, S.L., Nahmias, A.J., Starr, S.E., Wood, P.A., and McFarlin, D.E. (1974). Detection of celldependent cytotoxic antibody to cells infected with herpes simplex virus. Nature 251, 350-352.
Sillanpaa, N., Magureanu, C.G., Murumagi, A., Reinikainen, A., West, A., Manninen, A., Lahti,
M., Ranki, A., Saksela, K., Krohn, K., et al. (2004). Autoimmune regulator induced changes in the
gene expression profile of human monocyte-dendritic cell-lineage. Mol Immunol 41, 1185-1198.
Sintes, J., Gentile, M., Zhang, S., Garcia-Carmona, Y., Magri, G., Cassis, L., Segura-Garzon, D.,
Ciociola, A., Grasset, E.K., Bascones, S., et al. (2017). mTOR intersects antibody-inducing signals
from TACI in marginal zone B cells. Nat Commun 8, 1462.

197

Smith, K.G., Light, A., Nossal, G.J., and Tarlinton, D.M. (1997). The extent of affinity maturation
differs between the memory and antibody-forming cell compartments in the primary immune
response. EMBO J 16, 2996-3006.
Soulas-Sprauel, P., Le Guyader, G., Rivera-Munoz, P., Abramowski, V., Olivier-Martin, C.,
Goujet-Zalc, C., Charneau, P., and de Villartay, J.P. (2007). Role for DNA repair factor XRCC4
in immunoglobulin class switch recombination. The Journal of experimental medicine 204, 17171727.
Soumya, V., Padmanabhan, R.A., Titus, S., and Laloraya, M. (2016). Murine uterine
decidualization is a novel function of autoimmune regulator-beyond immune tolerance. Am J
Reprod Immunol 76, 224-234.
Spangrude, G.J., Heimfeld, S., and Weissman, I.L. (1988). Purification and characterization of
mouse hematopoietic stem cells. Science 241, 58-62.
Stavnezer, J., Linehan, E.K., Thompson, M.R., Habboub, G., Ucher, A.J., Kadungure, T.,
Tsuchimoto, D., Nakabeppu, Y., and Schrader, C.E. (2014). Differential expression of APE1 and
APE2 in germinal centers promotes error-prone repair and A:T mutations during somatic
hypermutation. Proceedings of the National Academy of Sciences of the United States of America
111, 9217-9222.
Stritesky, G.L., Xing, Y., Erickson, J.R., Kalekar, L.A., Wang, X., Mueller, D.L., Jameson, S.C.,
and Hogquist, K.A. (2013). Murine thymic selection quantified using a unique method to capture
deleted T cells. Proceedings of the National Academy of Sciences of the United States of America
110, 4679-4684.

198

Su, M.A., Giang, K., Zumer, K., Jiang, H., Oven, I., Rinn, J.L., Devoss, J.J., Johannes, K.P., Lu,
W., Gardner, J., et al. (2008). Mechanisms of an autoimmunity syndrome in mice caused by a
dominant mutation in Aire. J Clin Invest 118, 1712-1726.
Takahashi, Y., Ohta, H., and Takemori, T. (2001). Fas is required for clonal selection in germinal
centers and the subsequent establishment of the memory B cell repertoire. Immunity 14, 181-192.
Takata, M., Sabe, H., Hata, A., Inazu, T., Homma, Y., Nukada, T., Yamamura, H., and Kurosaki,
T. (1994). Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization
through distinct pathways. EMBO J 13, 1341-1349.
Tangye, S.G., Liu, Y.J., Aversa, G., Phillips, J.H., and de Vries, J.E. (1998). Identification of
functional human splenic memory B cells by expression of CD148 and CD27. The Journal of
experimental medicine 188, 1691-1703.
Taniguchi, R.T., DeVoss, J.J., Moon, J.J., Sidney, J., Sette, A., Jenkins, M.K., and Anderson, M.S.
(2012). Detection of an autoreactive T-cell population within the polyclonal repertoire that
undergoes distinct autoimmune regulator (Aire)-mediated selection. Proceedings of the National
Academy of Sciences of the United States of America 109, 7847-7852.
Tao, Y., Kupfer, R., Stewart, B.J., Williams-Skipp, C., Crowell, C.K., Patel, D.D., Sain, S., and
Scheinman, R.I. (2006). AIRE recruits multiple transcriptional components to specific genomic
regions through tethering to nuclear matrix. Mol Immunol 43, 335-345.
Tarlinton, D.M., and Smith, K.G. (2000). Dissecting affinity maturation: a model explaining
selection of antibody-forming cells and memory B cells in the germinal centre. Immunol Today
21, 436-441.

199

Tas, J.M., Mesin, L., Pasqual, G., Targ, S., Jacobsen, J.T., Mano, Y.M., Chen, C.S., Weill, J.C.,
Reynaud, C.A., Browne, E.P., et al. (2016). Visualizing antibody affinity maturation in germinal
centers. Science 351, 1048-1054.
Tedder, T.F. (2015). B10 cells: a functionally defined regulatory B cell subset. J Immunol 194,
1395-1401.
Thien, M., Phan, T.G., Gardam, S., Amesbury, M., Basten, A., Mackay, F., and Brink, R. (2004).
Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter
forbidden follicular and marginal zone niches. Immunity 20, 785-798.
Thomas, A.A., Vrijsen, R., and Boeye, A. (1986). Relationship between poliovirus neutralization
and aggregation. J Virol 59, 479-485.
Thouvenin, E., Schoehn, G., Rey, F., Petitpas, I., Mathieu, M., Vaney, M.C., Cohen, J., Kohli, E.,
Pothier, P., and Hewat, E. (2001). Antibody inhibition of the transcriptase activity of the rotavirus
DLP: a structural view. J Mol Biol 307, 161-172.
Tierens, A., Delabie, J., Michiels, L., Vandenberghe, P., and De Wolf-Peeters, C. (1999).
Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and
display clonal expansion. Blood 93, 226-234.
Tiselius, A., and Kabat, E.A. (1938). Electrophoresis of Immune Serum. Science 87, 416-417.
Tornberg, U.C., and Holmberg, D. (1995). B-1a, B-1b and B-2 B cells display unique VHDJH
repertoires formed at different stages of ontogeny and under different selection pressures. EMBO
J 14, 1680-1689.
Tran, T.H., Nakata, M., Suzuki, K., Begum, N.A., Shinkura, R., Fagarasan, S., Honjo, T., and
Nagaoka, H. (2010). B cell-specific and stimulation-responsive enhancers derepress Aicda by
overcoming the effects of silencers. Nat Immunol 11, 148-154.

200

Treml, L.S., Carlesso, G., Hoek, K.L., Stadanlick, J.E., Kambayashi, T., Bram, R.J., Cancro, M.P.,
and Khan, W.N. (2007). TLR stimulation modifies BLyS receptor expression in follicular and
marginal zone B cells. J Immunol 178, 7531-7539.
Uchida, N., and Weissman, I.L. (1992). Searching for hematopoietic stem cells: evidence that Thy1.1lo Lin- Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow. The Journal
of experimental medicine 175, 175-184.
Uchimura, Y., Barton, L.F., Rada, C., and Neuberger, M.S. (2011). REG-gamma associates with
and modulates the abundance of nuclear activation-induced deaminase. The Journal of
experimental medicine 208, 2385-2391.
Uehara, S., Grinberg, A., Farber, J.M., and Love, P.E. (2002). A role for CCR9 in T lymphocyte
development and migration. J Immunol 168, 2811-2819.
van Gent, D.C., Mizuuchi, K., and Gellert, M. (1996). Similarities between initiation of V(D)J
recombination and retroviral integration. Science 271, 1592-1594.
van Oers, N.S., Lowin-Kropf, B., Finlay, D., Connolly, K., and Weiss, A. (1996). alpha beta T cell
development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases. Immunity 5,
429-436.
Varghese, R., Mikyas, Y., Stewart, P.L., and Ralston, R. (2004). Postentry neutralization of
adenovirus type 5 by an antihexon antibody. J Virol 78, 12320-12332.
Vicari, A.P., Figueroa, D.J., Hedrick, J.A., Foster, J.S., Singh, K.P., Menon, S., Copeland, N.G.,
Gilbert, D.J., Jenkins, N.A., Bacon, K.B., et al. (1997). TECK: a novel CC chemokine specifically
expressed by thymic dendritic cells and potentially involved in T cell development. Immunity 7,
291-301.
Victora, G.D., and Nussenzweig, M.C. (2012). Germinal centers. Annu Rev Immunol 30, 429-457.

201

Victora, G.D., Schwickert, T.A., Fooksman, D.R., Kamphorst, A.O., Meyer-Hermann, M., Dustin,
M.L., and Nussenzweig, M.C. (2010). Germinal center dynamics revealed by multiphoton
microscopy with a photoactivatable fluorescent reporter. Cell 143, 592-605.
Vieira, P., and Rajewsky, K. (1990). Persistence of memory B cells in mice deprived of T cell help.
Int Immunol 2, 487-494.
Viglianti, G.A., Lau, C.M., Hanley, T.M., Miko, B.A., Shlomchik, M.J., and Marshak-Rothstein,
A. (2003). Activation of autoreactive B cells by CpG dsDNA. Immunity 19, 837-847.
Vikstrom, I., Carotta, S., Luthje, K., Peperzak, V., Jost, P.J., Glaser, S., Busslinger, M., Bouillet,
P., Strasser, A., Nutt, S.L., et al. (2010). Mcl-1 is essential for germinal center formation and B
cell memory. Science 330, 1095-1099.
Vinuesa, C.G., Tangye, S.G., Moser, B., and Mackay, C.R. (2005). Follicular B helper T cells in
antibody responses and autoimmunity. Nat Rev Immunol 5, 853-865.
Volkmann, C., Brings, N., Becker, M., Hobeika, E., Yang, J., and Reth, M. (2016). Molecular
requirements of the B-cell antigen receptor for sensing monovalent antigens. EMBO J 35, 23712381.
von Boehmer, H., and Fehling, H.J. (1997). Structure and function of the pre-T cell receptor. Annu
Rev Immunol 15, 433-452.
Wada, T., Takagi, T., Yamaguchi, Y., Ferdous, A., Imai, T., Hirose, S., Sugimoto, S., Yano, K.,
Hartzog, G.A., Winston, F., et al. (1998). DSIF, a novel transcription elongation factor that
regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes
Dev 12, 343-356.

202

Wardemann, H., Yurasov, S., Schaefer, A., Young, J.W., Meffre, E., and Nussenzweig, M.C.
(2003). Predominant autoantibody production by early human B cell precursors. Science 301,
1374-1377.
Watanabe, M., and Blobel, G. (1989). Site-specific antibodies against the PrlA (secY) protein of
Escherichia coli inhibit protein export by interfering with plasma membrane binding of preproteins.
Proceedings of the National Academy of Sciences of the United States of America 86, 1895-1899.
Webby, C.J., Wolf, A., Gromak, N., Dreger, M., Kramer, H., Kessler, B., Nielsen, M.L., Schmitz,
C., Butler, D.S., Yates, J.R., 3rd, et al. (2009). Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a
protein associated with RNA splicing. Science 325, 90-93.
Wei, S., Perera, M.L.W., Sakhtemani, R., and Bhagwat, A.S. (2017). A novel class of chemicals
that react with abasic sites in DNA and specifically kill B cell cancers. PLoS One 12, e0185010.
Wei, S., Shalhout, S., Ahn, Y.H., and Bhagwat, A.S. (2015). A versatile new tool to quantify abasic
sites in DNA and inhibit base excision repair. DNA Repair (Amst) 27, 9-18.
Weigert, M.G., Cesari, I.M., Yonkovich, S.J., and Cohn, M. (1970). Variability in the lambda light
chain sequences of mouse antibody. Nature 228, 1045-1047.
Weiner, G.J. (2010). Rituximab: mechanism of action. Semin Hematol 47, 115-123.
Weisel, F., and Shlomchik, M. (2017). Memory B Cells of Mice and Humans. Annu Rev Immunol
35, 255-284.
Weisel, F.J., Zuccarino-Catania, G.V., Chikina, M., and Shlomchik, M.J. (2016). A Temporal
Switch in the Germinal Center Determines Differential Output of Memory B and Plasma Cells.
Immunity 44, 116-130.
Weiss, R.A., and Esparza, J. (2015). The prevention and eradication of smallpox: a commentary
on Sloane (1755) 'An account of inoculation'. Philos Trans R Soc Lond B Biol Sci 370.

203

Weller, S., Faili, A., Garcia, C., Braun, M.C., Le Deist, F.F., de Saint Basile, G.G., Hermine, O.,
Fischer, A., Reynaud, C.A., and Weill, J.C. (2001). CD40-CD40L independent Ig gene
hypermutation suggests a second B cell diversification pathway in humans. Proceedings of the
National Academy of Sciences of the United States of America 98, 1166-1170.
Weller, S., Mamani-Matsuda, M., Picard, C., Cordier, C., Lecoeuche, D., Gauthier, F., Weill, J.C.,
and Reynaud, C.A. (2008). Somatic diversification in the absence of antigen-driven responses is
the hallmark of the IgM+ IgD+ CD27+ B cell repertoire in infants. The Journal of experimental
medicine 205, 1331-1342.
Wellmann, U., Letz, M., Herrmann, M., Angermuller, S., Kalden, J.R., and Winkler, T.H. (2005).
The evolution of human anti-double-stranded DNA autoantibodies. Proceedings of the National
Academy of Sciences of the United States of America 102, 9258-9263.
Werner, S.L., Kearns, J.D., Zadorozhnaya, V., Lynch, C., O'Dea, E., Boldin, M.P., Ma, A.,
Baltimore, D., and Hoffmann, A. (2008). Encoding NF-kappaB temporal control in response to
TNF: distinct roles for the negative regulators IkappaBalpha and A20. Genes Dev 22, 2093-2101.
Wesemann, D.R., Portuguese, A.J., Meyers, R.M., Gallagher, M.P., Cluff-Jones, K., Magee, J.M.,
Panchakshari, R.A., Rodig, S.J., Kepler, T.B., and Alt, F.W. (2013). Microbial colonization
influences early B-lineage development in the gut lamina propria. Nature 501, 112-115.
Whyte, W.A., Orlando, D.A., Hnisz, D., Abraham, B.J., Lin, C.Y., Kagey, M.H., Rahl, P.B., Lee,
T.I., and Young, R.A. (2013). Master transcription factors and mediator establish super-enhancers
at key cell identity genes. Cell 153, 307-319.
Wilson, A., Held, W., and MacDonald, H.R. (1994). Two waves of recombinase gene expression
in developing thymocytes. The Journal of experimental medicine 179, 1355-1360.

204

Wilson, A., MacDonald, H.R., and Radtke, F. (2001). Notch 1-deficient common lymphoid
precursors adopt a B cell fate in the thymus. The Journal of experimental medicine 194, 10031012.
Winkler, T.H., and Martensson, I.L. (2018). The Role of the Pre-B Cell Receptor in B Cell
Development, Repertoire Selection, and Tolerance. Front Immunol 9, 2423.
Wu, Y., El Shikh, M.E., El Sayed, R.M., Best, A.M., Szakal, A.K., and Tew, J.G. (2009). IL-6
produced by immune complex-activated follicular dendritic cells promotes germinal center
reactions, IgG responses and somatic hypermutation. Int Immunol 21, 745-756.
Xu, Z., Fulop, Z., Wu, G., Pone, E.J., Zhang, J., Mai, T., Thomas, L.M., Al-Qahtani, A., White,
C.A., Park, S.R., et al. (2010). 14-3-3 adaptor proteins recruit AID to 5'-AGCT-3'-rich switch
regions for class switch recombination. Nat Struct Mol Biol 17, 1124-1135.
Xu, Z., Pone, E.J., Al-Qahtani, A., Park, S.R., Zan, H., and Casali, P. (2007). Regulation of aicda
expression and AID activity: relevance to somatic hypermutation and class switch DNA
recombination. Crit Rev Immunol 27, 367-397.
Yamada, T., Yamaguchi, Y., Inukai, N., Okamoto, S., Mura, T., and Handa, H. (2006). P-TEFbmediated phosphorylation of hSpt5 C-terminal repeats is critical for processive transcription
elongation. Mol Cell 21, 227-237.
Yamaguchi, Y., Shibata, H., and Handa, H. (2013). Transcription elongation factors DSIF and
NELF: promoter-proximal pausing and beyond. Biochim Biophys Acta 1829, 98-104.
Yamano, T., Dobes, J., Voboril, M., Steinert, M., Brabec, T., Zietara, N., Dobesova, M., Ohnmacht,
C., Laan, M., Peterson, P., et al. (2019). Aire-expressing ILC3-like cells in the lymph node display
potent APC features. The Journal of experimental medicine 216, 1027-1037.

205

Yamano, T., Nedjic, J., Hinterberger, M., Steinert, M., Koser, S., Pinto, S., Gerdes, N., Lutgens,
E., Ishimaru, N., Busslinger, M., et al. (2015). Thymic B Cells Are Licensed to Present Self
Antigens for Central T Cell Tolerance Induction. Immunity 42, 1048-1061.
Yan, C.T., Boboila, C., Souza, E.K., Franco, S., Hickernell, T.R., Murphy, M., Gumaste, S., Geyer,
M., Zarrin, A.A., Manis, J.P., et al. (2007). IgH class switching and translocations use a robust
non-classical end-joining pathway. Nature 449, 478-482.
Yanagihara, T., Sanematsu, F., Sato, T., Uruno, T., Duan, X., Tomino, T., Harada, Y., Watanabe,
M., Wang, Y., Tanaka, Y., et al. (2015). Intronic regulation of Aire expression by Jmjd6 for selftolerance induction in the thymus. Nat Commun 6, 8820.
Yang, Z., Zhu, Q., Luo, K., and Zhou, Q. (2001). The 7SK small nuclear RNA inhibits the
CDK9/cyclin T1 kinase to control transcription. Nature 414, 317-322.
Ye, B.H., Cattoretti, G., Shen, Q., Zhang, J., Hawe, N., de Waard, R., Leung, C., Nouri-Shirazi,
M., Orazi, A., Chaganti, R.S., et al. (1997). The BCL-6 proto-oncogene controls germinal-centre
formation and Th2-type inflammation. Nat Genet 16, 161-170.
Yeh, C.H., Nojima, T., Kuraoka, M., and Kelsoe, G. (2018). Germinal center entry not selection
of B cells is controlled by peptide-MHCII complex density. Nat Commun 9, 928.
Yoshida, H., Bansal, K., Schaefer, U., Chapman, T., Rioja, I., Proekt, I., Anderson, M.S., Prinjha,
R.K., Tarakhovsky, A., Benoist, C., et al. (2015). Brd4 bridges the transcriptional regulators, Aire
and P-TEFb, to promote elongation of peripheral-tissue antigen transcripts in thymic stromal cells.
Proceedings of the National Academy of Sciences of the United States of America 112, E44484457.

206

Yoshino, T., Kondo, E., Cao, L., Takahashi, K., Hayashi, K., Nomura, S., and Akagi, T. (1994).
Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and
activated peripheral blood T and B lymphocytes. Blood 83, 1856-1861.
Yu, D., and Ye, L. (2018). A Portrait of CXCR5(+) Follicular Cytotoxic CD8(+) T cells. Trends
Immunol 39, 965-979.
Yurasov, S., Wardemann, H., Hammersen, J., Tsuiji, M., Meffre, E., Pascual, V., and Nussenzweig,
M.C. (2005). Defective B cell tolerance checkpoints in systemic lupus erythematosus. The Journal
of experimental medicine 201, 703-711.
Zan, H., and Casali, P. (2013). Regulation of Aicda expression and AID activity. Autoimmunity
46, 83-101.
Zanotti, K.J., and Gearhart, P.J. (2016). Antibody diversification caused by disrupted mismatch
repair and promiscuous DNA polymerases. DNA Repair (Amst) 38, 110-116.
Zaretsky, I., Atrakchi, O., Mazor, R.D., Stoler-Barak, L., Biram, A., Feigelson, S.W., Gitlin, A.D.,
Engelhardt, B., and Shulman, Z. (2017). ICAMs support B cell interactions with T follicular helper
cells and promote clonal selection. The Journal of experimental medicine 214, 3435-3448.
Zhang, P., Cox, C.J., Alvarez, K.M., and Cunningham, M.W. (2009). Cutting edge: cardiac myosin
activates innate immune responses through TLRs. J Immunol 183, 27-31.
Zhang, W., Du, Y., Su, Z., Wang, C., Zeng, X., Zhang, R., Hong, X., Nie, C., Wu, J., Cao, H., et
al. (2015). IMonitor: A Robust Pipeline for TCR and BCR Repertoire Analysis. Genetics 201,
459-472.
Zhang, X., Zhang, Y., Ba, Z., Kyritsis, N., Casellas, R., and Alt, F.W. (2019). Fundamental roles
of chromatin loop extrusion in antibody class switching. Nature 575, 385-389.

207

Zheng, S., Vuong, B.Q., Vaidyanathan, B., Lin, J.Y., Huang, F.T., and Chaudhuri, J. (2015). Noncoding RNA Generated following Lariat Debranching Mediates Targeting of AID to DNA. Cell
161, 762-773.
Zhou, R., Yazdi, A.S., Menu, P., and Tschopp, J. (2011). A role for mitochondria in NLRP3
inflammasome activation. Nature 469, 221-225.
Zlotoff, D.A., Sambandam, A., Logan, T.D., Bell, J.J., Schwarz, B.A., and Bhandoola, A. (2010).
CCR7 and CCR9 together recruit hematopoietic progenitors to the adult thymus. Blood 115, 18971905.
Zuccarino-Catania, G.V., Sadanand, S., Weisel, F.J., Tomayko, M.M., Meng, H., Kleinstein, S.H.,
Good-Jacobson, K.L., and Shlomchik, M.J. (2014). CD80 and PD-L2 define functionally distinct
memory B cell subsets that are independent of antibody isotype. Nat Immunol 15, 631-637.

208

ABSTRACT
GERMINAL CENTER B CELL EXPRESSION OF AIRE REGULATES ANTIBODY
DIVERSIFICATION AND AUTOIMMUNITY
by
JORDAN ZHENG ZHOU
December 2020
Advisor: Kang Chen
Major: Molecular Genetics and Genomics
Degree: Doctor of Philosophy
B cells are a unique subset of immune cells that, in response to antigen, diversify their
antibody repertoire to generate progressively higher affinity antibodies of different isotypes
through the processes of affinity maturation/somatic hypermutation (SHM) and class switch
recombination (CSR). One of the major sites in which this diversification occurs is in T cell
dependent microanatomical structures known as germinal centers (GC). Here, we find that GC B
cells express the protein, autoimmune regulator (Aire) in a CD40 dependent manner. In these cells,
Aire interacts with activation induced cytidine deaminase (AID), the protein responsible for
initiating the processes of diversification through the deamination of the immunoglobulin locus
and prevents AID function by inhibiting its targeting to the DNA substrate. Mice that receive Aire
deficient B cells are unable to clear the fungal pathogen Candida albicans as effectively as mice
with wild type B cell Aire and produce increased levels of autoreactive antibodies against Th17
cytokines. These results describe a novel mechanism for the regulation of antibody diversification
and potentially provide a new approach to generating high affinity antibodies for both therapeutic
and commercial applications.
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